id	sid	tid	token	lemma	pos
ajlm-1048	1	1	abstract	abstract	ADJ
ajlm-1048	1	2	introduction	introduction	NOUN
ajlm-1048	1	3	methods	method	NOUN
ajlm-1048	1	4	results	result	VERB
ajlm-1048	1	5	discussion	discussion	NOUN
ajlm-1048	1	6	acknowledgements	acknowledgement	NOUN
ajlm-1048	1	7	references	reference	NOUN
ajlm-1048	1	8	about	about	ADP
ajlm-1048	1	9	the	the	DET
ajlm-1048	1	10	author(s	author(s	NOUN
ajlm-1048	1	11	)	)	PUNCT
ajlm-1048	1	12	abdulazeez	abdulazeez	PROPN
ajlm-1048	1	13	a.	a.	PROPN
ajlm-1048	1	14	anjorin	anjorin	PROPN
ajlm-1048	1	15	department	department	PROPN
ajlm-1048	1	16	of	of	ADP
ajlm-1048	1	17	microbiology	microbiology	NOUN
ajlm-1048	1	18	,	,	PUNCT
ajlm-1048	1	19	faculty	faculty	NOUN
ajlm-1048	1	20	of	of	ADP
ajlm-1048	1	21	science	science	NOUN
ajlm-1048	1	22	,	,	PUNCT
ajlm-1048	1	23	lagos	lagos	NOUN
ajlm-1048	1	24	state	state	PROPN
ajlm-1048	1	25	university	university	PROPN
ajlm-1048	1	26	,	,	PUNCT
ajlm-1048	1	27	ojo	ojo	PROPN
ajlm-1048	1	28	,	,	PUNCT
ajlm-1048	1	29	nigeria	nigeria	PROPN
ajlm-1048	1	30	barakat	barakat	PROPN
ajlm-1048	1	31	a.	a.	PROPN
ajlm-1048	1	32	adepoju	adepoju	PROPN
ajlm-1048	1	33	department	department	PROPN
ajlm-1048	1	34	of	of	ADP
ajlm-1048	1	35	microbiology	microbiology	NOUN
ajlm-1048	1	36	,	,	PUNCT
ajlm-1048	1	37	faculty	faculty	NOUN
ajlm-1048	1	38	of	of	ADP
ajlm-1048	1	39	science	science	NOUN
ajlm-1048	1	40	,	,	PUNCT
ajlm-1048	1	41	lagos	lagos	NOUN
ajlm-1048	1	42	state	state	PROPN
ajlm-1048	1	43	university	university	PROPN
ajlm-1048	1	44	,	,	PUNCT
ajlm-1048	1	45	ojo	ojo	PROPN
ajlm-1048	1	46	,	,	PUNCT
ajlm-1048	1	47	nigeria	nigeria	PROPN
ajlm-1048	1	48	citation	citation	PROPN
ajlm-1048	1	49	anjorin	anjorin	PROPN
ajlm-1048	1	50	aa	aa	PROPN
ajlm-1048	1	51	,	,	PUNCT
ajlm-1048	1	52	adepoju	adepoju	PROPN
ajlm-1048	1	53	ab	ab	PROPN
ajlm-1048	1	54	.	.	PROPN
ajlm-1048	1	55	serologic	serologic	PROPN
ajlm-1048	1	56	evidence	evidence	NOUN
ajlm-1048	1	57	of	of	ADP
ajlm-1048	1	58	seasonal	seasonal	ADJ
ajlm-1048	1	59	influenza	influenza	NOUN
ajlm-1048	1	60	a	a	PRON
ajlm-1048	1	61	and	and	CCONJ
ajlm-1048	1	62	b	b	NOUN
ajlm-1048	1	63	in	in	ADP
ajlm-1048	1	64	hiv	hiv	PROPN
ajlm-1048	1	65	patients	patient	NOUN
ajlm-1048	1	66	on	on	ADP
ajlm-1048	1	67	combined	combine	VERB
ajlm-1048	1	68	antiretroviral	antiretroviral	ADJ
ajlm-1048	1	69	therapy	therapy	NOUN
ajlm-1048	1	70	in	in	ADP
ajlm-1048	1	71	lagos	lagos	PROPN
ajlm-1048	1	72	,	,	PUNCT
ajlm-1048	1	73	nigeria	nigeria	PROPN
ajlm-1048	1	74	.	.	PUNCT
ajlm-1048	2	1	afr	afr	PROPN
ajlm-1048	2	2	j	j	PROPN
ajlm-1048	2	3	lab	lab	PROPN
ajlm-1048	2	4	med	me	VERB
ajlm-1048	2	5	.	.	PUNCT
ajlm-1048	2	6	2020;9(1	2020;9(1	NUM
ajlm-1048	2	7	)	)	PUNCT
ajlm-1048	2	8	,	,	PUNCT
ajlm-1048	2	9	a1048	a1048	ADJ
ajlm-1048	2	10	.	.	PUNCT
ajlm-1048	3	1	https://doi.org/10.4102/ajlm.v9i1.1048	https://doi.org/10.4102/ajlm.v9i1.1048	ADJ
ajlm-1048	3	2	original	original	ADJ
ajlm-1048	3	3	research	research	NOUN
ajlm-1048	3	4	serologic	serologic	NOUN
ajlm-1048	3	5	evidence	evidence	NOUN
ajlm-1048	3	6	of	of	ADP
ajlm-1048	3	7	seasonal	seasonal	ADJ
ajlm-1048	3	8	influenza	influenza	NOUN
ajlm-1048	3	9	a	a	PRON
ajlm-1048	3	10	and	and	CCONJ
ajlm-1048	3	11	b	b	NOUN
ajlm-1048	3	12	in	in	ADP
ajlm-1048	3	13	hiv	hiv	PROPN
ajlm-1048	3	14	patients	patient	NOUN
ajlm-1048	3	15	on	on	ADP
ajlm-1048	3	16	combined	combine	VERB
ajlm-1048	3	17	antiretroviral	antiretroviral	ADJ
ajlm-1048	3	18	therapy	therapy	NOUN
ajlm-1048	3	19	in	in	ADP
ajlm-1048	3	20	lagos	lagos	PROPN
ajlm-1048	3	21	,	,	PUNCT
ajlm-1048	3	22	nigeria	nigeria	PROPN
ajlm-1048	3	23	abdulazeez	abdulazeez	PROPN
ajlm-1048	3	24	a.	a.	PROPN
ajlm-1048	3	25	anjorin	anjorin	PROPN
ajlm-1048	3	26	,	,	PUNCT
ajlm-1048	3	27	barakat	barakat	PROPN
ajlm-1048	3	28	a.	a.	PROPN
ajlm-1048	3	29	adepoju	adepoju	PROPN
ajlm-1048	3	30	received	receive	VERB
ajlm-1048	3	31	:	:	PUNCT
ajlm-1048	3	32	22	22	NUM
ajlm-1048	3	33	may	may	PROPN
ajlm-1048	3	34	2019	2019	NUM
ajlm-1048	3	35	;	;	PUNCT
ajlm-1048	3	36	accepted	accept	VERB
ajlm-1048	3	37	:	:	PUNCT
ajlm-1048	3	38	01	01	NUM
ajlm-1048	3	39	oct	oct	PROPN
ajlm-1048	3	40	.	.	PROPN
ajlm-1048	3	41	2020	2020	NUM
ajlm-1048	3	42	;	;	PUNCT
ajlm-1048	3	43	published	publish	VERB
ajlm-1048	3	44	:	:	PUNCT
ajlm-1048	3	45	21	21	NUM
ajlm-1048	3	46	dec	dec	PROPN
ajlm-1048	3	47	.	.	PROPN
ajlm-1048	3	48	2020	2020	NUM
ajlm-1048	4	1	copyright	copyright	NOUN
ajlm-1048	4	2	:	:	PUNCT
ajlm-1048	4	3	©	©	PROPN
ajlm-1048	4	4	2020	2020	NUM
ajlm-1048	4	5	.	.	PUNCT
ajlm-1048	5	1	the	the	DET
ajlm-1048	5	2	author(s	author(s	PROPN
ajlm-1048	5	3	)	)	PUNCT
ajlm-1048	5	4	.	.	PUNCT
ajlm-1048	6	1	licensee	licensee	NOUN
ajlm-1048	6	2	:	:	PUNCT
ajlm-1048	6	3	aosis	aosis	NOUN
ajlm-1048	6	4	.	.	PUNCT
ajlm-1048	7	1	this	this	PRON
ajlm-1048	7	2	is	be	AUX
ajlm-1048	7	3	an	an	DET
ajlm-1048	7	4	open	open	ADJ
ajlm-1048	7	5	access	access	NOUN
ajlm-1048	7	6	article	article	NOUN
ajlm-1048	7	7	distributed	distribute	VERB
ajlm-1048	7	8	under	under	ADP
ajlm-1048	7	9	the	the	DET
ajlm-1048	7	10	terms	term	NOUN
ajlm-1048	7	11	of	of	ADP
ajlm-1048	7	12	the	the	DET
ajlm-1048	7	13	creative	creative	ADJ
ajlm-1048	7	14	commons	common	NOUN
ajlm-1048	7	15	attribution	attribution	NOUN
ajlm-1048	7	16	license	license	NOUN
ajlm-1048	7	17	,	,	PUNCT
ajlm-1048	7	18	which	which	PRON
ajlm-1048	7	19	permits	permit	VERB
ajlm-1048	7	20	unrestricted	unrestricted	ADJ
ajlm-1048	7	21	use	use	NOUN
ajlm-1048	7	22	,	,	PUNCT
ajlm-1048	7	23	distribution	distribution	NOUN
ajlm-1048	7	24	,	,	PUNCT
ajlm-1048	7	25	and	and	CCONJ
ajlm-1048	7	26	reproduction	reproduction	NOUN
ajlm-1048	7	27	in	in	ADP
ajlm-1048	7	28	any	any	DET
ajlm-1048	7	29	medium	medium	NOUN
ajlm-1048	7	30	,	,	PUNCT
ajlm-1048	7	31	provided	provide	VERB
ajlm-1048	7	32	the	the	DET
ajlm-1048	7	33	original	original	ADJ
ajlm-1048	7	34	work	work	NOUN
ajlm-1048	7	35	is	be	AUX
ajlm-1048	7	36	properly	properly	ADV
ajlm-1048	7	37	cited	cite	VERB
ajlm-1048	7	38	.	.	PUNCT
ajlm-1048	8	1	abstract	abstract	ADJ
ajlm-1048	8	2	background	background	NOUN
ajlm-1048	8	3	:	:	PUNCT
ajlm-1048	8	4	influenza	influenza	NOUN
ajlm-1048	8	5	and	and	CCONJ
ajlm-1048	8	6	hiv	hiv	PROPN
ajlm-1048	8	7	are	be	AUX
ajlm-1048	8	8	endemic	endemic	ADJ
ajlm-1048	8	9	in	in	ADP
ajlm-1048	8	10	nigeria	nigeria	PROPN
ajlm-1048	8	11	but	but	CCONJ
ajlm-1048	8	12	there	there	PRON
ajlm-1048	8	13	is	be	VERB
ajlm-1048	8	14	no	no	DET
ajlm-1048	8	15	epidemiological	epidemiological	ADJ
ajlm-1048	8	16	data	datum	NOUN
ajlm-1048	8	17	on	on	ADP
ajlm-1048	8	18	the	the	DET
ajlm-1048	8	19	co	co	NOUN
ajlm-1048	8	20	-	-	NOUN
ajlm-1048	8	21	infection	infection	NOUN
ajlm-1048	8	22	of	of	ADP
ajlm-1048	8	23	influenza	influenza	NOUN
ajlm-1048	8	24	a	a	PRON
ajlm-1048	8	25	and	and	CCONJ
ajlm-1048	8	26	b	b	NOUN
ajlm-1048	8	27	among	among	ADP
ajlm-1048	8	28	hiv	hiv	PROPN
ajlm-1048	8	29	patients	patient	NOUN
ajlm-1048	8	30	.	.	PUNCT
ajlm-1048	9	1	objective	objective	NOUN
ajlm-1048	9	2	:	:	PUNCT
ajlm-1048	9	3	we	we	PRON
ajlm-1048	9	4	investigated	investigate	VERB
ajlm-1048	9	5	seasonal	seasonal	ADJ
ajlm-1048	9	6	influenza	influenza	NOUN
ajlm-1048	9	7	a	a	PRON
ajlm-1048	9	8	and	and	CCONJ
ajlm-1048	9	9	b	b	NOUN
ajlm-1048	9	10	,	,	PUNCT
ajlm-1048	9	11	and	and	CCONJ
ajlm-1048	9	12	co	co	NOUN
ajlm-1048	9	13	-	-	NOUN
ajlm-1048	9	14	infection	infection	NOUN
ajlm-1048	9	15	among	among	ADP
ajlm-1048	9	16	hiv	hiv	PROPN
ajlm-1048	9	17	patients	patient	NOUN
ajlm-1048	9	18	on	on	ADP
ajlm-1048	9	19	combined	combine	VERB
ajlm-1048	9	20	antiretroviral	antiretroviral	ADJ
ajlm-1048	9	21	therapy	therapy	NOUN
ajlm-1048	9	22	(	(	PUNCT
ajlm-1048	9	23	cart	cart	NOUN
ajlm-1048	9	24	)	)	PUNCT
ajlm-1048	9	25	in	in	ADP
ajlm-1048	9	26	lagos	lagos	PROPN
ajlm-1048	9	27	,	,	PUNCT
ajlm-1048	9	28	nigeria	nigeria	PROPN
ajlm-1048	9	29	.	.	PUNCT
ajlm-1048	10	1	methods	method	NOUN
ajlm-1048	10	2	:	:	PUNCT
ajlm-1048	10	3	in	in	ADP
ajlm-1048	10	4	a	a	DET
ajlm-1048	10	5	prospective	prospective	ADJ
ajlm-1048	10	6	cross	cross	ADJ
ajlm-1048	10	7	-	-	ADJ
ajlm-1048	10	8	sectional	sectional	ADJ
ajlm-1048	10	9	study	study	NOUN
ajlm-1048	10	10	,	,	PUNCT
ajlm-1048	10	11	clear	clear	ADJ
ajlm-1048	10	12	sera	sera	NOUN
ajlm-1048	10	13	collected	collect	VERB
ajlm-1048	10	14	from	from	ADP
ajlm-1048	10	15	174	174	NUM
ajlm-1048	10	16	hiv	hiv	PROPN
ajlm-1048	10	17	-	-	PUNCT
ajlm-1048	10	18	positive	positive	ADJ
ajlm-1048	10	19	patients	patient	NOUN
ajlm-1048	10	20	between	between	ADP
ajlm-1048	10	21	august	august	PROPN
ajlm-1048	10	22	and	and	CCONJ
ajlm-1048	10	23	september	september	PROPN
ajlm-1048	10	24	2018	2018	NUM
ajlm-1048	10	25	were	be	AUX
ajlm-1048	10	26	analysed	analyse	VERB
ajlm-1048	10	27	for	for	ADP
ajlm-1048	10	28	immunoglobulin	immunoglobulin	NOUN
ajlm-1048	10	29	m	m	PROPN
ajlm-1048	10	30	-	-	ADJ
ajlm-1048	10	31	specific	specific	ADJ
ajlm-1048	10	32	antibodies	antibody	NOUN
ajlm-1048	10	33	to	to	PART
ajlm-1048	10	34	seasonal	seasonal	ADJ
ajlm-1048	10	35	influenza	influenza	NOUN
ajlm-1048	10	36	a	a	DET
ajlm-1048	10	37	subtypes	subtype	NOUN
ajlm-1048	10	38	h1n1	h1n1	NOUN
ajlm-1048	10	39	and	and	CCONJ
ajlm-1048	10	40	h3n2	h3n2	NOUN
ajlm-1048	10	41	,	,	PUNCT
ajlm-1048	10	42	and	and	CCONJ
ajlm-1048	10	43	influenza	influenza	NOUN
ajlm-1048	10	44	b	b	NOUN
ajlm-1048	10	45	by	by	ADP
ajlm-1048	10	46	enzyme	enzyme	NOUN
ajlm-1048	10	47	immunoassay	immunoassay	NOUN
ajlm-1048	10	48	.	.	PUNCT
ajlm-1048	11	1	results	result	NOUN
ajlm-1048	11	2	:	:	PUNCT
ajlm-1048	11	3	a	a	DET
ajlm-1048	11	4	total	total	NOUN
ajlm-1048	11	5	of	of	ADP
ajlm-1048	11	6	39.7	39.7	NUM
ajlm-1048	11	7	%	%	NOUN
ajlm-1048	11	8	(	(	PUNCT
ajlm-1048	11	9	69/174	69/174	NOUN
ajlm-1048	11	10	)	)	PUNCT
ajlm-1048	11	11	of	of	ADP
ajlm-1048	11	12	hiv	hiv	PROPN
ajlm-1048	11	13	patients	patient	NOUN
ajlm-1048	11	14	were	be	AUX
ajlm-1048	11	15	seropositive	seropositive	ADJ
ajlm-1048	11	16	for	for	ADP
ajlm-1048	11	17	influenza	influenza	NOUN
ajlm-1048	11	18	a	a	DET
ajlm-1048	11	19	or	or	CCONJ
ajlm-1048	11	20	b	b	NOUN
ajlm-1048	11	21	viruses	virus	NOUN
ajlm-1048	11	22	with	with	ADP
ajlm-1048	11	23	84.1	84.1	NUM
ajlm-1048	11	24	%	%	NOUN
ajlm-1048	11	25	(	(	PUNCT
ajlm-1048	11	26	58/69	58/69	NUM
ajlm-1048	11	27	)	)	PUNCT
ajlm-1048	11	28	being	be	AUX
ajlm-1048	11	29	positive	positive	ADJ
ajlm-1048	11	30	for	for	ADP
ajlm-1048	11	31	influenza	influenza	NOUN
ajlm-1048	11	32	a	a	PRON
ajlm-1048	11	33	,	,	PUNCT
ajlm-1048	11	34	13.04	13.04	NUM
ajlm-1048	11	35	%	%	NOUN
ajlm-1048	11	36	(	(	PUNCT
ajlm-1048	11	37	9/69	9/69	NUM
ajlm-1048	11	38	)	)	PUNCT
ajlm-1048	11	39	seropositive	seropositive	ADJ
ajlm-1048	11	40	for	for	ADP
ajlm-1048	11	41	both	both	DET
ajlm-1048	11	42	influenza	influenza	NOUN
ajlm-1048	11	43	a	a	PRON
ajlm-1048	11	44	and	and	CCONJ
ajlm-1048	11	45	b	b	NOUN
ajlm-1048	11	46	,	,	PUNCT
ajlm-1048	11	47	and	and	CCONJ
ajlm-1048	11	48	only	only	ADV
ajlm-1048	11	49	2.9	2.9	NUM
ajlm-1048	11	50	%	%	NOUN
ajlm-1048	11	51	(	(	PUNCT
ajlm-1048	11	52	2/69	2/69	NUM
ajlm-1048	11	53	)	)	PUNCT
ajlm-1048	11	54	positive	positive	ADJ
ajlm-1048	11	55	for	for	ADP
ajlm-1048	11	56	influenza	influenza	NOUN
ajlm-1048	11	57	b	b	NOUN
ajlm-1048	11	58	mono	mono	NOUN
ajlm-1048	11	59	-	-	PUNCT
ajlm-1048	11	60	infection	infection	NOUN
ajlm-1048	11	61	.	.	PUNCT
ajlm-1048	12	1	median	median	ADJ
ajlm-1048	12	2	age	age	NOUN
ajlm-1048	12	3	was	be	AUX
ajlm-1048	12	4	44	44	NUM
ajlm-1048	12	5	(	(	PUNCT
ajlm-1048	12	6	mean	mean	PROPN
ajlm-1048	12	7	45	45	NUM
ajlm-1048	12	8	,	,	PUNCT
ajlm-1048	12	9	mode	mode	NOUN
ajlm-1048	12	10	40	40	NUM
ajlm-1048	12	11	,	,	PUNCT
ajlm-1048	12	12	range	range	NOUN
ajlm-1048	12	13	18–74	18–74	NUM
ajlm-1048	12	14	)	)	PUNCT
ajlm-1048	12	15	years	year	NOUN
ajlm-1048	12	16	.	.	PUNCT
ajlm-1048	13	1	the	the	DET
ajlm-1048	13	2	41–50	41–50	NUM
ajlm-1048	13	3	years	year	NOUN
ajlm-1048	13	4	age	age	NOUN
ajlm-1048	13	5	group	group	NOUN
ajlm-1048	13	6	had	have	VERB
ajlm-1048	13	7	the	the	DET
ajlm-1048	13	8	highest	high	ADJ
ajlm-1048	13	9	seroprevalence	seroprevalence	NOUN
ajlm-1048	13	10	(	(	PUNCT
ajlm-1048	13	11	39.1	39.1	NUM
ajlm-1048	13	12	%	%	NOUN
ajlm-1048	13	13	;	;	PUNCT
ajlm-1048	13	14	27/69	27/69	NUM
ajlm-1048	13	15	)	)	PUNCT
ajlm-1048	13	16	.	.	PUNCT
ajlm-1048	14	1	seropositivity	seropositivity	PROPN
ajlm-1048	14	2	was	be	AUX
ajlm-1048	14	3	highest	high	ADJ
ajlm-1048	14	4	among	among	ADP
ajlm-1048	14	5	women	woman	NOUN
ajlm-1048	14	6	(	(	PUNCT
ajlm-1048	14	7	65.2	65.2	NUM
ajlm-1048	14	8	%	%	NOUN
ajlm-1048	14	9	;	;	PUNCT
ajlm-1048	14	10	45/69	45/69	NUM
ajlm-1048	14	11	)	)	PUNCT
ajlm-1048	14	12	.	.	PUNCT
ajlm-1048	15	1	a	a	DET
ajlm-1048	15	2	total	total	NOUN
ajlm-1048	15	3	of	of	ADP
ajlm-1048	15	4	88.4	88.4	NUM
ajlm-1048	15	5	%	%	NOUN
ajlm-1048	15	6	(	(	PUNCT
ajlm-1048	15	7	61/69	61/69	NOUN
ajlm-1048	15	8	)	)	PUNCT
ajlm-1048	15	9	of	of	ADP
ajlm-1048	15	10	hiv	hiv	PROPN
ajlm-1048	15	11	patients	patient	NOUN
ajlm-1048	15	12	seropositive	seropositive	ADJ
ajlm-1048	15	13	for	for	ADP
ajlm-1048	15	14	influenza	influenza	NOUN
ajlm-1048	15	15	a	a	PRON
ajlm-1048	15	16	or	or	CCONJ
ajlm-1048	15	17	b	b	NOUN
ajlm-1048	15	18	were	be	AUX
ajlm-1048	15	19	on	on	ADP
ajlm-1048	15	20	fixed	fix	VERB
ajlm-1048	15	21	dose	dose	NOUN
ajlm-1048	15	22	cart	cart	NOUN
ajlm-1048	15	23	,	,	PUNCT
ajlm-1048	15	24	while	while	SCONJ
ajlm-1048	15	25	73.9	73.9	NUM
ajlm-1048	15	26	%	%	NOUN
ajlm-1048	15	27	(	(	PUNCT
ajlm-1048	15	28	51/69	51/69	NOUN
ajlm-1048	15	29	)	)	PUNCT
ajlm-1048	15	30	were	be	AUX
ajlm-1048	15	31	virologically	virologically	ADV
ajlm-1048	15	32	suppressed	suppress	VERB
ajlm-1048	15	33	.	.	PUNCT
ajlm-1048	16	1	furthermore	furthermore	ADV
ajlm-1048	16	2	,	,	PUNCT
ajlm-1048	16	3	27.5	27.5	NUM
ajlm-1048	16	4	%	%	NOUN
ajlm-1048	16	5	(	(	PUNCT
ajlm-1048	16	6	19/69	19/69	NUM
ajlm-1048	16	7	)	)	PUNCT
ajlm-1048	16	8	were	be	AUX
ajlm-1048	16	9	immunocompromised	immunocompromise	VERB
ajlm-1048	16	10	,	,	PUNCT
ajlm-1048	16	11	of	of	ADP
ajlm-1048	16	12	which	which	PRON
ajlm-1048	16	13	21.1	21.1	NUM
ajlm-1048	16	14	%	%	NOUN
ajlm-1048	16	15	(	(	PUNCT
ajlm-1048	16	16	4/19	4/19	NUM
ajlm-1048	16	17	)	)	PUNCT
ajlm-1048	16	18	were	be	AUX
ajlm-1048	16	19	severely	severely	ADV
ajlm-1048	16	20	immunosuppressed	immunosuppresse	VERB
ajlm-1048	16	21	(	(	PUNCT
ajlm-1048	16	22	cluster	cluster	NOUN
ajlm-1048	16	23	of	of	ADP
ajlm-1048	16	24	differentiation	differentiation	NOUN
ajlm-1048	16	25	4	4	NUM
ajlm-1048	16	26	<	<	SYM
ajlm-1048	16	27	200	200	NUM
ajlm-1048	16	28	cells	cell	NOUN
ajlm-1048	16	29	/	/	SYM
ajlm-1048	16	30	mm>3	mm>3	NOUN
ajlm-1048	16	31	)	)	PUNCT
ajlm-1048	16	32	.	.	PUNCT
ajlm-1048	17	1	conclusion	conclusion	NOUN
ajlm-1048	17	2	:	:	PUNCT
ajlm-1048	17	3	influenza	influenza	NOUN
ajlm-1048	17	4	a	a	PRON
ajlm-1048	17	5	and	and	CCONJ
ajlm-1048	17	6	b	b	NOUN
ajlm-1048	17	7	was	be	AUX
ajlm-1048	17	8	prevalent	prevalent	ADJ
ajlm-1048	17	9	among	among	ADP
ajlm-1048	17	10	hiv	hiv	PROPN
ajlm-1048	17	11	patients	patient	NOUN
ajlm-1048	17	12	on	on	ADP
ajlm-1048	17	13	cart	cart	NOUN
ajlm-1048	17	14	,	,	PUNCT
ajlm-1048	17	15	which	which	PRON
ajlm-1048	17	16	may	may	AUX
ajlm-1048	17	17	predispose	predispose	VERB
ajlm-1048	17	18	them	they	PRON
ajlm-1048	17	19	to	to	ADP
ajlm-1048	17	20	life	life	NOUN
ajlm-1048	17	21	-	-	PUNCT
ajlm-1048	17	22	threatening	threaten	VERB
ajlm-1048	17	23	complications	complication	NOUN
ajlm-1048	17	24	.	.	PUNCT
ajlm-1048	18	1	we	we	PRON
ajlm-1048	18	2	recommend	recommend	VERB
ajlm-1048	18	3	strong	strong	ADJ
ajlm-1048	18	4	advocacy	advocacy	NOUN
ajlm-1048	18	5	on	on	ADP
ajlm-1048	18	6	the	the	DET
ajlm-1048	18	7	need	need	NOUN
ajlm-1048	18	8	to	to	PART
ajlm-1048	18	9	reduce	reduce	VERB
ajlm-1048	18	10	the	the	DET
ajlm-1048	18	11	risk	risk	NOUN
ajlm-1048	18	12	of	of	ADP
ajlm-1048	18	13	exposure	exposure	NOUN
ajlm-1048	18	14	to	to	ADP
ajlm-1048	18	15	influenza	influenza	NOUN
ajlm-1048	18	16	and	and	CCONJ
ajlm-1048	18	17	for	for	ADP
ajlm-1048	18	18	the	the	DET
ajlm-1048	18	19	provision	provision	NOUN
ajlm-1048	18	20	of	of	ADP
ajlm-1048	18	21	an	an	DET
ajlm-1048	18	22	influenza	influenza	NOUN
ajlm-1048	18	23	vaccine	vaccine	NOUN
ajlm-1048	18	24	in	in	ADP
ajlm-1048	18	25	nigeria	nigeria	PROPN
ajlm-1048	18	26	.	.	PUNCT
ajlm-1048	19	1	keywords	keyword	NOUN
ajlm-1048	19	2	:	:	PUNCT
ajlm-1048	19	3	influenza	influenza	NOUN
ajlm-1048	19	4	a	a	X
ajlm-1048	19	5	;	;	PUNCT
ajlm-1048	19	6	influenza	influenza	NOUN
ajlm-1048	19	7	b	b	NOUN
ajlm-1048	19	8	;	;	PUNCT
ajlm-1048	19	9	hiv	hiv	PROPN
ajlm-1048	19	10	co	co	NOUN
ajlm-1048	19	11	-	-	NOUN
ajlm-1048	19	12	infection	infection	NOUN
ajlm-1048	19	13	;	;	PUNCT
ajlm-1048	19	14	seroprevalence	seroprevalence	NOUN
ajlm-1048	19	15	;	;	PUNCT
ajlm-1048	19	16	lagos	lago	NOUN
ajlm-1048	19	17	.	.	PUNCT
ajlm-1048	20	1	introduction	introduction	NOUN
ajlm-1048	20	2	in	in	ADP
ajlm-1048	20	3	humans	human	NOUN
ajlm-1048	20	4	,	,	PUNCT
ajlm-1048	20	5	seasonal	seasonal	ADJ
ajlm-1048	20	6	influenza	influenza	NOUN
ajlm-1048	20	7	viruses	virus	NOUN
ajlm-1048	20	8	cause	cause	VERB
ajlm-1048	20	9	an	an	DET
ajlm-1048	20	10	annual	annual	ADJ
ajlm-1048	20	11	3–5	3–5	NUM
ajlm-1048	20	12	million	million	NUM
ajlm-1048	20	13	illnesses	illness	NOUN
ajlm-1048	20	14	and	and	CCONJ
ajlm-1048	20	15	290	290	NUM
ajlm-1048	20	16	000–650	000–650	NUM
ajlm-1048	20	17	000	000	NUM
ajlm-1048	20	18	deaths	death	NOUN
ajlm-1048	20	19	worldwide.1	worldwide.1	ADP
ajlm-1048	20	20	the	the	DET
ajlm-1048	20	21	majority	majority	NOUN
ajlm-1048	20	22	of	of	ADP
ajlm-1048	20	23	the	the	DET
ajlm-1048	20	24	deaths	death	NOUN
ajlm-1048	20	25	and	and	CCONJ
ajlm-1048	20	26	severe	severe	ADJ
ajlm-1048	20	27	illness	illness	NOUN
ajlm-1048	20	28	occur	occur	VERB
ajlm-1048	20	29	in	in	ADP
ajlm-1048	20	30	lowand	lowand	ADJ
ajlm-1048	20	31	middle	middle	ADJ
ajlm-1048	20	32	-	-	PUNCT
ajlm-1048	20	33	income	income	NOUN
ajlm-1048	20	34	countries2	countries2	NOUN
ajlm-1048	20	35	especially	especially	ADV
ajlm-1048	20	36	in	in	ADP
ajlm-1048	20	37	africa	africa	PROPN
ajlm-1048	20	38	where	where	SCONJ
ajlm-1048	20	39	there	there	PRON
ajlm-1048	20	40	is	be	VERB
ajlm-1048	20	41	little	little	ADJ
ajlm-1048	20	42	or	or	CCONJ
ajlm-1048	20	43	scanty	scanty	ADJ
ajlm-1048	20	44	information	information	NOUN
ajlm-1048	20	45	on	on	ADP
ajlm-1048	20	46	epidemiological	epidemiological	ADJ
ajlm-1048	20	47	surveillance	surveillance	NOUN
ajlm-1048	20	48	.	.	PUNCT
ajlm-1048	21	1	influenza	influenza	NOUN
ajlm-1048	21	2	virus	virus	NOUN
ajlm-1048	21	3	infection	infection	NOUN
ajlm-1048	21	4	can	can	AUX
ajlm-1048	21	5	be	be	AUX
ajlm-1048	21	6	self	self	NOUN
ajlm-1048	21	7	-	-	PUNCT
ajlm-1048	21	8	limiting	limit	VERB
ajlm-1048	21	9	and	and	CCONJ
ajlm-1048	21	10	could	could	AUX
ajlm-1048	21	11	vary	vary	VERB
ajlm-1048	21	12	in	in	ADP
ajlm-1048	21	13	severity	severity	NOUN
ajlm-1048	21	14	from	from	ADP
ajlm-1048	21	15	asymptomatic	asymptomatic	ADJ
ajlm-1048	21	16	to	to	ADP
ajlm-1048	21	17	fatal	fatal	ADJ
ajlm-1048	21	18	disease	disease	NOUN
ajlm-1048	21	19	arising	arise	VERB
ajlm-1048	21	20	from	from	ADP
ajlm-1048	21	21	medical	medical	ADJ
ajlm-1048	21	22	complications	complication	NOUN
ajlm-1048	21	23	.	.	PUNCT
ajlm-1048	22	1	these	these	DET
ajlm-1048	22	2	complications	complication	NOUN
ajlm-1048	22	3	include	include	VERB
ajlm-1048	22	4	pneumonia	pneumonia	NOUN
ajlm-1048	22	5	,	,	PUNCT
ajlm-1048	22	6	meningitis	meningitis	NOUN
ajlm-1048	22	7	and	and	CCONJ
ajlm-1048	22	8	worsening	worsen	VERB
ajlm-1048	22	9	of	of	ADP
ajlm-1048	22	10	underlying	underlie	VERB
ajlm-1048	22	11	medical	medical	ADJ
ajlm-1048	22	12	conditions	condition	NOUN
ajlm-1048	22	13	,	,	PUNCT
ajlm-1048	22	14	mostly	mostly	ADV
ajlm-1048	22	15	in	in	ADP
ajlm-1048	22	16	immunocompromised	immunocompromise	VERB
ajlm-1048	22	17	individuals.1	individuals.1	NOUN
ajlm-1048	22	18	on	on	ADP
ajlm-1048	22	19	the	the	DET
ajlm-1048	22	20	other	other	ADJ
ajlm-1048	22	21	hand	hand	NOUN
ajlm-1048	22	22	,	,	PUNCT
ajlm-1048	22	23	hiv	hiv	PROPN
ajlm-1048	22	24	is	be	AUX
ajlm-1048	22	25	a	a	DET
ajlm-1048	22	26	retrovirus	retrovirus	NOUN
ajlm-1048	22	27	that	that	PRON
ajlm-1048	22	28	spreads	spread	VERB
ajlm-1048	22	29	through	through	ADP
ajlm-1048	22	30	the	the	DET
ajlm-1048	22	31	body	body	NOUN
ajlm-1048	22	32	rapidly	rapidly	ADV
ajlm-1048	22	33	,	,	PUNCT
ajlm-1048	22	34	causing	cause	VERB
ajlm-1048	22	35	damage	damage	NOUN
ajlm-1048	22	36	to	to	ADP
ajlm-1048	22	37	the	the	DET
ajlm-1048	22	38	immune	immune	ADJ
ajlm-1048	22	39	system	system	NOUN
ajlm-1048	22	40	by	by	ADP
ajlm-1048	22	41	attacking	attack	VERB
ajlm-1048	22	42	host	host	NOUN
ajlm-1048	22	43	cluster	cluster	NOUN
ajlm-1048	22	44	of	of	ADP
ajlm-1048	22	45	differentiation	differentiation	NOUN
ajlm-1048	22	46	4	4	NUM
ajlm-1048	22	47	(	(	PUNCT
ajlm-1048	22	48	cd4	cd4	PROPN
ajlm-1048	22	49	)	)	PUNCT
ajlm-1048	22	50	cells	cell	NOUN
ajlm-1048	22	51	with	with	ADP
ajlm-1048	22	52	resultant	resultant	NOUN
ajlm-1048	22	53	aids.3	aids.3	PROPN
ajlm-1048	22	54	in	in	ADP
ajlm-1048	22	55	2017	2017	NUM
ajlm-1048	22	56	,	,	PUNCT
ajlm-1048	22	57	hiv	hiv	PROPN
ajlm-1048	22	58	-	-	PUNCT
ajlm-1048	22	59	related	relate	VERB
ajlm-1048	22	60	causes	cause	NOUN
ajlm-1048	22	61	killed	kill	VERB
ajlm-1048	22	62	about	about	ADV
ajlm-1048	22	63	1	1	NUM
ajlm-1048	22	64	million	million	NUM
ajlm-1048	22	65	people	people	NOUN
ajlm-1048	22	66	worldwide	worldwide	ADV
ajlm-1048	22	67	,	,	PUNCT
ajlm-1048	22	68	having	having	AUX
ajlm-1048	22	69	claimed	claim	VERB
ajlm-1048	22	70	over	over	ADP
ajlm-1048	22	71	35	35	NUM
ajlm-1048	22	72	million	million	NUM
ajlm-1048	22	73	lives	life	NOUN
ajlm-1048	22	74	in	in	ADP
ajlm-1048	22	75	the	the	DET
ajlm-1048	22	76	last	last	ADJ
ajlm-1048	22	77	three	three	NUM
ajlm-1048	22	78	decades.4	decades.4	NOUN
ajlm-1048	22	79	according	accord	VERB
ajlm-1048	22	80	to	to	ADP
ajlm-1048	22	81	the	the	DET
ajlm-1048	22	82	world	world	NOUN
ajlm-1048	22	83	health	health	NOUN
ajlm-1048	22	84	organization,4	organization,4	NOUN
ajlm-1048	22	85	as	as	ADP
ajlm-1048	22	86	of	of	ADP
ajlm-1048	22	87	2018	2018	NUM
ajlm-1048	22	88	,	,	PUNCT
ajlm-1048	22	89	1.8	1.8	NUM
ajlm-1048	22	90	million	million	NUM
ajlm-1048	22	91	newly	newly	ADV
ajlm-1048	22	92	infected	infect	VERB
ajlm-1048	22	93	individuals	individual	NOUN
ajlm-1048	22	94	were	be	AUX
ajlm-1048	22	95	added	add	VERB
ajlm-1048	22	96	to	to	ADP
ajlm-1048	22	97	the	the	DET
ajlm-1048	22	98	36.9	36.9	NUM
ajlm-1048	22	99	million	million	NUM
ajlm-1048	22	100	people	people	NOUN
ajlm-1048	22	101	living	live	VERB
ajlm-1048	22	102	with	with	ADP
ajlm-1048	22	103	hiv	hiv	PROPN
ajlm-1048	22	104	,	,	PUNCT
ajlm-1048	22	105	with	with	ADP
ajlm-1048	22	106	25.7	25.7	NUM
ajlm-1048	22	107	million	million	NUM
ajlm-1048	22	108	(	(	PUNCT
ajlm-1048	22	109	>	>	X
ajlm-1048	22	110	66	66	NUM
ajlm-1048	22	111	%	%	NOUN
ajlm-1048	22	112	)	)	PUNCT
ajlm-1048	22	113	infected	infect	VERB
ajlm-1048	22	114	people	people	NOUN
ajlm-1048	22	115	living	live	VERB
ajlm-1048	22	116	in	in	ADP
ajlm-1048	22	117	the	the	DET
ajlm-1048	22	118	sub	sub	ADJ
ajlm-1048	22	119	-	-	ADJ
ajlm-1048	22	120	saharan	saharan	ADJ
ajlm-1048	22	121	africa	africa	PROPN
ajlm-1048	23	1	region.4,5	region.4,5	NOUN
ajlm-1048	23	2	there	there	PRON
ajlm-1048	23	3	are	be	VERB
ajlm-1048	23	4	about	about	ADV
ajlm-1048	23	5	197	197	NUM
ajlm-1048	23	6	997	997	NUM
ajlm-1048	23	7	230	230	NUM
ajlm-1048	23	8	people	people	NOUN
ajlm-1048	23	9	living	live	VERB
ajlm-1048	23	10	in	in	ADP
ajlm-1048	23	11	nigeria	nigeria	PROPN
ajlm-1048	23	12	,	,	PUNCT
ajlm-1048	23	13	equivalent	equivalent	ADJ
ajlm-1048	23	14	to	to	ADP
ajlm-1048	23	15	2.57	2.57	NUM
ajlm-1048	23	16	%	%	NOUN
ajlm-1048	23	17	of	of	ADP
ajlm-1048	23	18	the	the	DET
ajlm-1048	23	19	total	total	ADJ
ajlm-1048	23	20	world	world	NOUN
ajlm-1048	23	21	population	population	NOUN
ajlm-1048	23	22	(	(	PUNCT
ajlm-1048	23	23	www.worldometers.info	www.worldometers.info	PROPN
ajlm-1048	23	24	)	)	PUNCT
ajlm-1048	23	25	,	,	PUNCT
ajlm-1048	23	26	with	with	ADP
ajlm-1048	23	27	up	up	ADP
ajlm-1048	23	28	to	to	PART
ajlm-1048	23	29	3.2	3.2	NUM
ajlm-1048	23	30	million	million	NUM
ajlm-1048	23	31	people	people	NOUN
ajlm-1048	23	32	living	live	VERB
ajlm-1048	23	33	with	with	ADP
ajlm-1048	23	34	hiv.6	hiv.6	PROPN
ajlm-1048	23	35	this	this	PRON
ajlm-1048	23	36	is	be	AUX
ajlm-1048	23	37	the	the	DET
ajlm-1048	23	38	second	second	ADV
ajlm-1048	23	39	-	-	PUNCT
ajlm-1048	23	40	largest	large	ADJ
ajlm-1048	23	41	hiv	hiv	PROPN
ajlm-1048	23	42	epidemic	epidemic	NOUN
ajlm-1048	23	43	after	after	ADP
ajlm-1048	23	44	south	south	PROPN
ajlm-1048	23	45	africa	africa	PROPN
ajlm-1048	23	46	and	and	CCONJ
ajlm-1048	23	47	represents	represent	VERB
ajlm-1048	23	48	9	9	NUM
ajlm-1048	23	49	%	%	NOUN
ajlm-1048	23	50	of	of	ADP
ajlm-1048	23	51	the	the	DET
ajlm-1048	23	52	total	total	ADJ
ajlm-1048	23	53	population	population	NOUN
ajlm-1048	23	54	living	live	VERB
ajlm-1048	23	55	with	with	ADP
ajlm-1048	23	56	hiv	hiv	PROPN
ajlm-1048	23	57	globally	globally	ADV
ajlm-1048	23	58	,	,	PUNCT
ajlm-1048	23	59	among	among	ADP
ajlm-1048	23	60	whom	whom	PRON
ajlm-1048	23	61	1	1	NUM
ajlm-1048	23	62	million	million	NUM
ajlm-1048	23	63	people	people	NOUN
ajlm-1048	23	64	are	be	AUX
ajlm-1048	23	65	on	on	ADP
ajlm-1048	23	66	antiretroviral	antiretroviral	ADJ
ajlm-1048	23	67	therapy	therapy	NOUN
ajlm-1048	23	68	(	(	PUNCT
ajlm-1048	23	69	art).6,7,8	art).6,7,8	NOUN
ajlm-1048	23	70	lagos	lagos	NOUN
ajlm-1048	23	71	state	state	NOUN
ajlm-1048	23	72	with	with	ADP
ajlm-1048	23	73	a	a	DET
ajlm-1048	23	74	total	total	ADJ
ajlm-1048	23	75	population	population	NOUN
ajlm-1048	23	76	of	of	ADP
ajlm-1048	23	77	about	about	ADV
ajlm-1048	23	78	21	21	NUM
ajlm-1048	23	79	million	million	NUM
ajlm-1048	23	80	has	have	VERB
ajlm-1048	23	81	a	a	DET
ajlm-1048	23	82	hiv	hiv	PROPN
ajlm-1048	23	83	prevalence	prevalence	NOUN
ajlm-1048	23	84	of	of	ADP
ajlm-1048	23	85	2.2	2.2	NUM
ajlm-1048	23	86	%	%	NOUN
ajlm-1048	23	87	.	.	PUNCT
ajlm-1048	24	1	influenza	influenza	ADJ
ajlm-1048	24	2	viral	viral	ADJ
ajlm-1048	24	3	infection	infection	NOUN
ajlm-1048	24	4	is	be	AUX
ajlm-1048	24	5	a	a	DET
ajlm-1048	24	6	common	common	ADJ
ajlm-1048	24	7	cause	cause	NOUN
ajlm-1048	24	8	of	of	ADP
ajlm-1048	24	9	respiratory	respiratory	ADJ
ajlm-1048	24	10	illness	illness	NOUN
ajlm-1048	24	11	among	among	ADP
ajlm-1048	24	12	hiv	hiv	PROPN
ajlm-1048	24	13	-	-	PUNCT
ajlm-1048	24	14	infected	infect	VERB
ajlm-1048	24	15	persons	person	NOUN
ajlm-1048	24	16	in	in	ADP
ajlm-1048	24	17	whom	whom	PRON
ajlm-1048	24	18	it	it	PRON
ajlm-1048	24	19	can	can	AUX
ajlm-1048	24	20	be	be	AUX
ajlm-1048	24	21	more	more	ADV
ajlm-1048	24	22	severe	severe	ADJ
ajlm-1048	24	23	and	and	CCONJ
ajlm-1048	24	24	prolonged.9	prolonged.9	NOUN
ajlm-1048	24	25	hiv	hiv	PROPN
ajlm-1048	24	26	has	have	AUX
ajlm-1048	24	27	also	also	ADV
ajlm-1048	24	28	been	be	AUX
ajlm-1048	24	29	described	describe	VERB
ajlm-1048	24	30	as	as	ADP
ajlm-1048	24	31	the	the	DET
ajlm-1048	24	32	most	most	ADV
ajlm-1048	24	33	common	common	ADJ
ajlm-1048	24	34	underlying	underlying	ADJ
ajlm-1048	24	35	risk	risk	NOUN
ajlm-1048	24	36	factor	factor	NOUN
ajlm-1048	24	37	in	in	ADP
ajlm-1048	24	38	patients	patient	NOUN
ajlm-1048	24	39	with	with	ADP
ajlm-1048	24	40	respiratory	respiratory	ADJ
ajlm-1048	24	41	infection.10	infection.10	ADJ
ajlm-1048	24	42	influenza	influenza	NOUN
ajlm-1048	24	43	virus	virus	NOUN
ajlm-1048	24	44	co	co	NOUN
ajlm-1048	24	45	-	-	NOUN
ajlm-1048	24	46	infections	infection	NOUN
ajlm-1048	24	47	in	in	ADP
ajlm-1048	24	48	hiv	hiv	PROPN
ajlm-1048	24	49	-	-	PUNCT
ajlm-1048	24	50	infected	infect	VERB
ajlm-1048	24	51	patients	patient	NOUN
ajlm-1048	24	52	cause	cause	VERB
ajlm-1048	24	53	a	a	DET
ajlm-1048	24	54	4–8	4–8	NUM
ajlm-1048	24	55	times	time	NOUN
ajlm-1048	24	56	higher	high	ADJ
ajlm-1048	24	57	incidence	incidence	NOUN
ajlm-1048	24	58	of	of	ADP
ajlm-1048	24	59	hospitalisation	hospitalisation	NOUN
ajlm-1048	24	60	and	and	CCONJ
ajlm-1048	24	61	death	death	NOUN
ajlm-1048	24	62	compared	compare	VERB
ajlm-1048	24	63	to	to	ADP
ajlm-1048	24	64	non	non	ADJ
ajlm-1048	24	65	-	-	ADJ
ajlm-1048	24	66	hiv	hiv	ADV
ajlm-1048	24	67	-	-	PUNCT
ajlm-1048	24	68	infected	infect	VERB
ajlm-1048	24	69	individuals.11	individuals.11	NOUN
ajlm-1048	24	70	the	the	DET
ajlm-1048	24	71	reduction	reduction	NOUN
ajlm-1048	24	72	in	in	ADP
ajlm-1048	24	73	the	the	DET
ajlm-1048	24	74	number	number	NOUN
ajlm-1048	24	75	of	of	ADP
ajlm-1048	24	76	cd4	cd4	PROPN
ajlm-1048	24	77	t	t	PROPN
ajlm-1048	24	78	-	-	PUNCT
ajlm-1048	24	79	cells	cell	NOUN
ajlm-1048	24	80	due	due	ADJ
ajlm-1048	24	81	to	to	ADP
ajlm-1048	24	82	infection	infection	NOUN
ajlm-1048	24	83	with	with	ADP
ajlm-1048	24	84	hiv	hiv	PROPN
ajlm-1048	24	85	causes	cause	VERB
ajlm-1048	24	86	immunodeficiency	immunodeficiency	NOUN
ajlm-1048	24	87	and	and	CCONJ
ajlm-1048	24	88	thus	thus	ADV
ajlm-1048	24	89	higher	high	ADJ
ajlm-1048	24	90	susceptibility	susceptibility	NOUN
ajlm-1048	24	91	to	to	ADP
ajlm-1048	24	92	complications	complication	NOUN
ajlm-1048	24	93	of	of	ADP
ajlm-1048	24	94	influenza	influenza	NOUN
ajlm-1048	24	95	in	in	ADP
ajlm-1048	24	96	hiv	hiv	PROPN
ajlm-1048	24	97	patients.12	patients.12	PROPN
ajlm-1048	24	98	in	in	ADP
ajlm-1048	24	99	general	general	ADJ
ajlm-1048	24	100	,	,	PUNCT
ajlm-1048	24	101	the	the	DET
ajlm-1048	24	102	immunogenicity	immunogenicity	NOUN
ajlm-1048	24	103	of	of	ADP
ajlm-1048	24	104	influenza	influenza	ADJ
ajlm-1048	24	105	viral	viral	ADJ
ajlm-1048	24	106	infections	infection	NOUN
ajlm-1048	24	107	in	in	ADP
ajlm-1048	24	108	hiv	hiv	PROPN
ajlm-1048	24	109	-	-	PUNCT
ajlm-1048	24	110	infected	infect	VERB
ajlm-1048	24	111	patients	patient	NOUN
ajlm-1048	24	112	is	be	AUX
ajlm-1048	24	113	directly	directly	ADV
ajlm-1048	24	114	proportional	proportional	ADJ
ajlm-1048	24	115	to	to	ADP
ajlm-1048	24	116	the	the	DET
ajlm-1048	24	117	cd4	cd4	PROPN
ajlm-1048	24	118	cell	cell	NOUN
ajlm-1048	24	119	count	count	NOUN
ajlm-1048	24	120	and	and	CCONJ
ajlm-1048	24	121	correlates	correlate	VERB
ajlm-1048	24	122	negatively	negatively	ADV
ajlm-1048	24	123	to	to	ADP
ajlm-1048	24	124	the	the	DET
ajlm-1048	24	125	viral	viral	ADJ
ajlm-1048	24	126	load.13	load.13	NOUN
ajlm-1048	24	127	studies	study	NOUN
ajlm-1048	24	128	have	have	AUX
ajlm-1048	24	129	also	also	ADV
ajlm-1048	24	130	shown	show	VERB
ajlm-1048	24	131	that	that	SCONJ
ajlm-1048	24	132	better	well	ADJ
ajlm-1048	24	133	immune	immune	ADJ
ajlm-1048	24	134	health	health	NOUN
ajlm-1048	24	135	(	(	PUNCT
ajlm-1048	24	136	i.e.	i.e.	X
ajlm-1048	24	137	higher	high	ADJ
ajlm-1048	24	138	cd4	cd4	PROPN
ajlm-1048	24	139	cell	cell	NOUN
ajlm-1048	24	140	counts	count	NOUN
ajlm-1048	24	141	and	and	CCONJ
ajlm-1048	24	142	suppressed	suppress	VERB
ajlm-1048	24	143	viral	viral	ADJ
ajlm-1048	24	144	load	load	NOUN
ajlm-1048	24	145	of	of	ADP
ajlm-1048	24	146	hiv	hiv	PROPN
ajlm-1048	24	147	patients	patient	NOUN
ajlm-1048	24	148	on	on	ADP
ajlm-1048	24	149	combined	combine	VERB
ajlm-1048	24	150	antiretroviral	antiretroviral	ADJ
ajlm-1048	24	151	therapy	therapy	NOUN
ajlm-1048	24	152	[	[	X
ajlm-1048	24	153	cart	cart	NOUN
ajlm-1048	24	154	]	]	PUNCT
ajlm-1048	24	155	)	)	PUNCT
ajlm-1048	24	156	in	in	ADP
ajlm-1048	24	157	comparison	comparison	NOUN
ajlm-1048	24	158	with	with	ADP
ajlm-1048	24	159	immunocompromised	immunocompromise	VERB
ajlm-1048	24	160	patients	patient	NOUN
ajlm-1048	24	161	made	make	VERB
ajlm-1048	24	162	them	they	PRON
ajlm-1048	24	163	less	less	ADV
ajlm-1048	24	164	likely	likely	ADJ
ajlm-1048	24	165	to	to	PART
ajlm-1048	24	166	experience	experience	VERB
ajlm-1048	24	167	prolonged	prolonged	ADJ
ajlm-1048	24	168	shedding	shedding	NOUN
ajlm-1048	24	169	of	of	ADP
ajlm-1048	24	170	influenza	influenza	ADJ
ajlm-1048	24	171	virus.9	virus.9	NOUN
ajlm-1048	24	172	however	however	ADV
ajlm-1048	24	173	,	,	PUNCT
ajlm-1048	24	174	a	a	DET
ajlm-1048	24	175	lack	lack	NOUN
ajlm-1048	24	176	of	of	ADP
ajlm-1048	24	177	epidemiological	epidemiological	ADJ
ajlm-1048	24	178	data	datum	NOUN
ajlm-1048	24	179	on	on	ADP
ajlm-1048	24	180	seasonal	seasonal	ADJ
ajlm-1048	24	181	influenza	influenza	NOUN
ajlm-1048	24	182	in	in	ADP
ajlm-1048	24	183	hiv	hiv	PROPN
ajlm-1048	24	184	-	-	PUNCT
ajlm-1048	24	185	positive	positive	ADJ
ajlm-1048	24	186	individuals	individual	NOUN
ajlm-1048	24	187	is	be	AUX
ajlm-1048	24	188	a	a	DET
ajlm-1048	24	189	major	major	ADJ
ajlm-1048	24	190	problem	problem	NOUN
ajlm-1048	24	191	preventing	prevent	VERB
ajlm-1048	24	192	the	the	DET
ajlm-1048	24	193	development	development	NOUN
ajlm-1048	24	194	of	of	ADP
ajlm-1048	24	195	national	national	ADJ
ajlm-1048	24	196	policies	policy	NOUN
ajlm-1048	24	197	on	on	ADP
ajlm-1048	24	198	influenza	influenza	ADJ
ajlm-1048	24	199	preventive	preventive	ADJ
ajlm-1048	24	200	strategies	strategy	NOUN
ajlm-1048	24	201	in	in	ADP
ajlm-1048	24	202	sub	sub	ADJ
ajlm-1048	24	203	-	-	ADJ
ajlm-1048	24	204	saharan	saharan	ADJ
ajlm-1048	24	205	africa	africa	PROPN
ajlm-1048	24	206	,	,	PUNCT
ajlm-1048	24	207	including	include	VERB
ajlm-1048	24	208	nigeria	nigeria	PROPN
ajlm-1048	24	209	.	.	PUNCT
ajlm-1048	25	1	in	in	ADP
ajlm-1048	25	2	south	south	PROPN
ajlm-1048	25	3	africa	africa	PROPN
ajlm-1048	25	4	,	,	PUNCT
ajlm-1048	25	5	44	44	NUM
ajlm-1048	25	6	%	%	NOUN
ajlm-1048	25	7	of	of	ADP
ajlm-1048	25	8	influenza	influenza	NOUN
ajlm-1048	25	9	positive	positive	ADJ
ajlm-1048	25	10	patients	patient	NOUN
ajlm-1048	25	11	having	have	VERB
ajlm-1048	25	12	acute	acute	ADJ
ajlm-1048	25	13	respiratory	respiratory	ADJ
ajlm-1048	25	14	infections	infection	NOUN
ajlm-1048	25	15	are	be	AUX
ajlm-1048	25	16	hiv	hiv	NOUN
ajlm-1048	25	17	-	-	PUNCT
ajlm-1048	25	18	infected.10	infected.10	ADJ
ajlm-1048	25	19	no	no	DET
ajlm-1048	25	20	data	data	NOUN
ajlm-1048	25	21	is	be	AUX
ajlm-1048	25	22	available	available	ADJ
ajlm-1048	25	23	on	on	ADP
ajlm-1048	25	24	influenza	influenza	NOUN
ajlm-1048	25	25	virus	virus	NOUN
ajlm-1048	25	26	infection	infection	NOUN
ajlm-1048	25	27	in	in	ADP
ajlm-1048	25	28	hiv	hiv	PROPN
ajlm-1048	25	29	patients	patient	NOUN
ajlm-1048	25	30	from	from	ADP
ajlm-1048	25	31	nigeria	nigeria	PROPN
ajlm-1048	25	32	and	and	CCONJ
ajlm-1048	25	33	that	that	PRON
ajlm-1048	25	34	underscores	underscore	VERB
ajlm-1048	25	35	the	the	DET
ajlm-1048	25	36	importance	importance	NOUN
ajlm-1048	25	37	of	of	ADP
ajlm-1048	25	38	this	this	DET
ajlm-1048	25	39	study	study	NOUN
ajlm-1048	25	40	.	.	PUNCT
ajlm-1048	26	1	serological	serological	ADJ
ajlm-1048	26	2	assays	assay	NOUN
ajlm-1048	26	3	usually	usually	ADV
ajlm-1048	26	4	complement	complement	VERB
ajlm-1048	26	5	epidemiological	epidemiological	ADJ
ajlm-1048	26	6	and	and	CCONJ
ajlm-1048	26	7	clinical	clinical	ADJ
ajlm-1048	26	8	investigations	investigation	NOUN
ajlm-1048	26	9	in	in	ADP
ajlm-1048	26	10	the	the	DET
ajlm-1048	26	11	detection	detection	NOUN
ajlm-1048	26	12	and	and	CCONJ
ajlm-1048	26	13	identification	identification	NOUN
ajlm-1048	26	14	of	of	ADP
ajlm-1048	26	15	influenza	influenza	NOUN
ajlm-1048	26	16	viruses	virus	NOUN
ajlm-1048	26	17	.	.	PUNCT
ajlm-1048	27	1	they	they	PRON
ajlm-1048	27	2	measure	measure	VERB
ajlm-1048	27	3	antibodies	antibody	NOUN
ajlm-1048	27	4	developed	develop	VERB
ajlm-1048	27	5	in	in	ADP
ajlm-1048	27	6	response	response	NOUN
ajlm-1048	27	7	to	to	ADP
ajlm-1048	27	8	infection	infection	NOUN
ajlm-1048	27	9	with	with	ADP
ajlm-1048	27	10	antigenically	antigenically	ADV
ajlm-1048	27	11	novel	novel	ADJ
ajlm-1048	27	12	and	and	CCONJ
ajlm-1048	27	13	seasonal	seasonal	ADJ
ajlm-1048	27	14	influenza	influenza	NOUN
ajlm-1048	27	15	viruses.14	viruses.14	NOUN
ajlm-1048	27	16	the	the	DET
ajlm-1048	27	17	enzyme	enzyme	NOUN
ajlm-1048	27	18	-	-	PUNCT
ajlm-1048	27	19	linked	link	VERB
ajlm-1048	27	20	immunosorbent	immunosorbent	NOUN
ajlm-1048	27	21	assay	assay	NOUN
ajlm-1048	27	22	method	method	NOUN
ajlm-1048	27	23	has	have	AUX
ajlm-1048	27	24	been	be	AUX
ajlm-1048	27	25	used	use	VERB
ajlm-1048	27	26	in	in	ADP
ajlm-1048	27	27	different	different	ADJ
ajlm-1048	27	28	studies	study	NOUN
ajlm-1048	27	29	for	for	ADP
ajlm-1048	27	30	detecting	detect	VERB
ajlm-1048	27	31	serological	serological	ADJ
ajlm-1048	27	32	evidence	evidence	NOUN
ajlm-1048	27	33	of	of	ADP
ajlm-1048	27	34	the	the	DET
ajlm-1048	27	35	influenza	influenza	NOUN
ajlm-1048	27	36	virus	virus	NOUN
ajlm-1048	27	37	in	in	ADP
ajlm-1048	27	38	humans15,16,17	humans15,16,17	PROPN
ajlm-1048	27	39	because	because	SCONJ
ajlm-1048	27	40	it	it	PRON
ajlm-1048	27	41	is	be	AUX
ajlm-1048	27	42	apt	apt	ADJ
ajlm-1048	27	43	,	,	PUNCT
ajlm-1048	27	44	easy	easy	ADJ
ajlm-1048	27	45	,	,	PUNCT
ajlm-1048	27	46	fast	fast	ADV
ajlm-1048	27	47	,	,	PUNCT
ajlm-1048	27	48	can	can	AUX
ajlm-1048	27	49	be	be	AUX
ajlm-1048	27	50	automated	automate	VERB
ajlm-1048	27	51	and	and	CCONJ
ajlm-1048	27	52	is	be	AUX
ajlm-1048	27	53	commercially	commercially	ADV
ajlm-1048	27	54	available	available	ADJ
ajlm-1048	27	55	for	for	ADP
ajlm-1048	27	56	large	large	ADJ
ajlm-1048	27	57	-	-	PUNCT
ajlm-1048	27	58	scale	scale	NOUN
ajlm-1048	27	59	sero	sero	NOUN
ajlm-1048	27	60	survey	survey	NOUN
ajlm-1048	27	61	,	,	PUNCT
ajlm-1048	27	62	targeting	target	VERB
ajlm-1048	27	63	specific	specific	ADJ
ajlm-1048	27	64	antibodies	antibody	NOUN
ajlm-1048	27	65	against	against	ADP
ajlm-1048	27	66	different	different	ADJ
ajlm-1048	27	67	subtypes	subtype	NOUN
ajlm-1048	27	68	of	of	ADP
ajlm-1048	27	69	influenza	influenza	NOUN
ajlm-1048	27	70	virus	virus	NOUN
ajlm-1048	27	71	.	.	PUNCT
ajlm-1048	28	1	it	it	PRON
ajlm-1048	28	2	is	be	AUX
ajlm-1048	28	3	also	also	ADV
ajlm-1048	28	4	affordable	affordable	ADJ
ajlm-1048	28	5	for	for	ADP
ajlm-1048	28	6	sero	sero	ADJ
ajlm-1048	28	7	epidemiology	epidemiology	NOUN
ajlm-1048	28	8	in	in	ADP
ajlm-1048	28	9	poor	poor	ADJ
ajlm-1048	28	10	and	and	CCONJ
ajlm-1048	28	11	limited	limited	ADJ
ajlm-1048	28	12	resource	resource	NOUN
ajlm-1048	28	13	settings	setting	NOUN
ajlm-1048	28	14	.	.	PUNCT
ajlm-1048	29	1	this	this	DET
ajlm-1048	29	2	study	study	NOUN
ajlm-1048	29	3	was	be	AUX
ajlm-1048	29	4	therefore	therefore	ADV
ajlm-1048	29	5	designed	design	VERB
ajlm-1048	29	6	to	to	PART
ajlm-1048	29	7	investigate	investigate	VERB
ajlm-1048	29	8	seasonal	seasonal	ADJ
ajlm-1048	29	9	influenza	influenza	NOUN
ajlm-1048	29	10	a	a	DET
ajlm-1048	29	11	and	and	CCONJ
ajlm-1048	29	12	b	b	NOUN
ajlm-1048	29	13	virus	virus	NOUN
ajlm-1048	29	14	infections	infection	NOUN
ajlm-1048	29	15	in	in	ADP
ajlm-1048	29	16	hiv	hiv	PROPN
ajlm-1048	29	17	patients	patient	NOUN
ajlm-1048	29	18	on	on	ADP
ajlm-1048	29	19	cart	cart	NOUN
ajlm-1048	29	20	in	in	ADP
ajlm-1048	29	21	lagos	lagos	PROPN
ajlm-1048	29	22	,	,	PUNCT
ajlm-1048	29	23	nigeria	nigeria	PROPN
ajlm-1048	29	24	.	.	PUNCT
ajlm-1048	30	1	methods	method	NOUN
ajlm-1048	30	2	ethical	ethical	ADJ
ajlm-1048	30	3	considerations	consideration	NOUN
ajlm-1048	30	4	permission	permission	NOUN
ajlm-1048	30	5	was	be	AUX
ajlm-1048	30	6	sought	seek	VERB
ajlm-1048	30	7	from	from	ADP
ajlm-1048	30	8	the	the	DET
ajlm-1048	30	9	head	head	NOUN
ajlm-1048	30	10	of	of	ADP
ajlm-1048	30	11	the	the	DET
ajlm-1048	30	12	aids	aids	PROPN
ajlm-1048	30	13	prevention	prevention	PROPN
ajlm-1048	30	14	initiative	initiative	NOUN
ajlm-1048	30	15	in	in	ADP
ajlm-1048	30	16	nigeria	nigeria	PROPN
ajlm-1048	30	17	(	(	PUNCT
ajlm-1048	30	18	apin	apin	NOUN
ajlm-1048	30	19	)	)	PUNCT
ajlm-1048	30	20	clinic	clinic	NOUN
ajlm-1048	30	21	where	where	SCONJ
ajlm-1048	30	22	the	the	DET
ajlm-1048	30	23	samples	sample	NOUN
ajlm-1048	30	24	were	be	AUX
ajlm-1048	30	25	collected	collect	VERB
ajlm-1048	30	26	after	after	ADP
ajlm-1048	30	27	tendering	tender	VERB
ajlm-1048	30	28	the	the	DET
ajlm-1048	30	29	ethical	ethical	ADJ
ajlm-1048	30	30	approval	approval	NOUN
ajlm-1048	30	31	(	(	PUNCT
ajlm-1048	30	32	reference	reference	NOUN
ajlm-1048	30	33	no	no	INTJ
ajlm-1048	30	34	.	.	PUNCT
ajlm-1048	30	35	:	:	PUNCT
ajlm-1048	31	1	lrec.06/10/1030	lrec.06/10/1030	NOUN
ajlm-1048	31	2	)	)	PUNCT
ajlm-1048	31	3	obtained	obtain	VERB
ajlm-1048	31	4	from	from	ADP
ajlm-1048	31	5	the	the	DET
ajlm-1048	31	6	health	health	NOUN
ajlm-1048	31	7	research	research	NOUN
ajlm-1048	31	8	and	and	CCONJ
ajlm-1048	31	9	ethics	ethic	NOUN
ajlm-1048	31	10	committee	committee	NOUN
ajlm-1048	31	11	of	of	ADP
ajlm-1048	31	12	the	the	DET
ajlm-1048	31	13	lagos	lagos	PROPN
ajlm-1048	31	14	state	state	PROPN
ajlm-1048	31	15	university	university	PROPN
ajlm-1048	31	16	teaching	teaching	NOUN
ajlm-1048	31	17	hospital	hospital	NOUN
ajlm-1048	31	18	(	(	PUNCT
ajlm-1048	31	19	lasuth	lasuth	NOUN
ajlm-1048	31	20	)	)	PUNCT
ajlm-1048	31	21	.	.	PUNCT
ajlm-1048	32	1	study	study	NOUN
ajlm-1048	32	2	area	area	NOUN
ajlm-1048	32	3	,	,	PUNCT
ajlm-1048	32	4	population	population	NOUN
ajlm-1048	32	5	and	and	CCONJ
ajlm-1048	32	6	design	design	VERB
ajlm-1048	32	7	a	a	DET
ajlm-1048	32	8	prospective	prospective	ADJ
ajlm-1048	32	9	cross	cross	ADJ
ajlm-1048	32	10	-	-	ADJ
ajlm-1048	32	11	sectional	sectional	ADJ
ajlm-1048	32	12	study	study	NOUN
ajlm-1048	32	13	was	be	AUX
ajlm-1048	32	14	designed	design	VERB
ajlm-1048	32	15	.	.	PUNCT
ajlm-1048	33	1	outpatients	outpatient	NOUN
ajlm-1048	33	2	attending	attend	VERB
ajlm-1048	33	3	the	the	DET
ajlm-1048	33	4	aids	aids	PROPN
ajlm-1048	33	5	prevention	prevention	PROPN
ajlm-1048	33	6	initiative	initiative	NOUN
ajlm-1048	33	7	in	in	ADP
ajlm-1048	33	8	nigeria	nigeria	PROPN
ajlm-1048	33	9	(	(	PUNCT
ajlm-1048	33	10	apin)-lagos	apin)-lagos	PROPN
ajlm-1048	33	11	university	university	NOUN
ajlm-1048	33	12	teaching	teaching	NOUN
ajlm-1048	33	13	hospital	hospital	NOUN
ajlm-1048	33	14	clinic	clinic	NOUN
ajlm-1048	33	15	who	who	PRON
ajlm-1048	33	16	were	be	AUX
ajlm-1048	33	17	previously	previously	ADV
ajlm-1048	33	18	laboratory	laboratory	NOUN
ajlm-1048	33	19	confirmed	confirm	VERB
ajlm-1048	33	20	to	to	PART
ajlm-1048	33	21	be	be	AUX
ajlm-1048	33	22	hiv	hiv	NOUN
ajlm-1048	33	23	-	-	PUNCT
ajlm-1048	33	24	positive	positive	ADJ
ajlm-1048	33	25	were	be	AUX
ajlm-1048	33	26	recruited	recruit	VERB
ajlm-1048	33	27	for	for	ADP
ajlm-1048	33	28	this	this	DET
ajlm-1048	33	29	study	study	NOUN
ajlm-1048	33	30	from	from	ADP
ajlm-1048	33	31	august	august	PROPN
ajlm-1048	33	32	2018	2018	NUM
ajlm-1048	33	33	to	to	ADP
ajlm-1048	33	34	september	september	PROPN
ajlm-1048	33	35	2018	2018	NUM
ajlm-1048	33	36	.	.	PUNCT
ajlm-1048	34	1	apin	apin	NOUN
ajlm-1048	34	2	-	-	PUNCT
ajlm-1048	34	3	lagos	lagos	NOUN
ajlm-1048	34	4	university	university	NOUN
ajlm-1048	34	5	teaching	teaching	NOUN
ajlm-1048	34	6	hospital	hospital	NOUN
ajlm-1048	34	7	clinic	clinic	NOUN
ajlm-1048	34	8	is	be	AUX
ajlm-1048	34	9	a	a	DET
ajlm-1048	34	10	large	large	ADJ
ajlm-1048	34	11	university	university	NOUN
ajlm-1048	34	12	-	-	PUNCT
ajlm-1048	34	13	based	base	VERB
ajlm-1048	34	14	hiv	hiv	PROPN
ajlm-1048	34	15	clinic	clinic	PROPN
ajlm-1048	34	16	in	in	ADP
ajlm-1048	34	17	lagos	lagos	PROPN
ajlm-1048	34	18	,	,	PUNCT
ajlm-1048	34	19	nigeria	nigeria	PROPN
ajlm-1048	34	20	,	,	PUNCT
ajlm-1048	34	21	with	with	ADP
ajlm-1048	34	22	about	about	ADV
ajlm-1048	34	23	15	15	NUM
ajlm-1048	34	24	000	000	NUM
ajlm-1048	34	25	patients	patient	NOUN
ajlm-1048	34	26	currently	currently	ADV
ajlm-1048	34	27	enrolled	enrol	VERB
ajlm-1048	34	28	in	in	ADP
ajlm-1048	34	29	lagos	lago	NOUN
ajlm-1048	34	30	.	.	PUNCT
ajlm-1048	35	1	after	after	ADP
ajlm-1048	35	2	explaining	explain	VERB
ajlm-1048	35	3	the	the	DET
ajlm-1048	35	4	concept	concept	NOUN
ajlm-1048	35	5	of	of	ADP
ajlm-1048	35	6	the	the	DET
ajlm-1048	35	7	study	study	NOUN
ajlm-1048	35	8	,	,	PUNCT
ajlm-1048	35	9	a	a	DET
ajlm-1048	35	10	total	total	NOUN
ajlm-1048	35	11	of	of	ADP
ajlm-1048	35	12	174	174	NUM
ajlm-1048	35	13	hiv	hiv	PROPN
ajlm-1048	35	14	patients	patient	NOUN
ajlm-1048	35	15	,	,	PUNCT
ajlm-1048	35	16	including	include	VERB
ajlm-1048	35	17	165	165	NUM
ajlm-1048	35	18	on	on	ADP
ajlm-1048	35	19	cart	cart	NOUN
ajlm-1048	35	20	,	,	PUNCT
ajlm-1048	35	21	who	who	PRON
ajlm-1048	35	22	were	be	AUX
ajlm-1048	35	23	unvaccinated	unvaccinate	VERB
ajlm-1048	35	24	for	for	ADP
ajlm-1048	35	25	influenza	influenza	NOUN
ajlm-1048	35	26	and	and	CCONJ
ajlm-1048	35	27	gave	give	VERB
ajlm-1048	35	28	both	both	CCONJ
ajlm-1048	35	29	oral	oral	ADJ
ajlm-1048	35	30	and	and	CCONJ
ajlm-1048	35	31	written	write	VERB
ajlm-1048	35	32	informed	informed	ADJ
ajlm-1048	35	33	consent	consent	NOUN
ajlm-1048	35	34	,	,	PUNCT
ajlm-1048	35	35	were	be	AUX
ajlm-1048	35	36	bled	bleed	VERB
ajlm-1048	35	37	by	by	ADP
ajlm-1048	35	38	venepuncture	venepuncture	NOUN
ajlm-1048	35	39	.	.	PUNCT
ajlm-1048	36	1	demographic	demographic	ADJ
ajlm-1048	36	2	and	and	CCONJ
ajlm-1048	36	3	clinical	clinical	ADJ
ajlm-1048	36	4	data	datum	NOUN
ajlm-1048	36	5	were	be	AUX
ajlm-1048	36	6	appropriately	appropriately	ADV
ajlm-1048	36	7	collected	collect	VERB
ajlm-1048	36	8	with	with	ADP
ajlm-1048	36	9	a	a	DET
ajlm-1048	36	10	designed	design	VERB
ajlm-1048	36	11	questionnaire	questionnaire	NOUN
ajlm-1048	36	12	.	.	PUNCT
ajlm-1048	37	1	results	result	NOUN
ajlm-1048	37	2	of	of	ADP
ajlm-1048	37	3	further	further	ADJ
ajlm-1048	37	4	laboratory	laboratory	NOUN
ajlm-1048	37	5	analyses	analysis	NOUN
ajlm-1048	37	6	including	include	VERB
ajlm-1048	37	7	cd4	cd4	PROPN
ajlm-1048	37	8	count	count	NOUN
ajlm-1048	37	9	,	,	PUNCT
ajlm-1048	37	10	rna	rna	NOUN
ajlm-1048	37	11	viral	viral	ADJ
ajlm-1048	37	12	load	load	NOUN
ajlm-1048	37	13	and	and	CCONJ
ajlm-1048	37	14	cart	cart	NOUN
ajlm-1048	37	15	regimen	regiman	NOUN
ajlm-1048	37	16	were	be	AUX
ajlm-1048	37	17	obtained	obtain	VERB
ajlm-1048	37	18	from	from	ADP
ajlm-1048	37	19	the	the	DET
ajlm-1048	37	20	patients	patient	NOUN
ajlm-1048	37	21	’	'	PUNCT
ajlm-1048	37	22	clinical	clinical	ADJ
ajlm-1048	37	23	records	record	NOUN
ajlm-1048	37	24	.	.	PUNCT
ajlm-1048	38	1	sample	sample	NOUN
ajlm-1048	38	2	collection	collection	NOUN
ajlm-1048	38	3	and	and	CCONJ
ajlm-1048	38	4	treatment	treatment	NOUN
ajlm-1048	38	5	approximately	approximately	ADV
ajlm-1048	38	6	5	5	NUM
ajlm-1048	38	7	ml	ml	NOUN
ajlm-1048	38	8	of	of	ADP
ajlm-1048	38	9	whole	whole	ADJ
ajlm-1048	38	10	blood	blood	NOUN
ajlm-1048	38	11	samples	sample	NOUN
ajlm-1048	38	12	were	be	AUX
ajlm-1048	38	13	collected	collect	VERB
ajlm-1048	38	14	into	into	ADP
ajlm-1048	38	15	sterile	sterile	ADJ
ajlm-1048	38	16	plain	plain	ADJ
ajlm-1048	38	17	bottles	bottle	NOUN
ajlm-1048	38	18	.	.	PUNCT
ajlm-1048	39	1	they	they	PRON
ajlm-1048	39	2	were	be	AUX
ajlm-1048	39	3	stored	store	VERB
ajlm-1048	39	4	in	in	ADP
ajlm-1048	39	5	sample	sample	NOUN
ajlm-1048	39	6	coolers	cooler	NOUN
ajlm-1048	39	7	stacked	stack	VERB
ajlm-1048	39	8	with	with	ADP
ajlm-1048	39	9	ice	ice	NOUN
ajlm-1048	39	10	packs	pack	NOUN
ajlm-1048	39	11	before	before	ADP
ajlm-1048	39	12	being	be	AUX
ajlm-1048	39	13	conveyed	convey	VERB
ajlm-1048	39	14	to	to	ADP
ajlm-1048	39	15	the	the	DET
ajlm-1048	39	16	laboratory	laboratory	NOUN
ajlm-1048	39	17	.	.	PUNCT
ajlm-1048	40	1	the	the	DET
ajlm-1048	40	2	samples	sample	NOUN
ajlm-1048	40	3	were	be	AUX
ajlm-1048	40	4	centrifuged	centrifuge	VERB
ajlm-1048	40	5	at	at	ADP
ajlm-1048	40	6	704	704	NUM
ajlm-1048	40	7	×	×	NOUN
ajlm-1048	40	8	g	g	NOUN
ajlm-1048	40	9	for	for	ADP
ajlm-1048	40	10	15	15	NUM
ajlm-1048	40	11	min	min	NOUN
ajlm-1048	40	12	to	to	PART
ajlm-1048	40	13	obtain	obtain	VERB
ajlm-1048	40	14	clear	clear	ADJ
ajlm-1048	40	15	sera	sera	NOUN
ajlm-1048	40	16	that	that	PRON
ajlm-1048	40	17	were	be	AUX
ajlm-1048	40	18	aliquoted	aliquote	VERB
ajlm-1048	40	19	into	into	ADP
ajlm-1048	40	20	labelled	label	VERB
ajlm-1048	40	21	sterile	sterile	ADJ
ajlm-1048	40	22	plain	plain	ADJ
ajlm-1048	40	23	cryovial	cryovial	ADJ
ajlm-1048	40	24	tubes	tube	NOUN
ajlm-1048	40	25	.	.	PUNCT
ajlm-1048	41	1	the	the	DET
ajlm-1048	41	2	sera	sera	NOUN
ajlm-1048	41	3	were	be	AUX
ajlm-1048	41	4	then	then	ADV
ajlm-1048	41	5	stored	store	VERB
ajlm-1048	41	6	away	away	ADV
ajlm-1048	41	7	at	at	ADP
ajlm-1048	41	8	−30	−30	NOUN
ajlm-1048	41	9	°	°	ADP
ajlm-1048	41	10	c	c	NOUN
ajlm-1048	41	11	until	until	ADP
ajlm-1048	41	12	ready	ready	ADJ
ajlm-1048	41	13	for	for	ADP
ajlm-1048	41	14	serological	serological	ADJ
ajlm-1048	41	15	analysis	analysis	NOUN
ajlm-1048	41	16	.	.	PUNCT
ajlm-1048	42	1	laboratory	laboratory	NOUN
ajlm-1048	42	2	analysis	analysis	NOUN
ajlm-1048	42	3	clear	clear	ADJ
ajlm-1048	42	4	sera	sera	NOUN
ajlm-1048	42	5	were	be	AUX
ajlm-1048	42	6	analysed	analyse	VERB
ajlm-1048	42	7	for	for	ADP
ajlm-1048	42	8	the	the	DET
ajlm-1048	42	9	detection	detection	NOUN
ajlm-1048	42	10	and	and	CCONJ
ajlm-1048	42	11	quantitative	quantitative	ADJ
ajlm-1048	42	12	determination	determination	NOUN
ajlm-1048	42	13	of	of	ADP
ajlm-1048	42	14	immunoglobulin	immunoglobulin	NOUN
ajlm-1048	42	15	m	m	PROPN
ajlm-1048	42	16	antibody	antibody	NOUN
ajlm-1048	42	17	specific	specific	ADJ
ajlm-1048	42	18	for	for	ADP
ajlm-1048	42	19	influenza	influenza	NOUN
ajlm-1048	42	20	virus	virus	NOUN
ajlm-1048	42	21	by	by	ADP
ajlm-1048	42	22	enzyme	enzyme	NOUN
ajlm-1048	42	23	-	-	PUNCT
ajlm-1048	42	24	linked	link	VERB
ajlm-1048	42	25	immunoassay	immunoassay	NOUN
ajlm-1048	42	26	(	(	PUNCT
ajlm-1048	42	27	demeditec	demeditec	NOUN
ajlm-1048	42	28	diagnostics	diagnostic	NOUN
ajlm-1048	42	29	gmbh	gmbh	PROPN
ajlm-1048	42	30	,	,	PUNCT
ajlm-1048	42	31	kiel	kiel	PROPN
ajlm-1048	42	32	,	,	PUNCT
ajlm-1048	42	33	germany	germany	PROPN
ajlm-1048	42	34	)	)	PUNCT
ajlm-1048	42	35	in	in	ADP
ajlm-1048	42	36	the	the	DET
ajlm-1048	42	37	department	department	NOUN
ajlm-1048	42	38	of	of	ADP
ajlm-1048	42	39	microbiology	microbiology	NOUN
ajlm-1048	42	40	(	(	PUNCT
ajlm-1048	42	41	virology	virology	NOUN
ajlm-1048	42	42	research	research	NOUN
ajlm-1048	42	43	)	)	PUNCT
ajlm-1048	42	44	laboratory	laboratory	NOUN
ajlm-1048	42	45	,	,	PUNCT
ajlm-1048	42	46	lagos	lagos	NOUN
ajlm-1048	42	47	state	state	PROPN
ajlm-1048	42	48	university	university	PROPN
ajlm-1048	42	49	,	,	PUNCT
ajlm-1048	42	50	ojo	ojo	PROPN
ajlm-1048	42	51	.	.	PUNCT
ajlm-1048	43	1	following	follow	VERB
ajlm-1048	43	2	manufacturer	manufacturer	NOUN
ajlm-1048	43	3	’s	’s	PART
ajlm-1048	43	4	instructions	instruction	NOUN
ajlm-1048	43	5	,	,	PUNCT
ajlm-1048	43	6	sufficient	sufficient	ADJ
ajlm-1048	43	7	amounts	amount	NOUN
ajlm-1048	43	8	of	of	ADP
ajlm-1048	43	9	micro	micro	ADJ
ajlm-1048	43	10	titre	titre	NOUN
ajlm-1048	43	11	wells	well	NOUN
ajlm-1048	43	12	were	be	AUX
ajlm-1048	43	13	prepared	prepare	VERB
ajlm-1048	43	14	for	for	ADP
ajlm-1048	43	15	the	the	DET
ajlm-1048	43	16	standards	standard	NOUN
ajlm-1048	43	17	,	,	PUNCT
ajlm-1048	43	18	controls	control	NOUN
ajlm-1048	43	19	and	and	CCONJ
ajlm-1048	43	20	samples	sample	NOUN
ajlm-1048	43	21	as	as	ADV
ajlm-1048	43	22	well	well	ADV
ajlm-1048	43	23	as	as	ADP
ajlm-1048	43	24	for	for	ADP
ajlm-1048	43	25	the	the	DET
ajlm-1048	43	26	substrate	substrate	NOUN
ajlm-1048	43	27	blank	blank	NOUN
ajlm-1048	43	28	.	.	PUNCT
ajlm-1048	44	1	the	the	DET
ajlm-1048	44	2	samples	sample	NOUN
ajlm-1048	44	3	were	be	AUX
ajlm-1048	44	4	diluted	dilute	VERB
ajlm-1048	44	5	with	with	ADP
ajlm-1048	44	6	ready	ready	ADJ
ajlm-1048	44	7	-	-	PUNCT
ajlm-1048	44	8	to	to	PART
ajlm-1048	44	9	-	-	PUNCT
ajlm-1048	44	10	use	use	VERB
ajlm-1048	44	11	sample	sample	NOUN
ajlm-1048	44	12	diluent	diluent	NOUN
ajlm-1048	44	13	provided	provide	VERB
ajlm-1048	44	14	with	with	ADP
ajlm-1048	44	15	the	the	DET
ajlm-1048	44	16	test	test	NOUN
ajlm-1048	44	17	kit	kit	NOUN
ajlm-1048	44	18	in	in	ADP
ajlm-1048	44	19	the	the	DET
ajlm-1048	44	20	ratio	ratio	NOUN
ajlm-1048	44	21	1:100	1:100	NUM
ajlm-1048	44	22	(	(	PUNCT
ajlm-1048	44	23	2	2	NUM
ajlm-1048	44	24	µl	µl	ADP
ajlm-1048	44	25	serum	serum	NOUN
ajlm-1048	44	26	+	+	CCONJ
ajlm-1048	44	27	200	200	NUM
ajlm-1048	44	28	µl	µl	ADP
ajlm-1048	44	29	sample	sample	NOUN
ajlm-1048	44	30	diluents	diluent	NOUN
ajlm-1048	44	31	)	)	PUNCT
ajlm-1048	44	32	.	.	PUNCT
ajlm-1048	45	1	assay	assay	PROPN
ajlm-1048	45	2	absorbance	absorbance	NOUN
ajlm-1048	45	3	was	be	AUX
ajlm-1048	45	4	read	read	VERB
ajlm-1048	45	5	at	at	ADP
ajlm-1048	45	6	a	a	DET
ajlm-1048	45	7	wavelength	wavelength	NOUN
ajlm-1048	45	8	of	of	ADP
ajlm-1048	45	9	450	450	NUM
ajlm-1048	45	10	nanometres	nanometre	NOUN
ajlm-1048	45	11	with	with	ADP
ajlm-1048	45	12	an	an	DET
ajlm-1048	45	13	emax	emax	NOUN
ajlm-1048	45	14	precision	precision	NOUN
ajlm-1048	45	15	microplate	microplate	NOUN
ajlm-1048	45	16	reader	reader	NOUN
ajlm-1048	45	17	(	(	PUNCT
ajlm-1048	45	18	molecular	molecular	ADJ
ajlm-1048	45	19	devices	device	NOUN
ajlm-1048	45	20	,	,	PUNCT
ajlm-1048	45	21	llc	llc	PROPN
ajlm-1048	45	22	,	,	PUNCT
ajlm-1048	45	23	san	san	PROPN
ajlm-1048	45	24	jose	jose	PROPN
ajlm-1048	45	25	,	,	PUNCT
ajlm-1048	45	26	california	california	PROPN
ajlm-1048	45	27	,	,	PUNCT
ajlm-1048	45	28	united	united	PROPN
ajlm-1048	45	29	states	states	PROPN
ajlm-1048	45	30	)	)	PUNCT
ajlm-1048	45	31	.	.	PUNCT
ajlm-1048	46	1	sample	sample	NOUN
ajlm-1048	46	2	results	result	NOUN
ajlm-1048	46	3	were	be	AUX
ajlm-1048	46	4	compared	compare	VERB
ajlm-1048	46	5	with	with	ADP
ajlm-1048	46	6	the	the	DET
ajlm-1048	46	7	included	include	VERB
ajlm-1048	46	8	standards	standard	NOUN
ajlm-1048	46	9	and	and	CCONJ
ajlm-1048	46	10	controls	control	NOUN
ajlm-1048	46	11	and	and	CCONJ
ajlm-1048	46	12	were	be	AUX
ajlm-1048	46	13	interpreted	interpret	VERB
ajlm-1048	46	14	based	base	VERB
ajlm-1048	46	15	on	on	ADP
ajlm-1048	46	16	the	the	DET
ajlm-1048	46	17	assay	assay	PROPN
ajlm-1048	46	18	standard	standard	PROPN
ajlm-1048	46	19	curve	curve	NOUN
ajlm-1048	46	20	as	as	SCONJ
ajlm-1048	46	21	recommended	recommend	VERB
ajlm-1048	46	22	by	by	ADP
ajlm-1048	46	23	the	the	DET
ajlm-1048	46	24	manufacturer	manufacturer	NOUN
ajlm-1048	46	25	.	.	PUNCT
ajlm-1048	47	1	it	it	PRON
ajlm-1048	47	2	should	should	AUX
ajlm-1048	47	3	however	however	ADV
ajlm-1048	47	4	be	be	AUX
ajlm-1048	47	5	noted	note	VERB
ajlm-1048	47	6	that	that	SCONJ
ajlm-1048	47	7	positive	positive	ADJ
ajlm-1048	47	8	immunoglobulin	immunoglobulin	NOUN
ajlm-1048	47	9	m	m	NOUN
ajlm-1048	47	10	antibody	antibody	NOUN
ajlm-1048	47	11	specific	specific	ADJ
ajlm-1048	47	12	for	for	ADP
ajlm-1048	47	13	influenza	influenza	NOUN
ajlm-1048	47	14	virus	virus	NOUN
ajlm-1048	47	15	implies	imply	VERB
ajlm-1048	47	16	a	a	DET
ajlm-1048	47	17	recent	recent	ADJ
ajlm-1048	47	18	immunological	immunological	ADJ
ajlm-1048	47	19	reaction	reaction	NOUN
ajlm-1048	47	20	to	to	ADP
ajlm-1048	47	21	circulating	circulate	VERB
ajlm-1048	47	22	live	live	ADJ
ajlm-1048	47	23	influenza	influenza	NOUN
ajlm-1048	47	24	strains	strain	NOUN
ajlm-1048	47	25	as	as	ADP
ajlm-1048	47	26	a	a	DET
ajlm-1048	47	27	result	result	NOUN
ajlm-1048	47	28	of	of	ADP
ajlm-1048	47	29	infection	infection	NOUN
ajlm-1048	47	30	since	since	SCONJ
ajlm-1048	47	31	nigeria	nigeria	PROPN
ajlm-1048	47	32	does	do	AUX
ajlm-1048	47	33	not	not	PART
ajlm-1048	47	34	currently	currently	ADV
ajlm-1048	47	35	practise	practise	VERB
ajlm-1048	47	36	influenza	influenza	ADJ
ajlm-1048	47	37	vaccination	vaccination	NOUN
ajlm-1048	47	38	.	.	PUNCT
ajlm-1048	48	1	statistical	statistical	ADJ
ajlm-1048	48	2	analysis	analysis	NOUN
ajlm-1048	48	3	raw	raw	ADJ
ajlm-1048	48	4	data	datum	NOUN
ajlm-1048	48	5	were	be	AUX
ajlm-1048	48	6	entered	enter	VERB
ajlm-1048	48	7	into	into	ADP
ajlm-1048	48	8	microsoft	microsoft	PROPN
ajlm-1048	48	9	excel	excel	PROPN
ajlm-1048	48	10	,	,	PUNCT
ajlm-1048	48	11	version	version	NOUN
ajlm-1048	48	12	2013	2013	NUM
ajlm-1048	48	13	(	(	PUNCT
ajlm-1048	48	14	microsoft	microsoft	PROPN
ajlm-1048	48	15	corporation	corporation	PROPN
ajlm-1048	48	16	,	,	PUNCT
ajlm-1048	48	17	redmond	redmond	PROPN
ajlm-1048	48	18	,	,	PUNCT
ajlm-1048	48	19	washington	washington	PROPN
ajlm-1048	48	20	,	,	PUNCT
ajlm-1048	48	21	united	united	PROPN
ajlm-1048	48	22	states	states	PROPN
ajlm-1048	48	23	)	)	PUNCT
ajlm-1048	48	24	.	.	PUNCT
ajlm-1048	49	1	descriptive	descriptive	ADJ
ajlm-1048	49	2	statistics	statistic	NOUN
ajlm-1048	49	3	was	be	AUX
ajlm-1048	49	4	performed	perform	VERB
ajlm-1048	49	5	while	while	SCONJ
ajlm-1048	49	6	inferential	inferential	ADJ
ajlm-1048	49	7	statistics	statistic	NOUN
ajlm-1048	49	8	was	be	AUX
ajlm-1048	49	9	analysed	analyse	VERB
ajlm-1048	49	10	with	with	ADP
ajlm-1048	49	11	chi	chi	NOUN
ajlm-1048	49	12	-	-	PUNCT
ajlm-1048	49	13	square	square	NOUN
ajlm-1048	49	14	at	at	ADP
ajlm-1048	49	15	p	p	NOUN
ajlm-1048	49	16	less	less	ADJ
ajlm-1048	49	17	than	than	ADP
ajlm-1048	49	18	0.05	0.05	NUM
ajlm-1048	49	19	for	for	ADP
ajlm-1048	49	20	statistical	statistical	ADJ
ajlm-1048	49	21	significance	significance	NOUN
ajlm-1048	49	22	using	use	VERB
ajlm-1048	49	23	graphpad	graphpad	NOUN
ajlm-1048	49	24	prism	prism	NOUN
ajlm-1048	49	25	version	version	NOUN
ajlm-1048	49	26	8.0.1	8.0.1	PROPN
ajlm-1048	49	27	(	(	PUNCT
ajlm-1048	49	28	graphpad	graphpad	PROPN
ajlm-1048	49	29	software	software	PROPN
ajlm-1048	49	30	inc	inc	PROPN
ajlm-1048	49	31	.	.	PROPN
ajlm-1048	49	32	,	,	PUNCT
ajlm-1048	49	33	san	san	PROPN
ajlm-1048	49	34	diego	diego	PROPN
ajlm-1048	49	35	,	,	PUNCT
ajlm-1048	49	36	california	california	PROPN
ajlm-1048	49	37	,	,	PUNCT
ajlm-1048	49	38	united	united	PROPN
ajlm-1048	49	39	states	states	PROPN
ajlm-1048	49	40	)	)	PUNCT
ajlm-1048	49	41	.	.	PUNCT
ajlm-1048	50	1	results	result	VERB
ajlm-1048	50	2	out	out	ADP
ajlm-1048	50	3	of	of	ADP
ajlm-1048	50	4	the	the	DET
ajlm-1048	50	5	174	174	NUM
ajlm-1048	50	6	hiv	hiv	NOUN
ajlm-1048	50	7	-	-	PUNCT
ajlm-1048	50	8	positive	positive	ADJ
ajlm-1048	50	9	patients	patient	NOUN
ajlm-1048	50	10	tested	test	VERB
ajlm-1048	50	11	,	,	PUNCT
ajlm-1048	50	12	69/174	69/174	PROPN
ajlm-1048	50	13	(	(	PUNCT
ajlm-1048	50	14	39.7	39.7	NUM
ajlm-1048	50	15	%	%	NOUN
ajlm-1048	50	16	)	)	PUNCT
ajlm-1048	50	17	were	be	AUX
ajlm-1048	50	18	seropositive	seropositive	ADJ
ajlm-1048	50	19	for	for	ADP
ajlm-1048	50	20	influenza	influenza	NOUN
ajlm-1048	50	21	a	a	PRON
ajlm-1048	50	22	or	or	CCONJ
ajlm-1048	50	23	b	b	NOUN
ajlm-1048	50	24	viruses	virus	NOUN
ajlm-1048	50	25	,	,	PUNCT
ajlm-1048	50	26	with	with	ADP
ajlm-1048	50	27	58/69	58/69	NUM
ajlm-1048	50	28	(	(	PUNCT
ajlm-1048	50	29	84.1	84.1	NUM
ajlm-1048	50	30	%	%	NOUN
ajlm-1048	50	31	)	)	PUNCT
ajlm-1048	50	32	positive	positive	ADJ
ajlm-1048	50	33	for	for	ADP
ajlm-1048	50	34	influenza	influenza	NOUN
ajlm-1048	50	35	a	a	PRON
ajlm-1048	50	36	,	,	PUNCT
ajlm-1048	50	37	2/69	2/69	NUM
ajlm-1048	50	38	(	(	PUNCT
ajlm-1048	50	39	2.9	2.9	NUM
ajlm-1048	50	40	%	%	NOUN
ajlm-1048	50	41	)	)	PUNCT
ajlm-1048	50	42	for	for	ADP
ajlm-1048	50	43	influenza	influenza	NOUN
ajlm-1048	50	44	b	b	NOUN
ajlm-1048	50	45	,	,	PUNCT
ajlm-1048	50	46	and	and	CCONJ
ajlm-1048	50	47	9/69	9/69	NUM
ajlm-1048	50	48	(	(	PUNCT
ajlm-1048	50	49	13.0	13.0	NUM
ajlm-1048	50	50	%	%	NOUN
ajlm-1048	50	51	)	)	PUNCT
ajlm-1048	50	52	for	for	ADP
ajlm-1048	50	53	both	both	PRON
ajlm-1048	50	54	influenza	influenza	NOUN
ajlm-1048	50	55	a	a	PRON
ajlm-1048	50	56	and	and	CCONJ
ajlm-1048	50	57	b	b	NOUN
ajlm-1048	50	58	(	(	PUNCT
ajlm-1048	50	59	table	table	NOUN
ajlm-1048	50	60	1	1	NUM
ajlm-1048	50	61	)	)	PUNCT
ajlm-1048	50	62	.	.	PUNCT
ajlm-1048	51	1	the	the	DET
ajlm-1048	51	2	median	median	ADJ
ajlm-1048	51	3	age	age	NOUN
ajlm-1048	51	4	of	of	ADP
ajlm-1048	51	5	patients	patient	NOUN
ajlm-1048	51	6	was	be	AUX
ajlm-1048	51	7	44	44	NUM
ajlm-1048	51	8	,	,	PUNCT
ajlm-1048	51	9	mean	mean	VERB
ajlm-1048	51	10	45	45	NUM
ajlm-1048	51	11	,	,	PUNCT
ajlm-1048	51	12	mode	mode	NOUN
ajlm-1048	51	13	40	40	NUM
ajlm-1048	51	14	,	,	PUNCT
ajlm-1048	51	15	and	and	CCONJ
ajlm-1048	51	16	range	range	VERB
ajlm-1048	51	17	18–74	18–74	NUM
ajlm-1048	51	18	years	year	NOUN
ajlm-1048	51	19	.	.	PUNCT
ajlm-1048	52	1	seropositivity	seropositivity	NOUN
ajlm-1048	52	2	was	be	AUX
ajlm-1048	52	3	higher	high	ADJ
ajlm-1048	52	4	in	in	ADP
ajlm-1048	52	5	female	female	ADJ
ajlm-1048	52	6	patients	patient	NOUN
ajlm-1048	52	7	(	(	PUNCT
ajlm-1048	52	8	45/69	45/69	ADJ
ajlm-1048	52	9	;	;	PUNCT
ajlm-1048	52	10	65.2	65.2	NUM
ajlm-1048	52	11	%	%	NOUN
ajlm-1048	52	12	)	)	PUNCT
ajlm-1048	52	13	compared	compare	VERB
ajlm-1048	52	14	to	to	ADP
ajlm-1048	52	15	male	male	ADJ
ajlm-1048	52	16	patients	patient	NOUN
ajlm-1048	52	17	(	(	PUNCT
ajlm-1048	52	18	17/69	17/69	NUM
ajlm-1048	52	19	;	;	PUNCT
ajlm-1048	52	20	24.6	24.6	NUM
ajlm-1048	52	21	%	%	NOUN
ajlm-1048	52	22	)	)	PUNCT
ajlm-1048	52	23	.	.	PUNCT
ajlm-1048	53	1	a	a	DET
ajlm-1048	53	2	total	total	NOUN
ajlm-1048	53	3	of	of	ADP
ajlm-1048	53	4	51/69	51/69	NUM
ajlm-1048	53	5	(	(	PUNCT
ajlm-1048	53	6	73.9	73.9	NUM
ajlm-1048	53	7	%	%	NOUN
ajlm-1048	53	8	)	)	PUNCT
ajlm-1048	53	9	of	of	ADP
ajlm-1048	53	10	the	the	DET
ajlm-1048	53	11	patients	patient	NOUN
ajlm-1048	53	12	were	be	AUX
ajlm-1048	53	13	virologically	virologically	ADV
ajlm-1048	53	14	suppressed	suppress	VERB
ajlm-1048	53	15	with	with	ADP
ajlm-1048	53	16	hiv	hiv	PROPN
ajlm-1048	53	17	rna	rna	PROPN
ajlm-1048	53	18	under	under	ADP
ajlm-1048	53	19	400	400	NUM
ajlm-1048	53	20	copies	copy	NOUN
ajlm-1048	53	21	/	/	SYM
ajlm-1048	53	22	ml	ml	NOUN
ajlm-1048	53	23	,	,	PUNCT
ajlm-1048	53	24	and	and	CCONJ
ajlm-1048	53	25	19/69	19/69	NUM
ajlm-1048	53	26	(	(	PUNCT
ajlm-1048	53	27	27.5	27.5	NUM
ajlm-1048	53	28	%	%	NOUN
ajlm-1048	53	29	)	)	PUNCT
ajlm-1048	53	30	were	be	AUX
ajlm-1048	53	31	immunocompromised	immunocompromise	VERB
ajlm-1048	53	32	(	(	PUNCT
ajlm-1048	53	33	cd4	cd4	X
ajlm-1048	53	34	<	<	X
ajlm-1048	53	35	400	400	NUM
ajlm-1048	53	36	cells	cell	NOUN
ajlm-1048	53	37	/	/	SYM
ajlm-1048	53	38	mm3	mm3	NOUN
ajlm-1048	53	39	)	)	PUNCT
ajlm-1048	53	40	.	.	PUNCT
ajlm-1048	54	1	out	out	ADP
ajlm-1048	54	2	of	of	ADP
ajlm-1048	54	3	the	the	DET
ajlm-1048	54	4	immunocompromised	immunocompromise	VERB
ajlm-1048	54	5	patients	patient	NOUN
ajlm-1048	54	6	,	,	PUNCT
ajlm-1048	54	7	4/19	4/19	NUM
ajlm-1048	54	8	(	(	PUNCT
ajlm-1048	54	9	21.1	21.1	NUM
ajlm-1048	54	10	%	%	NOUN
ajlm-1048	54	11	)	)	PUNCT
ajlm-1048	54	12	were	be	AUX
ajlm-1048	54	13	severely	severely	ADV
ajlm-1048	54	14	immunosuppressed	immunosuppresse	VERB
ajlm-1048	54	15	(	(	PUNCT
ajlm-1048	54	16	cd4	cd4	X
ajlm-1048	54	17	<	<	X
ajlm-1048	54	18	200	200	NUM
ajlm-1048	54	19	cells	cell	NOUN
ajlm-1048	54	20	/	/	SYM
ajlm-1048	54	21	mm3	mm3	NOUN
ajlm-1048	54	22	)	)	PUNCT
ajlm-1048	54	23	.	.	PUNCT
ajlm-1048	55	1	61/69	61/69	NUM
ajlm-1048	55	2	(	(	PUNCT
ajlm-1048	55	3	88.4	88.4	NUM
ajlm-1048	55	4	%	%	NOUN
ajlm-1048	55	5	)	)	PUNCT
ajlm-1048	55	6	of	of	ADP
ajlm-1048	55	7	hiv	hiv	PROPN
ajlm-1048	55	8	patients	patient	NOUN
ajlm-1048	55	9	seropositive	seropositive	ADJ
ajlm-1048	55	10	for	for	ADP
ajlm-1048	55	11	influenza	influenza	NOUN
ajlm-1048	55	12	a	a	PRON
ajlm-1048	55	13	or	or	CCONJ
ajlm-1048	55	14	b	b	NOUN
ajlm-1048	55	15	were	be	AUX
ajlm-1048	55	16	on	on	ADP
ajlm-1048	55	17	fixed	fix	VERB
ajlm-1048	55	18	dose	dose	NOUN
ajlm-1048	55	19	cart	cart	NOUN
ajlm-1048	55	20	compared	compare	VERB
ajlm-1048	55	21	to	to	ADP
ajlm-1048	55	22	those	those	PRON
ajlm-1048	55	23	that	that	PRON
ajlm-1048	55	24	were	be	AUX
ajlm-1048	55	25	seronegative	seronegative	ADJ
ajlm-1048	55	26	:	:	PUNCT
ajlm-1048	55	27	96/105	96/105	NUM
ajlm-1048	55	28	(	(	PUNCT
ajlm-1048	55	29	91.4	91.4	NUM
ajlm-1048	55	30	%	%	NOUN
ajlm-1048	55	31	)	)	PUNCT
ajlm-1048	56	1	(	(	PUNCT
ajlm-1048	56	2	p	p	X
ajlm-1048	56	3	<	<	X
ajlm-1048	56	4	0.001	0.001	NUM
ajlm-1048	56	5	)	)	PUNCT
ajlm-1048	56	6	.	.	PUNCT
ajlm-1048	57	1	table	table	NOUN
ajlm-1048	57	2	1	1	NUM
ajlm-1048	57	3	:	:	PUNCT
ajlm-1048	57	4	 	 	SPACE
ajlm-1048	57	5	characteristics	characteristic	NOUN
ajlm-1048	57	6	of	of	ADP
ajlm-1048	57	7	hiv	hiv	PROPN
ajlm-1048	57	8	patients	patient	NOUN
ajlm-1048	57	9	positive	positive	ADJ
ajlm-1048	57	10	for	for	ADP
ajlm-1048	57	11	influenza	influenza	NOUN
ajlm-1048	57	12	a	a	PRON
ajlm-1048	57	13	and	and	CCONJ
ajlm-1048	57	14	b	b	NOUN
ajlm-1048	57	15	viruses	virus	NOUN
ajlm-1048	57	16	in	in	ADP
ajlm-1048	57	17	2018	2018	NUM
ajlm-1048	57	18	in	in	ADP
ajlm-1048	57	19	a	a	DET
ajlm-1048	57	20	university	university	NOUN
ajlm-1048	57	21	-	-	PUNCT
ajlm-1048	57	22	based	base	VERB
ajlm-1048	57	23	hiv	hiv	PROPN
ajlm-1048	57	24	clinic	clinic	PROPN
ajlm-1048	57	25	in	in	ADP
ajlm-1048	57	26	lagos	lagos	PROPN
ajlm-1048	57	27	,	,	PUNCT
ajlm-1048	57	28	nigeria	nigeria	PROPN
ajlm-1048	57	29	.	.	PUNCT
ajlm-1048	58	1	the	the	DET
ajlm-1048	58	2	most	most	ADV
ajlm-1048	58	3	commonly	commonly	ADV
ajlm-1048	58	4	prescribed	prescribe	VERB
ajlm-1048	58	5	cart	cart	NOUN
ajlm-1048	58	6	used	use	VERB
ajlm-1048	58	7	as	as	ADP
ajlm-1048	58	8	a	a	DET
ajlm-1048	58	9	single	single	ADJ
ajlm-1048	58	10	-	-	PUNCT
ajlm-1048	58	11	pill	pill	NOUN
ajlm-1048	58	12	combination	combination	NOUN
ajlm-1048	58	13	at	at	ADP
ajlm-1048	58	14	the	the	DET
ajlm-1048	58	15	apin	apin	NOUN
ajlm-1048	58	16	clinic	clinic	NOUN
ajlm-1048	58	17	included	include	VERB
ajlm-1048	58	18	atazanavir	atazanavir	PROPN
ajlm-1048	58	19	,	,	PUNCT
ajlm-1048	58	20	azidothymidine	azidothymidine	NOUN
ajlm-1048	58	21	,	,	PUNCT
ajlm-1048	58	22	efavirenz	efavirenz	NOUN
ajlm-1048	58	23	,	,	PUNCT
ajlm-1048	58	24	lamivudine	lamivudine	NOUN
ajlm-1048	58	25	,	,	PUNCT
ajlm-1048	58	26	lopinavir	lopinavir	NOUN
ajlm-1048	58	27	or	or	CCONJ
ajlm-1048	58	28	ritonavir	ritonavir	PROPN
ajlm-1048	58	29	,	,	PUNCT
ajlm-1048	58	30	nevirapine	nevirapine	ADJ
ajlm-1048	58	31	,	,	PUNCT
ajlm-1048	58	32	and	and	CCONJ
ajlm-1048	58	33	tenofovir	tenofovir	NOUN
ajlm-1048	58	34	(	(	PUNCT
ajlm-1048	58	35	table	table	NOUN
ajlm-1048	58	36	2	2	NUM
ajlm-1048	58	37	)	)	PUNCT
ajlm-1048	58	38	.	.	PUNCT
ajlm-1048	59	1	the	the	DET
ajlm-1048	59	2	majority	majority	NOUN
ajlm-1048	59	3	of	of	ADP
ajlm-1048	59	4	patients	patient	NOUN
ajlm-1048	59	5	received	receive	VERB
ajlm-1048	59	6	a	a	DET
ajlm-1048	59	7	combined	combine	VERB
ajlm-1048	59	8	therapy	therapy	NOUN
ajlm-1048	59	9	of	of	ADP
ajlm-1048	59	10	tenofovir	tenofovir	NOUN
ajlm-1048	59	11	,	,	PUNCT
ajlm-1048	59	12	lamivudine	lamivudine	NOUN
ajlm-1048	59	13	and	and	CCONJ
ajlm-1048	59	14	efavirenz	efavirenz	NOUN
ajlm-1048	59	15	(	(	PUNCT
ajlm-1048	59	16	74/174	74/174	NUM
ajlm-1048	59	17	;	;	PUNCT
ajlm-1048	59	18	42.5	42.5	NUM
ajlm-1048	59	19	%	%	NOUN
ajlm-1048	59	20	)	)	PUNCT
ajlm-1048	59	21	or	or	CCONJ
ajlm-1048	59	22	azidothymidine	azidothymidine	NOUN
ajlm-1048	59	23	,	,	PUNCT
ajlm-1048	59	24	lamivudine	lamivudine	NOUN
ajlm-1048	59	25	and	and	CCONJ
ajlm-1048	59	26	nevirapine	nevirapine	PROPN
ajlm-1048	59	27	(	(	PUNCT
ajlm-1048	59	28	64/174	64/174	ADJ
ajlm-1048	59	29	;	;	PUNCT
ajlm-1048	59	30	36.8	36.8	NUM
ajlm-1048	59	31	%	%	NOUN
ajlm-1048	59	32	)	)	PUNCT
ajlm-1048	59	33	.	.	PUNCT
ajlm-1048	60	1	table	table	NOUN
ajlm-1048	60	2	2	2	NUM
ajlm-1048	60	3	:	:	PUNCT
ajlm-1048	60	4	 	 	SPACE
ajlm-1048	60	5	commonly	commonly	ADV
ajlm-1048	60	6	prescribed	prescribe	VERB
ajlm-1048	60	7	combined	combine	VERB
ajlm-1048	60	8	antiretroviral	antiretroviral	ADJ
ajlm-1048	60	9	therapy	therapy	NOUN
ajlm-1048	60	10	regimens	regimen	NOUN
ajlm-1048	60	11	in	in	ADP
ajlm-1048	60	12	hiv	hiv	PROPN
ajlm-1048	60	13	patients	patient	NOUN
ajlm-1048	60	14	positive	positive	ADJ
ajlm-1048	60	15	for	for	ADP
ajlm-1048	60	16	influenza	influenza	NOUN
ajlm-1048	60	17	virus	virus	NOUN
ajlm-1048	60	18	immunoglobulin	immunoglobulin	PROPN
ajlm-1048	60	19	m	m	PROPN
ajlm-1048	60	20	antibodies	antibodie	VERB
ajlm-1048	60	21	in	in	ADP
ajlm-1048	60	22	2018	2018	NUM
ajlm-1048	60	23	in	in	ADP
ajlm-1048	60	24	a	a	DET
ajlm-1048	60	25	university	university	NOUN
ajlm-1048	60	26	-	-	PUNCT
ajlm-1048	60	27	based	base	VERB
ajlm-1048	60	28	hiv	hiv	PROPN
ajlm-1048	60	29	clinic	clinic	PROPN
ajlm-1048	60	30	in	in	ADP
ajlm-1048	60	31	lagos	lagos	PROPN
ajlm-1048	60	32	,	,	PUNCT
ajlm-1048	60	33	nigeria	nigeria	PROPN
ajlm-1048	60	34	.	.	PUNCT
ajlm-1048	61	1	seroprevalence	seroprevalence	NOUN
ajlm-1048	61	2	was	be	AUX
ajlm-1048	61	3	highest	high	ADJ
ajlm-1048	61	4	in	in	ADP
ajlm-1048	61	5	patients	patient	NOUN
ajlm-1048	61	6	aged	age	VERB
ajlm-1048	61	7	41–50	41–50	NUM
ajlm-1048	61	8	years	year	NOUN
ajlm-1048	61	9	(	(	PUNCT
ajlm-1048	61	10	39.1	39.1	NUM
ajlm-1048	61	11	%	%	NOUN
ajlm-1048	61	12	;	;	PUNCT
ajlm-1048	61	13	27/69	27/69	NUM
ajlm-1048	61	14	)	)	PUNCT
ajlm-1048	61	15	,	,	PUNCT
ajlm-1048	61	16	with	with	ADP
ajlm-1048	61	17	no	no	DET
ajlm-1048	61	18	detections	detection	NOUN
ajlm-1048	61	19	in	in	ADP
ajlm-1048	61	20	the	the	DET
ajlm-1048	61	21	age	age	NOUN
ajlm-1048	61	22	groups	group	NOUN
ajlm-1048	61	23	61–70	61–70	PROPN
ajlm-1048	61	24	and	and	CCONJ
ajlm-1048	61	25	71–80	71–80	NUM
ajlm-1048	61	26	years	year	NOUN
ajlm-1048	61	27	(	(	PUNCT
ajlm-1048	61	28	figure	figure	NOUN
ajlm-1048	61	29	1	1	NUM
ajlm-1048	61	30	)	)	PUNCT
ajlm-1048	61	31	.	.	PUNCT
ajlm-1048	62	1	figure	figure	VERB
ajlm-1048	62	2	1	1	NUM
ajlm-1048	62	3	:	:	PUNCT
ajlm-1048	62	4	age	age	NOUN
ajlm-1048	62	5	(	(	PUNCT
ajlm-1048	62	6	years	year	NOUN
ajlm-1048	62	7	)	)	PUNCT
ajlm-1048	62	8	distribution	distribution	NOUN
ajlm-1048	62	9	of	of	ADP
ajlm-1048	62	10	hiv	hiv	PROPN
ajlm-1048	62	11	patients	patient	NOUN
ajlm-1048	62	12	seropositive	seropositive	ADJ
ajlm-1048	62	13	to	to	ADP
ajlm-1048	62	14	influenza	influenza	NOUN
ajlm-1048	62	15	in	in	ADP
ajlm-1048	62	16	2018	2018	NUM
ajlm-1048	62	17	in	in	ADP
ajlm-1048	62	18	a	a	DET
ajlm-1048	62	19	university	university	NOUN
ajlm-1048	62	20	-	-	PUNCT
ajlm-1048	62	21	based	base	VERB
ajlm-1048	62	22	hiv	hiv	PROPN
ajlm-1048	62	23	clinic	clinic	PROPN
ajlm-1048	62	24	in	in	ADP
ajlm-1048	62	25	lagos	lagos	PROPN
ajlm-1048	62	26	,	,	PUNCT
ajlm-1048	62	27	nigeria	nigeria	PROPN
ajlm-1048	62	28	.	.	PUNCT
ajlm-1048	63	1	discussion	discussion	NOUN
ajlm-1048	63	2	in	in	ADP
ajlm-1048	63	3	this	this	DET
ajlm-1048	63	4	study	study	NOUN
ajlm-1048	63	5	,	,	PUNCT
ajlm-1048	63	6	we	we	PRON
ajlm-1048	63	7	described	describe	VERB
ajlm-1048	63	8	the	the	DET
ajlm-1048	63	9	recent	recent	ADJ
ajlm-1048	63	10	infection	infection	NOUN
ajlm-1048	63	11	of	of	ADP
ajlm-1048	63	12	seasonal	seasonal	ADJ
ajlm-1048	63	13	influenza	influenza	NOUN
ajlm-1048	63	14	a	a	PRON
ajlm-1048	63	15	and	and	CCONJ
ajlm-1048	63	16	b	b	NOUN
ajlm-1048	63	17	,	,	PUNCT
ajlm-1048	63	18	and	and	CCONJ
ajlm-1048	63	19	their	their	PRON
ajlm-1048	63	20	co	co	NOUN
ajlm-1048	63	21	-	-	NOUN
ajlm-1048	63	22	infection	infection	NOUN
ajlm-1048	63	23	,	,	PUNCT
ajlm-1048	63	24	among	among	ADP
ajlm-1048	63	25	hiv	hiv	PROPN
ajlm-1048	63	26	patients	patient	NOUN
ajlm-1048	63	27	on	on	ADP
ajlm-1048	63	28	cart	cart	NOUN
ajlm-1048	63	29	in	in	ADP
ajlm-1048	63	30	lagos	lagos	PROPN
ajlm-1048	63	31	,	,	PUNCT
ajlm-1048	63	32	nigeria	nigeria	PROPN
ajlm-1048	63	33	,	,	PUNCT
ajlm-1048	63	34	with	with	ADP
ajlm-1048	63	35	a	a	DET
ajlm-1048	63	36	high	high	ADJ
ajlm-1048	63	37	predominance	predominance	NOUN
ajlm-1048	63	38	of	of	ADP
ajlm-1048	63	39	influenza	influenza	NOUN
ajlm-1048	63	40	a	a	DET
ajlm-1048	63	41	virus	virus	NOUN
ajlm-1048	63	42	.	.	PUNCT
ajlm-1048	64	1	while	while	SCONJ
ajlm-1048	64	2	a	a	DET
ajlm-1048	64	3	high	high	ADJ
ajlm-1048	64	4	proportion	proportion	NOUN
ajlm-1048	64	5	of	of	ADP
ajlm-1048	64	6	the	the	DET
ajlm-1048	64	7	patients	patient	NOUN
ajlm-1048	64	8	were	be	AUX
ajlm-1048	64	9	virologically	virologically	ADV
ajlm-1048	64	10	suppressed	suppress	VERB
ajlm-1048	64	11	,	,	PUNCT
ajlm-1048	64	12	having	have	VERB
ajlm-1048	64	13	hiv	hiv	PROPN
ajlm-1048	64	14	rna	rna	NOUN
ajlm-1048	64	15	under	under	ADP
ajlm-1048	64	16	400	400	NUM
ajlm-1048	64	17	copies	copy	NOUN
ajlm-1048	64	18	/	/	SYM
ajlm-1048	64	19	ml	ml	NOUN
ajlm-1048	64	20	,	,	PUNCT
ajlm-1048	64	21	27.5	27.5	NUM
ajlm-1048	64	22	%	%	NOUN
ajlm-1048	64	23	of	of	ADP
ajlm-1048	64	24	them	they	PRON
ajlm-1048	64	25	were	be	AUX
ajlm-1048	64	26	immunocompromised	immunocompromise	VERB
ajlm-1048	64	27	while	while	SCONJ
ajlm-1048	64	28	21.1	21.1	NUM
ajlm-1048	64	29	%	%	NOUN
ajlm-1048	64	30	were	be	AUX
ajlm-1048	64	31	severely	severely	ADV
ajlm-1048	64	32	immunosuppressed	immunosuppresse	VERB
ajlm-1048	64	33	(	(	PUNCT
ajlm-1048	64	34	cd4	cd4	X
ajlm-1048	64	35	<	<	X
ajlm-1048	64	36	200	200	NUM
ajlm-1048	64	37	cells	cell	NOUN
ajlm-1048	64	38	/	/	SYM
ajlm-1048	64	39	mm3	mm3	NOUN
ajlm-1048	64	40	)	)	PUNCT
ajlm-1048	64	41	.	.	PUNCT
ajlm-1048	65	1	the	the	DET
ajlm-1048	65	2	hospital	hospital	NOUN
ajlm-1048	65	3	population	population	NOUN
ajlm-1048	65	4	-	-	PUNCT
ajlm-1048	65	5	based	base	VERB
ajlm-1048	65	6	study	study	NOUN
ajlm-1048	65	7	revealed	reveal	VERB
ajlm-1048	65	8	an	an	DET
ajlm-1048	65	9	overall	overall	ADJ
ajlm-1048	65	10	seasonal	seasonal	ADJ
ajlm-1048	65	11	influenza	influenza	NOUN
ajlm-1048	65	12	serological	serological	ADJ
ajlm-1048	65	13	prevalence	prevalence	NOUN
ajlm-1048	65	14	of	of	ADP
ajlm-1048	65	15	39.7	39.7	NUM
ajlm-1048	65	16	%	%	NOUN
ajlm-1048	65	17	(	(	PUNCT
ajlm-1048	65	18	69/174	69/174	NOUN
ajlm-1048	65	19	)	)	PUNCT
ajlm-1048	65	20	that	that	PRON
ajlm-1048	65	21	will	will	AUX
ajlm-1048	65	22	serve	serve	VERB
ajlm-1048	65	23	as	as	ADP
ajlm-1048	65	24	a	a	DET
ajlm-1048	65	25	baseline	baseline	NOUN
ajlm-1048	65	26	for	for	ADP
ajlm-1048	65	27	other	other	ADJ
ajlm-1048	65	28	studies	study	NOUN
ajlm-1048	65	29	in	in	ADP
ajlm-1048	65	30	nigeria	nigeria	PROPN
ajlm-1048	65	31	.	.	PUNCT
ajlm-1048	66	1	we	we	PRON
ajlm-1048	66	2	defined	define	VERB
ajlm-1048	66	3	the	the	DET
ajlm-1048	66	4	seasonal	seasonal	ADJ
ajlm-1048	66	5	influenza	influenza	NOUN
ajlm-1048	66	6	virus	virus	NOUN
ajlm-1048	66	7	as	as	ADP
ajlm-1048	66	8	any	any	DET
ajlm-1048	66	9	type	type	NOUN
ajlm-1048	66	10	or	or	CCONJ
ajlm-1048	66	11	subtype	subtype	NOUN
ajlm-1048	66	12	of	of	ADP
ajlm-1048	66	13	influenza	influenza	NOUN
ajlm-1048	66	14	virus	virus	NOUN
ajlm-1048	66	15	including	include	VERB
ajlm-1048	66	16	influenza	influenza	NOUN
ajlm-1048	66	17	a	a	PRON
ajlm-1048	66	18	or	or	CCONJ
ajlm-1048	66	19	b	b	NOUN
ajlm-1048	66	20	that	that	PRON
ajlm-1048	66	21	are	be	AUX
ajlm-1048	66	22	commonly	commonly	ADV
ajlm-1048	66	23	circulating	circulate	VERB
ajlm-1048	66	24	in	in	ADP
ajlm-1048	66	25	our	our	PRON
ajlm-1048	66	26	environment	environment	NOUN
ajlm-1048	66	27	at	at	ADP
ajlm-1048	66	28	any	any	DET
ajlm-1048	66	29	particular	particular	ADJ
ajlm-1048	66	30	point	point	NOUN
ajlm-1048	66	31	in	in	ADP
ajlm-1048	66	32	time	time	NOUN
ajlm-1048	66	33	as	as	ADP
ajlm-1048	66	34	against	against	ADP
ajlm-1048	66	35	a	a	DET
ajlm-1048	66	36	pandemic	pandemic	ADJ
ajlm-1048	66	37	influenza	influenza	NOUN
ajlm-1048	66	38	virus	virus	NOUN
ajlm-1048	66	39	.	.	PUNCT
ajlm-1048	67	1	to	to	ADP
ajlm-1048	67	2	our	our	PRON
ajlm-1048	67	3	knowledge	knowledge	NOUN
ajlm-1048	67	4	,	,	PUNCT
ajlm-1048	67	5	this	this	PRON
ajlm-1048	67	6	is	be	AUX
ajlm-1048	67	7	the	the	DET
ajlm-1048	67	8	first	first	ADJ
ajlm-1048	67	9	study	study	NOUN
ajlm-1048	67	10	on	on	ADP
ajlm-1048	67	11	clinical	clinical	ADJ
ajlm-1048	67	12	and	and	CCONJ
ajlm-1048	67	13	sero	sero	ADJ
ajlm-1048	67	14	-	-	PUNCT
ajlm-1048	67	15	epidemiological	epidemiological	ADJ
ajlm-1048	67	16	prevalence	prevalence	NOUN
ajlm-1048	67	17	of	of	ADP
ajlm-1048	67	18	influenza	influenza	NOUN
ajlm-1048	67	19	viruses	virus	NOUN
ajlm-1048	67	20	in	in	ADP
ajlm-1048	67	21	hiv	hiv	PROPN
ajlm-1048	67	22	patients	patient	NOUN
ajlm-1048	67	23	on	on	ADP
ajlm-1048	67	24	cart	cart	NOUN
ajlm-1048	67	25	in	in	ADP
ajlm-1048	67	26	nigeria	nigeria	PROPN
ajlm-1048	67	27	.	.	PUNCT
ajlm-1048	68	1	the	the	DET
ajlm-1048	68	2	seroprevalence	seroprevalence	NOUN
ajlm-1048	68	3	rate	rate	NOUN
ajlm-1048	68	4	is	be	AUX
ajlm-1048	68	5	comparable	comparable	ADJ
ajlm-1048	68	6	with	with	ADP
ajlm-1048	68	7	the	the	DET
ajlm-1048	68	8	31	31	NUM
ajlm-1048	68	9	%	%	NOUN
ajlm-1048	68	10	serological	serological	ADJ
ajlm-1048	68	11	response	response	NOUN
ajlm-1048	68	12	recorded	record	VERB
ajlm-1048	68	13	in	in	ADP
ajlm-1048	68	14	hiv	hiv	PROPN
ajlm-1048	68	15	-	-	PUNCT
ajlm-1048	68	16	positive	positive	ADJ
ajlm-1048	68	17	individuals	individual	NOUN
ajlm-1048	68	18	in	in	ADP
ajlm-1048	68	19	miami	miami	PROPN
ajlm-1048	68	20	,	,	PUNCT
ajlm-1048	68	21	united	united	PROPN
ajlm-1048	68	22	states.18	states.18	PROPN
ajlm-1048	68	23	a	a	DET
ajlm-1048	68	24	significantly	significantly	ADV
ajlm-1048	68	25	lower	low	ADJ
ajlm-1048	68	26	seroprevalence	seroprevalence	NOUN
ajlm-1048	68	27	rate	rate	NOUN
ajlm-1048	68	28	of	of	ADP
ajlm-1048	68	29	14.7	14.7	NUM
ajlm-1048	68	30	%	%	NOUN
ajlm-1048	68	31	was	be	AUX
ajlm-1048	68	32	recorded	record	VERB
ajlm-1048	68	33	in	in	ADP
ajlm-1048	68	34	taiwan.19	taiwan.19	PROPN
ajlm-1048	68	35	a	a	DET
ajlm-1048	68	36	higher	high	ADJ
ajlm-1048	68	37	prevalence	prevalence	NOUN
ajlm-1048	68	38	rate	rate	NOUN
ajlm-1048	68	39	of	of	ADP
ajlm-1048	68	40	71.6	71.6	NUM
ajlm-1048	68	41	%	%	NOUN
ajlm-1048	68	42	for	for	ADP
ajlm-1048	68	43	influenza	influenza	NOUN
ajlm-1048	68	44	-	-	PUNCT
ajlm-1048	68	45	specific	specific	ADJ
ajlm-1048	68	46	antibody	antibody	NOUN
ajlm-1048	68	47	responses	response	NOUN
ajlm-1048	68	48	in	in	ADP
ajlm-1048	68	49	hiv	hiv	PROPN
ajlm-1048	68	50	patients	patient	NOUN
ajlm-1048	68	51	was	be	AUX
ajlm-1048	68	52	recorded	record	VERB
ajlm-1048	68	53	in	in	ADP
ajlm-1048	68	54	rome	rome	PROPN
ajlm-1048	68	55	,	,	PUNCT
ajlm-1048	68	56	italy.20	italy.20	PROPN
ajlm-1048	68	57	in	in	ADP
ajlm-1048	68	58	africa	africa	PROPN
ajlm-1048	68	59	,	,	PUNCT
ajlm-1048	68	60	lower	low	ADJ
ajlm-1048	68	61	prevalence	prevalence	NOUN
ajlm-1048	68	62	rates	rate	NOUN
ajlm-1048	68	63	of	of	ADP
ajlm-1048	68	64	11	11	NUM
ajlm-1048	68	65	%	%	NOUN
ajlm-1048	68	66	and	and	CCONJ
ajlm-1048	68	67	24.5	24.5	NUM
ajlm-1048	68	68	%	%	NOUN
ajlm-1048	68	69	were	be	AUX
ajlm-1048	68	70	also	also	ADV
ajlm-1048	68	71	recorded	record	VERB
ajlm-1048	68	72	in	in	ADP
ajlm-1048	68	73	malawi	malawi	PROPN
ajlm-1048	68	74	and	and	CCONJ
ajlm-1048	68	75	kenya.21,22	kenya.21,22	VERB
ajlm-1048	68	76	the	the	DET
ajlm-1048	68	77	disparity	disparity	NOUN
ajlm-1048	68	78	observed	observe	VERB
ajlm-1048	68	79	in	in	ADP
ajlm-1048	68	80	the	the	DET
ajlm-1048	68	81	prevalence	prevalence	NOUN
ajlm-1048	68	82	rates	rate	NOUN
ajlm-1048	68	83	could	could	AUX
ajlm-1048	68	84	be	be	AUX
ajlm-1048	68	85	attributed	attribute	VERB
ajlm-1048	68	86	to	to	ADP
ajlm-1048	68	87	differences	difference	NOUN
ajlm-1048	68	88	in	in	ADP
ajlm-1048	68	89	many	many	ADJ
ajlm-1048	68	90	factors	factor	NOUN
ajlm-1048	68	91	including	include	VERB
ajlm-1048	68	92	sample	sample	NOUN
ajlm-1048	68	93	size	size	NOUN
ajlm-1048	68	94	and	and	CCONJ
ajlm-1048	68	95	the	the	DET
ajlm-1048	68	96	assay	assay	NOUN
ajlm-1048	68	97	type	type	NOUN
ajlm-1048	68	98	used	use	VERB
ajlm-1048	68	99	.	.	PUNCT
ajlm-1048	69	1	our	our	PRON
ajlm-1048	69	2	investigation	investigation	NOUN
ajlm-1048	69	3	further	far	ADV
ajlm-1048	69	4	revealed	reveal	VERB
ajlm-1048	69	5	that	that	SCONJ
ajlm-1048	69	6	84.1	84.1	NUM
ajlm-1048	69	7	%	%	NOUN
ajlm-1048	69	8	(	(	PUNCT
ajlm-1048	69	9	58/69	58/69	NUM
ajlm-1048	69	10	)	)	PUNCT
ajlm-1048	69	11	were	be	AUX
ajlm-1048	69	12	immunoglobulin	immunoglobulin	NOUN
ajlm-1048	69	13	m	m	NOUN
ajlm-1048	69	14	seropositive	seropositive	ADJ
ajlm-1048	69	15	for	for	ADP
ajlm-1048	69	16	influenza	influenza	NOUN
ajlm-1048	69	17	a	a	PRON
ajlm-1048	69	18	,	,	PUNCT
ajlm-1048	69	19	indicating	indicate	VERB
ajlm-1048	69	20	an	an	DET
ajlm-1048	69	21	epidemiological	epidemiological	ADJ
ajlm-1048	69	22	predominance	predominance	NOUN
ajlm-1048	69	23	of	of	ADP
ajlm-1048	69	24	the	the	DET
ajlm-1048	69	25	influenza	influenza	NOUN
ajlm-1048	69	26	a	a	PRON
ajlm-1048	69	27	over	over	ADP
ajlm-1048	69	28	the	the	DET
ajlm-1048	69	29	influenza	influenza	NOUN
ajlm-1048	69	30	b	b	PROPN
ajlm-1048	69	31	virus	virus	NOUN
ajlm-1048	69	32	during	during	ADP
ajlm-1048	69	33	the	the	DET
ajlm-1048	69	34	study	study	NOUN
ajlm-1048	69	35	period	period	NOUN
ajlm-1048	69	36	in	in	ADP
ajlm-1048	69	37	lagos	lagos	PROPN
ajlm-1048	69	38	,	,	PUNCT
ajlm-1048	69	39	nigeria	nigeria	PROPN
ajlm-1048	69	40	.	.	PUNCT
ajlm-1048	70	1	in	in	ADP
ajlm-1048	70	2	a	a	DET
ajlm-1048	70	3	study	study	NOUN
ajlm-1048	70	4	conducted	conduct	VERB
ajlm-1048	70	5	in	in	ADP
ajlm-1048	70	6	malawi,21	malawi,21	NOUN
ajlm-1048	70	7	it	it	PRON
ajlm-1048	70	8	was	be	AUX
ajlm-1048	70	9	also	also	ADV
ajlm-1048	70	10	reported	report	VERB
ajlm-1048	70	11	that	that	SCONJ
ajlm-1048	70	12	in	in	ADP
ajlm-1048	70	13	low	low	ADJ
ajlm-1048	70	14	-	-	PUNCT
ajlm-1048	70	15	resource	resource	NOUN
ajlm-1048	70	16	settings	setting	NOUN
ajlm-1048	70	17	with	with	ADP
ajlm-1048	70	18	high	high	ADJ
ajlm-1048	70	19	hiv	hiv	PROPN
ajlm-1048	70	20	prevalence	prevalence	NOUN
ajlm-1048	70	21	,	,	PUNCT
ajlm-1048	70	22	there	there	PRON
ajlm-1048	70	23	is	be	VERB
ajlm-1048	70	24	a	a	DET
ajlm-1048	70	25	high	high	ADJ
ajlm-1048	70	26	prevalence	prevalence	NOUN
ajlm-1048	70	27	of	of	ADP
ajlm-1048	70	28	influenza	influenza	NOUN
ajlm-1048	70	29	illness	illness	NOUN
ajlm-1048	70	30	and	and	CCONJ
ajlm-1048	70	31	greater	great	ADJ
ajlm-1048	70	32	risk	risk	NOUN
ajlm-1048	70	33	of	of	ADP
ajlm-1048	70	34	hospitalisation	hospitalisation	NOUN
ajlm-1048	70	35	among	among	ADP
ajlm-1048	70	36	hiv	hiv	PROPN
ajlm-1048	70	37	-	-	PUNCT
ajlm-1048	70	38	infected	infect	VERB
ajlm-1048	70	39	persons	person	NOUN
ajlm-1048	70	40	which	which	PRON
ajlm-1048	70	41	supports	support	VERB
ajlm-1048	70	42	the	the	DET
ajlm-1048	70	43	high	high	ADJ
ajlm-1048	70	44	prevalence	prevalence	NOUN
ajlm-1048	70	45	rate	rate	NOUN
ajlm-1048	70	46	of	of	ADP
ajlm-1048	70	47	influenza	influenza	NOUN
ajlm-1048	70	48	a	a	DET
ajlm-1048	70	49	detected	detect	VERB
ajlm-1048	70	50	in	in	ADP
ajlm-1048	70	51	this	this	DET
ajlm-1048	70	52	study	study	NOUN
ajlm-1048	70	53	.	.	PUNCT
ajlm-1048	71	1	interestingly	interestingly	ADV
ajlm-1048	71	2	,	,	PUNCT
ajlm-1048	71	3	13.04	13.04	NUM
ajlm-1048	71	4	%	%	NOUN
ajlm-1048	71	5	(	(	PUNCT
ajlm-1048	71	6	9/69	9/69	NUM
ajlm-1048	71	7	)	)	PUNCT
ajlm-1048	71	8	of	of	ADP
ajlm-1048	71	9	the	the	DET
ajlm-1048	71	10	hiv	hiv	PROPN
ajlm-1048	71	11	patients	patient	NOUN
ajlm-1048	71	12	were	be	AUX
ajlm-1048	71	13	seropositive	seropositive	ADJ
ajlm-1048	71	14	for	for	ADP
ajlm-1048	71	15	both	both	PRON
ajlm-1048	71	16	influenza	influenza	NOUN
ajlm-1048	71	17	a	a	DET
ajlm-1048	71	18	and	and	CCONJ
ajlm-1048	71	19	b	b	NOUN
ajlm-1048	71	20	viruses	virus	NOUN
ajlm-1048	71	21	.	.	PUNCT
ajlm-1048	72	1	co	co	NOUN
ajlm-1048	72	2	-	-	NOUN
ajlm-1048	72	3	infection	infection	NOUN
ajlm-1048	72	4	of	of	ADP
ajlm-1048	72	5	influenza	influenza	NOUN
ajlm-1048	72	6	a	a	PRON
ajlm-1048	72	7	and	and	CCONJ
ajlm-1048	72	8	b	b	NOUN
ajlm-1048	72	9	viruses	virus	NOUN
ajlm-1048	72	10	in	in	ADP
ajlm-1048	72	11	hiv	hiv	PROPN
ajlm-1048	72	12	patients	patient	NOUN
ajlm-1048	72	13	may	may	AUX
ajlm-1048	72	14	exacerbate	exacerbate	VERB
ajlm-1048	72	15	the	the	DET
ajlm-1048	72	16	immunocompromised	immunocompromise	VERB
ajlm-1048	72	17	status	status	NOUN
ajlm-1048	72	18	by	by	ADP
ajlm-1048	72	19	further	far	ADV
ajlm-1048	72	20	impairing	impair	VERB
ajlm-1048	72	21	t	t	PROPN
ajlm-1048	72	22	-	-	PUNCT
ajlm-1048	72	23	cell	cell	NOUN
ajlm-1048	72	24	responses	response	NOUN
ajlm-1048	72	25	with	with	ADP
ajlm-1048	72	26	resultant	resultant	ADJ
ajlm-1048	72	27	fatal	fatal	ADJ
ajlm-1048	72	28	consequences	consequence	NOUN
ajlm-1048	72	29	in	in	ADP
ajlm-1048	72	30	such	such	ADJ
ajlm-1048	72	31	individuals	individual	NOUN
ajlm-1048	72	32	.	.	PUNCT
ajlm-1048	73	1	this	this	DET
ajlm-1048	73	2	position	position	NOUN
ajlm-1048	73	3	agrees	agree	VERB
ajlm-1048	73	4	with	with	ADP
ajlm-1048	73	5	previous	previous	ADJ
ajlm-1048	73	6	studies	study	NOUN
ajlm-1048	73	7	that	that	SCONJ
ajlm-1048	73	8	influenza	influenza	NOUN
ajlm-1048	73	9	in	in	ADP
ajlm-1048	73	10	hiv	hiv	PROPN
ajlm-1048	73	11	-	-	PUNCT
ajlm-1048	73	12	infected	infect	VERB
ajlm-1048	73	13	persons	person	NOUN
ajlm-1048	73	14	leads	lead	VERB
ajlm-1048	73	15	to	to	ADP
ajlm-1048	73	16	increased	increase	VERB
ajlm-1048	73	17	and	and	CCONJ
ajlm-1048	73	18	prolonged	prolonged	ADJ
ajlm-1048	73	19	hospitalisation	hospitalisation	NOUN
ajlm-1048	73	20	,	,	PUNCT
ajlm-1048	73	21	and	and	CCONJ
ajlm-1048	73	22	an	an	DET
ajlm-1048	73	23	elevated	elevated	ADJ
ajlm-1048	73	24	risk	risk	NOUN
ajlm-1048	73	25	of	of	ADP
ajlm-1048	73	26	in	in	ADP
ajlm-1048	73	27	-	-	PUNCT
ajlm-1048	73	28	hospital	hospital	NOUN
ajlm-1048	73	29	death.9,11	death.9,11	NOUN
ajlm-1048	73	30	furthermore	furthermore	ADV
ajlm-1048	73	31	,	,	PUNCT
ajlm-1048	73	32	it	it	PRON
ajlm-1048	73	33	is	be	AUX
ajlm-1048	73	34	evident	evident	ADJ
ajlm-1048	73	35	from	from	ADP
ajlm-1048	73	36	previous	previous	ADJ
ajlm-1048	73	37	reports	report	NOUN
ajlm-1048	73	38	that	that	SCONJ
ajlm-1048	73	39	even	even	ADV
ajlm-1048	73	40	mono	mono	NOUN
ajlm-1048	73	41	-	-	PUNCT
ajlm-1048	73	42	infection	infection	NOUN
ajlm-1048	73	43	due	due	ADP
ajlm-1048	73	44	to	to	ADP
ajlm-1048	73	45	influenza	influenza	NOUN
ajlm-1048	73	46	a	a	DET
ajlm-1048	73	47	(	(	PUNCT
ajlm-1048	73	48	h1n1	h1n1	NOUN
ajlm-1048	73	49	)	)	PUNCT
ajlm-1048	73	50	pandemic09	pandemic09	NOUN
ajlm-1048	73	51	(	(	PUNCT
ajlm-1048	73	52	now	now	ADV
ajlm-1048	73	53	seasonal	seasonal	ADJ
ajlm-1048	73	54	influenza	influenza	NOUN
ajlm-1048	73	55	virus	virus	NOUN
ajlm-1048	73	56	)	)	PUNCT
ajlm-1048	73	57	caused	cause	VERB
ajlm-1048	73	58	severe	severe	ADJ
ajlm-1048	73	59	pneumonia	pneumonia	NOUN
ajlm-1048	73	60	leading	lead	VERB
ajlm-1048	73	61	to	to	ADP
ajlm-1048	73	62	acute	acute	ADJ
ajlm-1048	73	63	respiratory	respiratory	ADJ
ajlm-1048	73	64	distress	distress	NOUN
ajlm-1048	73	65	syndrome	syndrome	NOUN
ajlm-1048	73	66	and	and	CCONJ
ajlm-1048	73	67	multiple	multiple	ADJ
ajlm-1048	73	68	organ	organ	NOUN
ajlm-1048	73	69	dysfunction	dysfunction	NOUN
ajlm-1048	73	70	associated	associate	VERB
ajlm-1048	73	71	with	with	ADP
ajlm-1048	73	72	deaths.23,24	deaths.23,24	NOUN
ajlm-1048	73	73	hence	hence	ADV
ajlm-1048	73	74	,	,	PUNCT
ajlm-1048	73	75	simultaneous	simultaneous	ADJ
ajlm-1048	73	76	detection	detection	NOUN
ajlm-1048	73	77	of	of	ADP
ajlm-1048	73	78	influenza	influenza	NOUN
ajlm-1048	73	79	a	a	PRON
ajlm-1048	73	80	and	and	CCONJ
ajlm-1048	73	81	b	b	NOUN
ajlm-1048	73	82	in	in	ADP
ajlm-1048	73	83	patients	patient	NOUN
ajlm-1048	73	84	calls	call	VERB
ajlm-1048	73	85	for	for	ADP
ajlm-1048	73	86	serious	serious	ADJ
ajlm-1048	73	87	public	public	ADJ
ajlm-1048	73	88	health	health	NOUN
ajlm-1048	73	89	intervention	intervention	NOUN
ajlm-1048	73	90	to	to	PART
ajlm-1048	73	91	ameliorate	ameliorate	VERB
ajlm-1048	73	92	the	the	DET
ajlm-1048	73	93	menace	menace	NOUN
ajlm-1048	73	94	of	of	ADP
ajlm-1048	73	95	influenza	influenza	NOUN
ajlm-1048	73	96	co	co	NOUN
ajlm-1048	73	97	-	-	NOUN
ajlm-1048	73	98	infection	infection	NOUN
ajlm-1048	73	99	especially	especially	ADV
ajlm-1048	73	100	in	in	ADP
ajlm-1048	73	101	people	people	NOUN
ajlm-1048	73	102	living	live	VERB
ajlm-1048	73	103	with	with	ADP
ajlm-1048	73	104	hiv	hiv	PROPN
ajlm-1048	73	105	.	.	PUNCT
ajlm-1048	74	1	our	our	PRON
ajlm-1048	74	2	study	study	NOUN
ajlm-1048	74	3	demonstrated	demonstrate	VERB
ajlm-1048	74	4	the	the	DET
ajlm-1048	74	5	highest	high	ADJ
ajlm-1048	74	6	39.1	39.1	NUM
ajlm-1048	74	7	%	%	NOUN
ajlm-1048	74	8	seroprevalence	seroprevalence	NOUN
ajlm-1048	74	9	of	of	ADP
ajlm-1048	74	10	influenza	influenza	NOUN
ajlm-1048	74	11	among	among	ADP
ajlm-1048	74	12	hiv	hiv	PROPN
ajlm-1048	74	13	patients	patient	NOUN
ajlm-1048	74	14	in	in	ADP
ajlm-1048	74	15	the	the	DET
ajlm-1048	74	16	age	age	NOUN
ajlm-1048	74	17	group	group	NOUN
ajlm-1048	74	18	41–50	41–50	NUM
ajlm-1048	74	19	years	year	NOUN
ajlm-1048	74	20	which	which	PRON
ajlm-1048	74	21	disagrees	disagree	VERB
ajlm-1048	74	22	with	with	ADP
ajlm-1048	74	23	the	the	DET
ajlm-1048	74	24	united	united	PROPN
ajlm-1048	74	25	states	states	PROPN
ajlm-1048	74	26	centers	center	NOUN
ajlm-1048	74	27	for	for	ADP
ajlm-1048	74	28	disease	disease	NOUN
ajlm-1048	74	29	control	control	NOUN
ajlm-1048	74	30	and	and	CCONJ
ajlm-1048	74	31	prevention	prevention	NOUN
ajlm-1048	74	32	report	report	NOUN
ajlm-1048	74	33	that	that	SCONJ
ajlm-1048	74	34	persons	person	NOUN
ajlm-1048	74	35	older	old	ADJ
ajlm-1048	74	36	than	than	ADP
ajlm-1048	74	37	65	65	NUM
ajlm-1048	74	38	years	year	NOUN
ajlm-1048	74	39	are	be	AUX
ajlm-1048	74	40	more	more	ADV
ajlm-1048	74	41	likely	likely	ADJ
ajlm-1048	74	42	to	to	PART
ajlm-1048	74	43	be	be	AUX
ajlm-1048	74	44	at	at	ADP
ajlm-1048	74	45	risk	risk	NOUN
ajlm-1048	74	46	of	of	ADP
ajlm-1048	74	47	the	the	DET
ajlm-1048	74	48	influenza	influenza	NOUN
ajlm-1048	74	49	virus.25	virus.25	VERB
ajlm-1048	74	50	our	our	PRON
ajlm-1048	74	51	observation	observation	NOUN
ajlm-1048	74	52	is	be	AUX
ajlm-1048	74	53	however	however	ADV
ajlm-1048	74	54	supported	support	VERB
ajlm-1048	74	55	by	by	ADP
ajlm-1048	74	56	earlier	early	ADJ
ajlm-1048	74	57	findings	finding	NOUN
ajlm-1048	74	58	in	in	ADP
ajlm-1048	74	59	south	south	PROPN
ajlm-1048	74	60	africa	africa	PROPN
ajlm-1048	74	61	in	in	ADP
ajlm-1048	74	62	2009	2009	NUM
ajlm-1048	74	63	to	to	ADP
ajlm-1048	74	64	201111	201111	NUM
ajlm-1048	74	65	and	and	CCONJ
ajlm-1048	74	66	the	the	DET
ajlm-1048	74	67	united	united	PROPN
ajlm-1048	74	68	states	states	PROPN
ajlm-1048	74	69	in	in	ADP
ajlm-1048	74	70	201326	201326	NUM
ajlm-1048	74	71	which	which	PRON
ajlm-1048	74	72	reported	report	VERB
ajlm-1048	74	73	that	that	SCONJ
ajlm-1048	74	74	on	on	ADP
ajlm-1048	74	75	account	account	NOUN
ajlm-1048	74	76	of	of	ADP
ajlm-1048	74	77	hospitalisation	hospitalisation	NOUN
ajlm-1048	74	78	and	and	CCONJ
ajlm-1048	74	79	mortality	mortality	NOUN
ajlm-1048	74	80	rates	rate	NOUN
ajlm-1048	74	81	,	,	PUNCT
ajlm-1048	74	82	older	old	ADJ
ajlm-1048	74	83	adults	adult	NOUN
ajlm-1048	74	84	do	do	AUX
ajlm-1048	74	85	not	not	PART
ajlm-1048	74	86	have	have	VERB
ajlm-1048	74	87	the	the	DET
ajlm-1048	74	88	highest	high	ADJ
ajlm-1048	74	89	rate	rate	NOUN
ajlm-1048	74	90	of	of	ADP
ajlm-1048	74	91	infection	infection	NOUN
ajlm-1048	74	92	and	and	CCONJ
ajlm-1048	74	93	do	do	AUX
ajlm-1048	74	94	not	not	PART
ajlm-1048	74	95	represent	represent	VERB
ajlm-1048	74	96	the	the	DET
ajlm-1048	74	97	main	main	ADJ
ajlm-1048	74	98	contributors	contributor	NOUN
ajlm-1048	74	99	to	to	ADP
ajlm-1048	74	100	local	local	ADJ
ajlm-1048	74	101	outbreaks	outbreak	NOUN
ajlm-1048	74	102	.	.	PUNCT
ajlm-1048	75	1	based	base	VERB
ajlm-1048	75	2	on	on	ADP
ajlm-1048	75	3	gender	gender	NOUN
ajlm-1048	75	4	,	,	PUNCT
ajlm-1048	75	5	a	a	DET
ajlm-1048	75	6	higher	high	ADJ
ajlm-1048	75	7	65.2	65.2	NUM
ajlm-1048	75	8	%	%	NOUN
ajlm-1048	75	9	seroprevalence	seroprevalence	NOUN
ajlm-1048	75	10	was	be	AUX
ajlm-1048	75	11	detected	detect	VERB
ajlm-1048	75	12	among	among	ADP
ajlm-1048	75	13	women	woman	NOUN
ajlm-1048	75	14	compared	compare	VERB
ajlm-1048	75	15	to	to	ADP
ajlm-1048	75	16	24.6	24.6	NUM
ajlm-1048	75	17	%	%	NOUN
ajlm-1048	75	18	among	among	ADP
ajlm-1048	75	19	men	man	NOUN
ajlm-1048	75	20	in	in	ADP
ajlm-1048	75	21	our	our	PRON
ajlm-1048	75	22	study	study	NOUN
ajlm-1048	75	23	,	,	PUNCT
ajlm-1048	75	24	which	which	PRON
ajlm-1048	75	25	is	be	AUX
ajlm-1048	75	26	consistent	consistent	ADJ
ajlm-1048	75	27	with	with	ADP
ajlm-1048	75	28	findings	finding	NOUN
ajlm-1048	75	29	from	from	ADP
ajlm-1048	75	30	malawi27	malawi27	NOUN
ajlm-1048	75	31	that	that	PRON
ajlm-1048	75	32	reported	report	VERB
ajlm-1048	75	33	higher	high	ADJ
ajlm-1048	75	34	seroprevalence	seroprevalence	NOUN
ajlm-1048	75	35	among	among	ADP
ajlm-1048	75	36	women	woman	NOUN
ajlm-1048	75	37	.	.	PUNCT
ajlm-1048	76	1	in	in	ADP
ajlm-1048	76	2	contrast	contrast	NOUN
ajlm-1048	76	3	,	,	PUNCT
ajlm-1048	76	4	a	a	DET
ajlm-1048	76	5	united	united	PROPN
ajlm-1048	76	6	states	states	PROPN
ajlm-1048	76	7	study	study	NOUN
ajlm-1048	76	8	recorded	record	VERB
ajlm-1048	76	9	a	a	DET
ajlm-1048	76	10	higher	high	ADJ
ajlm-1048	76	11	seroprevalence	seroprevalence	NOUN
ajlm-1048	76	12	in	in	ADP
ajlm-1048	76	13	men	man	NOUN
ajlm-1048	76	14	than	than	ADP
ajlm-1048	76	15	in	in	ADP
ajlm-1048	76	16	women.9	women.9	NOUN
ajlm-1048	76	17	a	a	DET
ajlm-1048	76	18	suggested	suggest	VERB
ajlm-1048	76	19	reason	reason	NOUN
ajlm-1048	76	20	for	for	ADP
ajlm-1048	76	21	the	the	DET
ajlm-1048	76	22	higher	high	ADJ
ajlm-1048	76	23	seroprevalence	seroprevalence	NOUN
ajlm-1048	76	24	among	among	ADP
ajlm-1048	76	25	women	woman	NOUN
ajlm-1048	76	26	could	could	AUX
ajlm-1048	76	27	be	be	AUX
ajlm-1048	76	28	the	the	DET
ajlm-1048	76	29	overwhelming	overwhelming	ADJ
ajlm-1048	76	30	burden	burden	NOUN
ajlm-1048	76	31	of	of	ADP
ajlm-1048	76	32	hiv	hiv	PROPN
ajlm-1048	76	33	that	that	PRON
ajlm-1048	76	34	affects	affect	VERB
ajlm-1048	76	35	more	more	ADJ
ajlm-1048	76	36	women	woman	NOUN
ajlm-1048	76	37	in	in	ADP
ajlm-1048	76	38	sub	sub	ADJ
ajlm-1048	76	39	-	-	ADJ
ajlm-1048	76	40	saharan	saharan	ADJ
ajlm-1048	76	41	africa	africa	PROPN
ajlm-1048	76	42	making	make	VERB
ajlm-1048	76	43	them	they	PRON
ajlm-1048	76	44	more	more	ADV
ajlm-1048	76	45	susceptible	susceptible	ADJ
ajlm-1048	76	46	to	to	ADP
ajlm-1048	76	47	influenza	influenza	ADJ
ajlm-1048	76	48	infection	infection	NOUN
ajlm-1048	76	49	.	.	PUNCT
ajlm-1048	77	1	of	of	ADP
ajlm-1048	77	2	the	the	DET
ajlm-1048	77	3	19/69	19/69	NUM
ajlm-1048	77	4	(	(	PUNCT
ajlm-1048	77	5	27.5	27.5	NUM
ajlm-1048	77	6	%	%	NOUN
ajlm-1048	77	7	)	)	PUNCT
ajlm-1048	77	8	immunocompromised	immunocompromise	VERB
ajlm-1048	77	9	patients	patient	NOUN
ajlm-1048	77	10	seropositive	seropositive	ADJ
ajlm-1048	77	11	for	for	ADP
ajlm-1048	77	12	the	the	DET
ajlm-1048	77	13	influenza	influenza	NOUN
ajlm-1048	77	14	virus	virus	NOUN
ajlm-1048	77	15	,	,	PUNCT
ajlm-1048	77	16	4/19	4/19	NUM
ajlm-1048	77	17	(	(	PUNCT
ajlm-1048	77	18	21.1	21.1	NUM
ajlm-1048	77	19	%	%	NOUN
ajlm-1048	77	20	)	)	PUNCT
ajlm-1048	77	21	were	be	AUX
ajlm-1048	77	22	severely	severely	ADV
ajlm-1048	77	23	immunosuppressed	immunosuppresse	VERB
ajlm-1048	77	24	(	(	PUNCT
ajlm-1048	77	25	cd4	cd4	X
ajlm-1048	77	26	<	<	X
ajlm-1048	77	27	200	200	NUM
ajlm-1048	77	28	cells	cell	NOUN
ajlm-1048	77	29	/	/	SYM
ajlm-1048	77	30	mm3	mm3	NOUN
ajlm-1048	77	31	)	)	PUNCT
ajlm-1048	77	32	.	.	PUNCT
ajlm-1048	78	1	however	however	ADV
ajlm-1048	78	2	,	,	PUNCT
ajlm-1048	78	3	the	the	DET
ajlm-1048	78	4	role	role	NOUN
ajlm-1048	78	5	of	of	ADP
ajlm-1048	78	6	cd4	cd4	PROPN
ajlm-1048	78	7	and	and	CCONJ
ajlm-1048	78	8	its	its	PRON
ajlm-1048	78	9	impact	impact	NOUN
ajlm-1048	78	10	on	on	ADP
ajlm-1048	78	11	influenza	influenza	NOUN
ajlm-1048	78	12	in	in	ADP
ajlm-1048	78	13	hiv	hiv	PROPN
ajlm-1048	78	14	-	-	PUNCT
ajlm-1048	78	15	positive	positive	ADJ
ajlm-1048	78	16	patients	patient	NOUN
ajlm-1048	78	17	is	be	AUX
ajlm-1048	78	18	poorly	poorly	ADV
ajlm-1048	78	19	understood	understand	VERB
ajlm-1048	78	20	,	,	PUNCT
ajlm-1048	78	21	partly	partly	ADV
ajlm-1048	78	22	due	due	ADP
ajlm-1048	78	23	to	to	ADP
ajlm-1048	78	24	their	their	PRON
ajlm-1048	78	25	heterogeneity	heterogeneity	NOUN
ajlm-1048	78	26	and	and	CCONJ
ajlm-1048	78	27	lack	lack	NOUN
ajlm-1048	78	28	of	of	ADP
ajlm-1048	78	29	epitope	epitope	NOUN
ajlm-1048	78	30	-	-	PUNCT
ajlm-1048	78	31	specific	specific	ADJ
ajlm-1048	78	32	systems.28	systems.28	NOUN
ajlm-1048	78	33	contrary	contrary	ADJ
ajlm-1048	78	34	to	to	ADP
ajlm-1048	78	35	studies	study	NOUN
ajlm-1048	78	36	in	in	ADP
ajlm-1048	78	37	south	south	PROPN
ajlm-1048	78	38	africa	africa	PROPN
ajlm-1048	78	39	from	from	ADP
ajlm-1048	78	40	2009	2009	NUM
ajlm-1048	78	41	to	to	ADP
ajlm-1048	78	42	201111	201111	NUM
ajlm-1048	78	43	and	and	CCONJ
ajlm-1048	78	44	2012–2016,29	2012–2016,29	NUM
ajlm-1048	78	45	the	the	DET
ajlm-1048	78	46	prevalence	prevalence	NOUN
ajlm-1048	78	47	of	of	ADP
ajlm-1048	78	48	influenza	influenza	NOUN
ajlm-1048	78	49	in	in	ADP
ajlm-1048	78	50	the	the	DET
ajlm-1048	78	51	current	current	ADJ
ajlm-1048	78	52	study	study	NOUN
ajlm-1048	78	53	was	be	AUX
ajlm-1048	78	54	higher	high	ADJ
ajlm-1048	78	55	among	among	ADP
ajlm-1048	78	56	individuals	individual	NOUN
ajlm-1048	78	57	with	with	ADP
ajlm-1048	78	58	a	a	DET
ajlm-1048	78	59	cd4	cd4	PROPN
ajlm-1048	78	60	count	count	NOUN
ajlm-1048	78	61	over	over	ADP
ajlm-1048	78	62	400	400	NUM
ajlm-1048	78	63	compared	compare	VERB
ajlm-1048	78	64	to	to	ADP
ajlm-1048	78	65	those	those	PRON
ajlm-1048	78	66	with	with	ADP
ajlm-1048	78	67	a	a	DET
ajlm-1048	78	68	lower	low	ADJ
ajlm-1048	78	69	cd4	cd4	PROPN
ajlm-1048	78	70	count	count	NOUN
ajlm-1048	78	71	.	.	PUNCT
ajlm-1048	79	1	however	however	ADV
ajlm-1048	79	2	,	,	PUNCT
ajlm-1048	79	3	it	it	PRON
ajlm-1048	79	4	should	should	AUX
ajlm-1048	79	5	be	be	AUX
ajlm-1048	79	6	noted	note	VERB
ajlm-1048	79	7	that	that	SCONJ
ajlm-1048	79	8	the	the	DET
ajlm-1048	79	9	south	south	ADJ
ajlm-1048	79	10	african	african	ADJ
ajlm-1048	79	11	study11	study11	NOUN
ajlm-1048	79	12	reported	report	VERB
ajlm-1048	79	13	influenza	influenza	NOUN
ajlm-1048	79	14	based	base	VERB
ajlm-1048	79	15	on	on	ADP
ajlm-1048	79	16	detection	detection	NOUN
ajlm-1048	79	17	of	of	ADP
ajlm-1048	79	18	virus	virus	NOUN
ajlm-1048	79	19	nucleic	nucleic	ADJ
ajlm-1048	79	20	acids	acid	NOUN
ajlm-1048	79	21	in	in	ADP
ajlm-1048	79	22	symptomatic	symptomatic	ADJ
ajlm-1048	79	23	patients	patient	NOUN
ajlm-1048	79	24	whereas	whereas	SCONJ
ajlm-1048	79	25	the	the	DET
ajlm-1048	79	26	current	current	ADJ
ajlm-1048	79	27	study	study	NOUN
ajlm-1048	79	28	detected	detect	VERB
ajlm-1048	79	29	with	with	ADP
ajlm-1048	79	30	serology	serology	NOUN
ajlm-1048	79	31	a	a	DET
ajlm-1048	79	32	fraction	fraction	NOUN
ajlm-1048	79	33	of	of	ADP
ajlm-1048	79	34	patients	patient	NOUN
ajlm-1048	79	35	who	who	PRON
ajlm-1048	79	36	had	have	VERB
ajlm-1048	79	37	asymptomatic	asymptomatic	ADJ
ajlm-1048	79	38	influenza	influenza	NOUN
ajlm-1048	79	39	infections	infection	NOUN
ajlm-1048	79	40	.	.	PUNCT
ajlm-1048	80	1	similar	similar	ADJ
ajlm-1048	80	2	to	to	ADP
ajlm-1048	80	3	this	this	DET
ajlm-1048	80	4	study	study	NOUN
ajlm-1048	80	5	,	,	PUNCT
ajlm-1048	80	6	a	a	DET
ajlm-1048	80	7	study	study	NOUN
ajlm-1048	80	8	in	in	ADP
ajlm-1048	80	9	the	the	DET
ajlm-1048	80	10	united	united	PROPN
ajlm-1048	80	11	states	states	PROPN
ajlm-1048	80	12	from	from	ADP
ajlm-1048	80	13	2010	2010	NUM
ajlm-1048	80	14	to	to	ADP
ajlm-1048	80	15	20119	20119	NUM
ajlm-1048	80	16	recorded	record	VERB
ajlm-1048	80	17	a	a	DET
ajlm-1048	80	18	higher	high	ADJ
ajlm-1048	80	19	prevalence	prevalence	NOUN
ajlm-1048	80	20	of	of	ADP
ajlm-1048	80	21	influenza	influenza	NOUN
ajlm-1048	80	22	in	in	ADP
ajlm-1048	80	23	patients	patient	NOUN
ajlm-1048	80	24	with	with	ADP
ajlm-1048	80	25	a	a	DET
ajlm-1048	80	26	cd4	cd4	PROPN
ajlm-1048	80	27	count	count	NOUN
ajlm-1048	80	28	over	over	ADP
ajlm-1048	80	29	200	200	NUM
ajlm-1048	80	30	cells	cell	NOUN
ajlm-1048	80	31	/	/	SYM
ajlm-1048	80	32	mm3	mm3	NOUN
ajlm-1048	80	33	than	than	ADP
ajlm-1048	80	34	those	those	PRON
ajlm-1048	80	35	with	with	ADP
ajlm-1048	80	36	less	less	ADJ
ajlm-1048	80	37	than	than	ADP
ajlm-1048	80	38	200	200	NUM
ajlm-1048	80	39	cells	cell	NOUN
ajlm-1048	80	40	/	/	SYM
ajlm-1048	80	41	mm3	mm3	NOUN
ajlm-1048	80	42	.	.	PUNCT
ajlm-1048	81	1	one	one	NUM
ajlm-1048	81	2	possible	possible	ADJ
ajlm-1048	81	3	explanation	explanation	NOUN
ajlm-1048	81	4	for	for	ADP
ajlm-1048	81	5	these	these	DET
ajlm-1048	81	6	observations	observation	NOUN
ajlm-1048	81	7	is	be	AUX
ajlm-1048	81	8	the	the	DET
ajlm-1048	81	9	traditionally	traditionally	ADV
ajlm-1048	81	10	accepted	accept	VERB
ajlm-1048	81	11	role	role	NOUN
ajlm-1048	81	12	of	of	ADP
ajlm-1048	81	13	influenza	influenza	NOUN
ajlm-1048	81	14	-	-	PUNCT
ajlm-1048	81	15	specific	specific	ADJ
ajlm-1048	81	16	cd4	cd4	PROPN
ajlm-1048	81	17	t	t	PROPN
ajlm-1048	81	18	-	-	PUNCT
ajlm-1048	81	19	cells	cell	NOUN
ajlm-1048	81	20	in	in	ADP
ajlm-1048	81	21	providing	provide	VERB
ajlm-1048	81	22	help	help	NOUN
ajlm-1048	81	23	to	to	ADP
ajlm-1048	81	24	b	b	NOUN
ajlm-1048	81	25	-	-	PUNCT
ajlm-1048	81	26	cells	cell	NOUN
ajlm-1048	81	27	for	for	ADP
ajlm-1048	81	28	the	the	DET
ajlm-1048	81	29	production	production	NOUN
ajlm-1048	81	30	of	of	ADP
ajlm-1048	81	31	high	high	ADJ
ajlm-1048	81	32	-	-	PUNCT
ajlm-1048	81	33	quality	quality	NOUN
ajlm-1048	81	34	antibodies.30	antibodies.30	NOUN
ajlm-1048	81	35	hence	hence	ADV
ajlm-1048	81	36	,	,	PUNCT
ajlm-1048	81	37	depletion	depletion	NOUN
ajlm-1048	81	38	of	of	ADP
ajlm-1048	81	39	cd4	cd4	PROPN
ajlm-1048	81	40	t	t	PROPN
ajlm-1048	81	41	-	-	PUNCT
ajlm-1048	81	42	cells	cell	NOUN
ajlm-1048	81	43	prior	prior	ADV
ajlm-1048	81	44	to	to	ADP
ajlm-1048	81	45	influenza	influenza	NOUN
ajlm-1048	81	46	virus	virus	NOUN
ajlm-1048	81	47	infection	infection	NOUN
ajlm-1048	81	48	may	may	AUX
ajlm-1048	81	49	be	be	AUX
ajlm-1048	81	50	responsible	responsible	ADJ
ajlm-1048	81	51	for	for	SCONJ
ajlm-1048	81	52	the	the	DET
ajlm-1048	81	53	low	low	ADJ
ajlm-1048	81	54	prevalence	prevalence	NOUN
ajlm-1048	81	55	observed	observe	VERB
ajlm-1048	81	56	.	.	PUNCT
ajlm-1048	82	1	people	people	NOUN
ajlm-1048	82	2	with	with	ADP
ajlm-1048	82	3	a	a	DET
ajlm-1048	82	4	viral	viral	ADJ
ajlm-1048	82	5	load	load	NOUN
ajlm-1048	82	6	under	under	ADP
ajlm-1048	82	7	400	400	NUM
ajlm-1048	82	8	copies	copy	NOUN
ajlm-1048	82	9	/	/	SYM
ajlm-1048	82	10	ml	ml	PROPN
ajlm-1048	82	11	(	(	PUNCT
ajlm-1048	82	12	73.9	73.9	NUM
ajlm-1048	82	13	%	%	NOUN
ajlm-1048	82	14	)	)	PUNCT
ajlm-1048	82	15	had	have	VERB
ajlm-1048	82	16	the	the	DET
ajlm-1048	82	17	highest	high	ADJ
ajlm-1048	82	18	seroprevalence	seroprevalence	NOUN
ajlm-1048	82	19	of	of	ADP
ajlm-1048	82	20	influenza	influenza	NOUN
ajlm-1048	82	21	virus	virus	NOUN
ajlm-1048	82	22	.	.	PUNCT
ajlm-1048	83	1	this	this	PRON
ajlm-1048	83	2	agrees	agree	VERB
ajlm-1048	83	3	with	with	ADP
ajlm-1048	83	4	a	a	DET
ajlm-1048	83	5	study	study	NOUN
ajlm-1048	83	6	in	in	ADP
ajlm-1048	83	7	the	the	DET
ajlm-1048	83	8	united	united	PROPN
ajlm-1048	83	9	states	states	PROPN
ajlm-1048	83	10	between	between	ADP
ajlm-1048	83	11	2010	2010	NUM
ajlm-1048	83	12	and	and	CCONJ
ajlm-1048	83	13	20119	20119	NUM
ajlm-1048	83	14	that	that	PRON
ajlm-1048	83	15	detected	detect	VERB
ajlm-1048	83	16	influenza	influenza	ADJ
ajlm-1048	83	17	virus	virus	NOUN
ajlm-1048	83	18	in	in	ADP
ajlm-1048	83	19	85	85	NUM
ajlm-1048	83	20	%	%	NOUN
ajlm-1048	83	21	of	of	ADP
ajlm-1048	83	22	virologically	virologically	ADV
ajlm-1048	83	23	suppressed	suppress	VERB
ajlm-1048	83	24	(	(	PUNCT
ajlm-1048	83	25	hiv	hiv	PROPN
ajlm-1048	83	26	rna	rna	PROPN
ajlm-1048	83	27	<	<	X
ajlm-1048	83	28	400	400	NUM
ajlm-1048	83	29	copies	copy	NOUN
ajlm-1048	83	30	/	/	SYM
ajlm-1048	83	31	ml	ml	NOUN
ajlm-1048	83	32	)	)	PUNCT
ajlm-1048	83	33	patients	patient	NOUN
ajlm-1048	83	34	.	.	PUNCT
ajlm-1048	84	1	this	this	PRON
ajlm-1048	84	2	indicates	indicate	VERB
ajlm-1048	84	3	that	that	SCONJ
ajlm-1048	84	4	reduced	reduced	ADJ
ajlm-1048	84	5	viraemia	viraemia	NOUN
ajlm-1048	84	6	of	of	ADP
ajlm-1048	84	7	hiv	hiv	PROPN
ajlm-1048	84	8	does	do	AUX
ajlm-1048	84	9	not	not	PART
ajlm-1048	84	10	reduce	reduce	VERB
ajlm-1048	84	11	the	the	DET
ajlm-1048	84	12	susceptibility	susceptibility	NOUN
ajlm-1048	84	13	of	of	ADP
ajlm-1048	84	14	hiv	hiv	PROPN
ajlm-1048	84	15	patients	patient	NOUN
ajlm-1048	84	16	to	to	ADP
ajlm-1048	84	17	the	the	DET
ajlm-1048	84	18	influenza	influenza	NOUN
ajlm-1048	84	19	virus	virus	NOUN
ajlm-1048	84	20	.	.	PUNCT
ajlm-1048	85	1	among	among	ADP
ajlm-1048	85	2	the	the	DET
ajlm-1048	85	3	165	165	NUM
ajlm-1048	85	4	hiv	hiv	PROPN
ajlm-1048	85	5	patients	patient	NOUN
ajlm-1048	85	6	on	on	ADP
ajlm-1048	85	7	a	a	DET
ajlm-1048	85	8	fixed	fix	VERB
ajlm-1048	85	9	dose	dose	NOUN
ajlm-1048	85	10	combination	combination	NOUN
ajlm-1048	85	11	of	of	ADP
ajlm-1048	85	12	some	some	DET
ajlm-1048	85	13	regularly	regularly	ADV
ajlm-1048	85	14	prescribed	prescribe	VERB
ajlm-1048	85	15	cart	cart	NOUN
ajlm-1048	85	16	including	include	VERB
ajlm-1048	85	17	tenofovir	tenofovir	PROPN
ajlm-1048	85	18	,	,	PUNCT
ajlm-1048	85	19	emtricitabine	emtricitabine	PROPN
ajlm-1048	85	20	,	,	PUNCT
ajlm-1048	85	21	azidothymidine	azidothymidine	NOUN
ajlm-1048	85	22	,	,	PUNCT
ajlm-1048	85	23	atazanavir	atazanavir	PROPN
ajlm-1048	85	24	,	,	PUNCT
ajlm-1048	85	25	efavirenz	efavirenz	PROPN
ajlm-1048	85	26	,	,	PUNCT
ajlm-1048	85	27	nevirapine	nevirapine	ADJ
ajlm-1048	85	28	,	,	PUNCT
ajlm-1048	85	29	and	and	CCONJ
ajlm-1048	85	30	lopinavir	lopinavir	NOUN
ajlm-1048	85	31	or	or	CCONJ
ajlm-1048	85	32	ritonavir	ritonavir	PRON
ajlm-1048	85	33	,	,	PUNCT
ajlm-1048	85	34	61	61	NUM
ajlm-1048	85	35	(	(	PUNCT
ajlm-1048	85	36	37	37	NUM
ajlm-1048	85	37	%	%	NOUN
ajlm-1048	85	38	)	)	PUNCT
ajlm-1048	85	39	were	be	AUX
ajlm-1048	85	40	seropositive	seropositive	ADJ
ajlm-1048	85	41	for	for	ADP
ajlm-1048	85	42	influenza	influenza	NOUN
ajlm-1048	85	43	a	a	PRON
ajlm-1048	85	44	and	and	CCONJ
ajlm-1048	85	45	b	b	NOUN
ajlm-1048	85	46	viruses	virus	NOUN
ajlm-1048	85	47	.	.	PUNCT
ajlm-1048	86	1	the	the	DET
ajlm-1048	86	2	direct	direct	ADJ
ajlm-1048	86	3	relationship	relationship	NOUN
ajlm-1048	86	4	of	of	ADP
ajlm-1048	86	5	cart	cart	NOUN
ajlm-1048	86	6	on	on	ADP
ajlm-1048	86	7	patients	patient	NOUN
ajlm-1048	86	8	and	and	CCONJ
ajlm-1048	86	9	their	their	PRON
ajlm-1048	86	10	seropositivity	seropositivity	NOUN
ajlm-1048	86	11	to	to	ADP
ajlm-1048	86	12	influenza	influenza	NOUN
ajlm-1048	86	13	is	be	AUX
ajlm-1048	86	14	not	not	PART
ajlm-1048	86	15	well	well	ADV
ajlm-1048	86	16	understood	understand	VERB
ajlm-1048	86	17	.	.	PUNCT
ajlm-1048	87	1	nonetheless	nonetheless	ADV
ajlm-1048	87	2	,	,	PUNCT
ajlm-1048	87	3	our	our	PRON
ajlm-1048	87	4	study	study	NOUN
ajlm-1048	87	5	demonstrated	demonstrate	VERB
ajlm-1048	87	6	that	that	SCONJ
ajlm-1048	87	7	hiv	hiv	PROPN
ajlm-1048	87	8	patients	patient	NOUN
ajlm-1048	87	9	on	on	ADP
ajlm-1048	87	10	cart	cart	NOUN
ajlm-1048	87	11	were	be	AUX
ajlm-1048	87	12	susceptible	susceptible	ADJ
ajlm-1048	87	13	to	to	ADP
ajlm-1048	87	14	recent	recent	ADJ
ajlm-1048	87	15	infection	infection	NOUN
ajlm-1048	87	16	with	with	ADP
ajlm-1048	87	17	influenza	influenza	ADJ
ajlm-1048	87	18	viruses	virus	NOUN
ajlm-1048	87	19	.	.	PUNCT
ajlm-1048	88	1	in	in	ADP
ajlm-1048	88	2	support	support	NOUN
ajlm-1048	88	3	of	of	ADP
ajlm-1048	88	4	this	this	DET
ajlm-1048	88	5	finding	finding	NOUN
ajlm-1048	88	6	,	,	PUNCT
ajlm-1048	88	7	a	a	DET
ajlm-1048	88	8	systematic	systematic	ADJ
ajlm-1048	88	9	review	review	NOUN
ajlm-1048	88	10	done	do	VERB
ajlm-1048	88	11	on	on	ADP
ajlm-1048	88	12	co	co	NOUN
ajlm-1048	88	13	-	-	NOUN
ajlm-1048	88	14	infections	infection	NOUN
ajlm-1048	88	15	and	and	CCONJ
ajlm-1048	88	16	comorbidities	comorbiditie	NOUN
ajlm-1048	88	17	of	of	ADP
ajlm-1048	88	18	influenza	influenza	NOUN
ajlm-1048	88	19	in	in	ADP
ajlm-1048	88	20	africa	africa	PROPN
ajlm-1048	88	21	from	from	ADP
ajlm-1048	88	22	1900	1900	NUM
ajlm-1048	88	23	to	to	ADP
ajlm-1048	88	24	20132	20132	NUM
ajlm-1048	88	25	estimated	estimate	VERB
ajlm-1048	88	26	an	an	DET
ajlm-1048	88	27	increased	increased	ADJ
ajlm-1048	88	28	risk	risk	NOUN
ajlm-1048	88	29	of	of	ADP
ajlm-1048	88	30	influenza	influenza	NOUN
ajlm-1048	88	31	-	-	PUNCT
ajlm-1048	88	32	associated	associate	VERB
ajlm-1048	88	33	mortality	mortality	NOUN
ajlm-1048	88	34	among	among	ADP
ajlm-1048	88	35	hiv	hiv	PROPN
ajlm-1048	88	36	-	-	PUNCT
ajlm-1048	88	37	positive	positive	ADJ
ajlm-1048	88	38	individuals	individual	NOUN
ajlm-1048	88	39	even	even	ADV
ajlm-1048	88	40	after	after	ADP
ajlm-1048	88	41	the	the	DET
ajlm-1048	88	42	widespread	widespread	ADJ
ajlm-1048	88	43	introduction	introduction	NOUN
ajlm-1048	88	44	of	of	ADP
ajlm-1048	88	45	cart	cart	NOUN
ajlm-1048	88	46	.	.	PUNCT
ajlm-1048	89	1	also	also	ADV
ajlm-1048	89	2	,	,	PUNCT
ajlm-1048	89	3	a	a	DET
ajlm-1048	89	4	study	study	NOUN
ajlm-1048	89	5	in	in	ADP
ajlm-1048	89	6	the	the	DET
ajlm-1048	89	7	united	united	PROPN
ajlm-1048	89	8	states	states	PROPN
ajlm-1048	89	9	from	from	ADP
ajlm-1048	89	10	2011	2011	NUM
ajlm-1048	89	11	to	to	ADP
ajlm-1048	89	12	201218	201218	NUM
ajlm-1048	89	13	concluded	conclude	VERB
ajlm-1048	89	14	that	that	SCONJ
ajlm-1048	89	15	regardless	regardless	ADV
ajlm-1048	89	16	of	of	ADP
ajlm-1048	89	17	influenza	influenza	NOUN
ajlm-1048	89	18	vaccination	vaccination	NOUN
ajlm-1048	89	19	and	and	CCONJ
ajlm-1048	89	20	control	control	NOUN
ajlm-1048	89	21	of	of	ADP
ajlm-1048	89	22	viral	viral	ADJ
ajlm-1048	89	23	load	load	NOUN
ajlm-1048	89	24	with	with	ADP
ajlm-1048	89	25	cart	cart	NOUN
ajlm-1048	89	26	,	,	PUNCT
ajlm-1048	89	27	hiv	hiv	PROPN
ajlm-1048	89	28	-	-	PUNCT
ajlm-1048	89	29	infected	infect	VERB
ajlm-1048	89	30	patients	patient	NOUN
ajlm-1048	89	31	are	be	AUX
ajlm-1048	89	32	at	at	ADP
ajlm-1048	89	33	an	an	DET
ajlm-1048	89	34	elevated	elevated	ADJ
ajlm-1048	89	35	risk	risk	NOUN
ajlm-1048	89	36	of	of	ADP
ajlm-1048	89	37	acquiring	acquire	VERB
ajlm-1048	89	38	seasonal	seasonal	ADJ
ajlm-1048	89	39	influenza	influenza	ADJ
ajlm-1048	89	40	infection	infection	NOUN
ajlm-1048	89	41	.	.	PUNCT
ajlm-1048	90	1	however	however	ADV
ajlm-1048	90	2	,	,	PUNCT
ajlm-1048	90	3	in	in	ADP
ajlm-1048	90	4	malawi	malawi	PROPN
ajlm-1048	90	5	,	,	PUNCT
ajlm-1048	90	6	the	the	DET
ajlm-1048	90	7	introduction	introduction	NOUN
ajlm-1048	90	8	of	of	ADP
ajlm-1048	90	9	highly	highly	ADV
ajlm-1048	90	10	active	active	ADJ
ajlm-1048	90	11	antiretroviral	antiretroviral	ADJ
ajlm-1048	90	12	therapy	therapy	NOUN
ajlm-1048	90	13	has	have	AUX
ajlm-1048	90	14	led	lead	VERB
ajlm-1048	90	15	to	to	ADP
ajlm-1048	90	16	the	the	DET
ajlm-1048	90	17	reduction	reduction	NOUN
ajlm-1048	90	18	of	of	ADP
ajlm-1048	90	19	influenza	influenza	NOUN
ajlm-1048	90	20	-	-	PUNCT
ajlm-1048	90	21	related	relate	VERB
ajlm-1048	90	22	complications	complication	NOUN
ajlm-1048	90	23	among	among	ADP
ajlm-1048	90	24	hiv	hiv	PROPN
ajlm-1048	90	25	-	-	PUNCT
ajlm-1048	90	26	infected	infect	VERB
ajlm-1048	90	27	patients.31	patients.31	NOUN
ajlm-1048	90	28	limitations	limitation	VERB
ajlm-1048	90	29	one	one	NUM
ajlm-1048	90	30	of	of	ADP
ajlm-1048	90	31	the	the	DET
ajlm-1048	90	32	limitations	limitation	NOUN
ajlm-1048	90	33	of	of	ADP
ajlm-1048	90	34	this	this	DET
ajlm-1048	90	35	study	study	NOUN
ajlm-1048	90	36	is	be	AUX
ajlm-1048	90	37	that	that	SCONJ
ajlm-1048	90	38	positive	positive	ADJ
ajlm-1048	90	39	samples	sample	NOUN
ajlm-1048	90	40	for	for	ADP
ajlm-1048	90	41	the	the	DET
ajlm-1048	90	42	influenza	influenza	NOUN
ajlm-1048	90	43	virus	virus	NOUN
ajlm-1048	90	44	by	by	ADP
ajlm-1048	90	45	enzyme	enzyme	NOUN
ajlm-1048	90	46	linked	link	VERB
ajlm-1048	90	47	immunoassay	immunoassay	NOUN
ajlm-1048	90	48	could	could	AUX
ajlm-1048	90	49	not	not	PART
ajlm-1048	90	50	be	be	AUX
ajlm-1048	90	51	further	far	ADV
ajlm-1048	90	52	tested	test	VERB
ajlm-1048	90	53	by	by	ADP
ajlm-1048	90	54	polymerase	polymerase	NOUN
ajlm-1048	90	55	chain	chain	NOUN
ajlm-1048	90	56	reaction	reaction	NOUN
ajlm-1048	90	57	due	due	ADP
ajlm-1048	90	58	to	to	ADP
ajlm-1048	90	59	the	the	DET
ajlm-1048	90	60	cost	cost	NOUN
ajlm-1048	90	61	implication	implication	NOUN
ajlm-1048	90	62	.	.	PUNCT
ajlm-1048	91	1	also	also	ADV
ajlm-1048	91	2	,	,	PUNCT
ajlm-1048	91	3	serological	serological	ADJ
ajlm-1048	91	4	evidence	evidence	NOUN
ajlm-1048	91	5	from	from	ADP
ajlm-1048	91	6	different	different	ADJ
ajlm-1048	91	7	hiv	hiv	PROPN
ajlm-1048	91	8	treatment	treatment	NOUN
ajlm-1048	91	9	centres	centre	NOUN
ajlm-1048	91	10	are	be	AUX
ajlm-1048	91	11	necessary	necessary	ADJ
ajlm-1048	91	12	for	for	ADP
ajlm-1048	91	13	representative	representative	ADJ
ajlm-1048	91	14	data	datum	NOUN
ajlm-1048	91	15	in	in	ADP
ajlm-1048	91	16	nigeria	nigeria	PROPN
ajlm-1048	91	17	.	.	PUNCT
ajlm-1048	92	1	another	another	DET
ajlm-1048	92	2	limitation	limitation	NOUN
ajlm-1048	92	3	is	be	AUX
ajlm-1048	92	4	that	that	SCONJ
ajlm-1048	92	5	an	an	DET
ajlm-1048	92	6	hiv	hiv	PROPN
ajlm-1048	92	7	-	-	PUNCT
ajlm-1048	92	8	uninfected	uninfected	ADJ
ajlm-1048	92	9	control	control	NOUN
ajlm-1048	92	10	group	group	NOUN
ajlm-1048	92	11	was	be	AUX
ajlm-1048	92	12	not	not	PART
ajlm-1048	92	13	included	include	VERB
ajlm-1048	92	14	in	in	ADP
ajlm-1048	92	15	the	the	DET
ajlm-1048	92	16	study	study	NOUN
ajlm-1048	92	17	for	for	ADP
ajlm-1048	92	18	possible	possible	ADJ
ajlm-1048	92	19	comparison	comparison	NOUN
ajlm-1048	92	20	of	of	ADP
ajlm-1048	92	21	the	the	DET
ajlm-1048	92	22	prevalence	prevalence	NOUN
ajlm-1048	92	23	rates	rate	NOUN
ajlm-1048	92	24	of	of	ADP
ajlm-1048	92	25	influenza	influenza	NOUN
ajlm-1048	92	26	.	.	PUNCT
ajlm-1048	93	1	finally	finally	ADV
ajlm-1048	93	2	,	,	PUNCT
ajlm-1048	93	3	it	it	PRON
ajlm-1048	93	4	should	should	AUX
ajlm-1048	93	5	be	be	AUX
ajlm-1048	93	6	noted	note	VERB
ajlm-1048	93	7	that	that	SCONJ
ajlm-1048	93	8	the	the	DET
ajlm-1048	93	9	study	study	NOUN
ajlm-1048	93	10	was	be	AUX
ajlm-1048	93	11	conducted	conduct	VERB
ajlm-1048	93	12	over	over	ADP
ajlm-1048	93	13	one	one	NUM
ajlm-1048	93	14	influenza	influenza	NOUN
ajlm-1048	93	15	season	season	NOUN
ajlm-1048	93	16	and	and	CCONJ
ajlm-1048	93	17	therefore	therefore	ADV
ajlm-1048	93	18	the	the	DET
ajlm-1048	93	19	impact	impact	NOUN
ajlm-1048	93	20	of	of	ADP
ajlm-1048	93	21	seasonal	seasonal	ADJ
ajlm-1048	93	22	changes	change	NOUN
ajlm-1048	93	23	in	in	ADP
ajlm-1048	93	24	influenza	influenza	NOUN
ajlm-1048	93	25	strains	strain	NOUN
ajlm-1048	93	26	was	be	AUX
ajlm-1048	93	27	not	not	PART
ajlm-1048	93	28	studied	study	VERB
ajlm-1048	93	29	.	.	PUNCT
ajlm-1048	94	1	rather	rather	ADV
ajlm-1048	94	2	our	our	PRON
ajlm-1048	94	3	study	study	NOUN
ajlm-1048	94	4	has	have	AUX
ajlm-1048	94	5	provided	provide	VERB
ajlm-1048	94	6	sero	sero	ADJ
ajlm-1048	94	7	-	-	PUNCT
ajlm-1048	94	8	epidemiological	epidemiological	ADJ
ajlm-1048	94	9	data	datum	NOUN
ajlm-1048	94	10	on	on	ADP
ajlm-1048	94	11	the	the	DET
ajlm-1048	94	12	commonly	commonly	ADV
ajlm-1048	94	13	circulating	circulate	VERB
ajlm-1048	94	14	seasonal	seasonal	ADJ
ajlm-1048	94	15	influenza	influenza	NOUN
ajlm-1048	94	16	virus	virus	NOUN
ajlm-1048	94	17	in	in	ADP
ajlm-1048	94	18	hiv	hiv	PROPN
ajlm-1048	94	19	patients	patient	NOUN
ajlm-1048	94	20	.	.	PUNCT
ajlm-1048	95	1	conclusion	conclusion	NOUN
ajlm-1048	95	2	this	this	DET
ajlm-1048	95	3	study	study	NOUN
ajlm-1048	95	4	demonstrated	demonstrate	VERB
ajlm-1048	95	5	using	use	VERB
ajlm-1048	95	6	serology	serology	NOUN
ajlm-1048	95	7	that	that	PRON
ajlm-1048	95	8	hiv	hiv	PROPN
ajlm-1048	95	9	patients	patient	NOUN
ajlm-1048	95	10	on	on	ADP
ajlm-1048	95	11	cart	cart	NOUN
ajlm-1048	95	12	are	be	AUX
ajlm-1048	95	13	susceptible	susceptible	ADJ
ajlm-1048	95	14	to	to	ADP
ajlm-1048	95	15	both	both	PRON
ajlm-1048	95	16	influenza	influenza	NOUN
ajlm-1048	95	17	a	a	DET
ajlm-1048	95	18	and	and	CCONJ
ajlm-1048	95	19	b	b	NOUN
ajlm-1048	95	20	viruses	virus	NOUN
ajlm-1048	95	21	.	.	PUNCT
ajlm-1048	96	1	it	it	PRON
ajlm-1048	96	2	however	however	ADV
ajlm-1048	96	3	revealed	reveal	VERB
ajlm-1048	96	4	low	low	ADJ
ajlm-1048	96	5	seroprevalence	seroprevalence	NOUN
ajlm-1048	96	6	of	of	ADP
ajlm-1048	96	7	influenza	influenza	NOUN
ajlm-1048	96	8	b	b	PROPN
ajlm-1048	96	9	mono	mono	NOUN
ajlm-1048	96	10	-	-	PUNCT
ajlm-1048	96	11	infection	infection	NOUN
ajlm-1048	96	12	,	,	PUNCT
ajlm-1048	96	13	and	and	CCONJ
ajlm-1048	96	14	influenza	influenza	NOUN
ajlm-1048	96	15	a	a	DET
ajlm-1048	96	16	and	and	CCONJ
ajlm-1048	96	17	b	b	NOUN
ajlm-1048	96	18	co	co	NOUN
ajlm-1048	96	19	-	-	NOUN
ajlm-1048	96	20	infections	infection	NOUN
ajlm-1048	96	21	among	among	ADP
ajlm-1048	96	22	hiv	hiv	PROPN
ajlm-1048	96	23	patients	patient	NOUN
ajlm-1048	96	24	.	.	PUNCT
ajlm-1048	97	1	viral	viral	ADJ
ajlm-1048	97	2	co	co	NOUN
ajlm-1048	97	3	-	-	NOUN
ajlm-1048	97	4	infections	infection	NOUN
ajlm-1048	97	5	may	may	AUX
ajlm-1048	97	6	further	far	ADV
ajlm-1048	97	7	impair	impair	VERB
ajlm-1048	97	8	the	the	DET
ajlm-1048	97	9	already	already	ADV
ajlm-1048	97	10	compromised	compromise	VERB
ajlm-1048	97	11	immune	immune	ADJ
ajlm-1048	97	12	system	system	NOUN
ajlm-1048	97	13	of	of	ADP
ajlm-1048	97	14	hiv	hiv	PROPN
ajlm-1048	97	15	patients	patient	NOUN
ajlm-1048	97	16	.	.	PUNCT
ajlm-1048	98	1	strong	strong	ADJ
ajlm-1048	98	2	advocacy	advocacy	NOUN
ajlm-1048	98	3	on	on	ADP
ajlm-1048	98	4	the	the	DET
ajlm-1048	98	5	need	need	NOUN
ajlm-1048	98	6	to	to	PART
ajlm-1048	98	7	reduce	reduce	VERB
ajlm-1048	98	8	risk	risk	NOUN
ajlm-1048	98	9	of	of	ADP
ajlm-1048	98	10	exposure	exposure	NOUN
ajlm-1048	98	11	to	to	ADP
ajlm-1048	98	12	influenza	influenza	NOUN
ajlm-1048	98	13	,	,	PUNCT
ajlm-1048	98	14	and	and	CCONJ
ajlm-1048	98	15	for	for	ADP
ajlm-1048	98	16	provision	provision	NOUN
ajlm-1048	98	17	of	of	ADP
ajlm-1048	98	18	an	an	DET
ajlm-1048	98	19	influenza	influenza	NOUN
ajlm-1048	98	20	vaccine	vaccine	NOUN
ajlm-1048	98	21	in	in	ADP
ajlm-1048	98	22	nigeria	nigeria	PROPN
ajlm-1048	98	23	,	,	PUNCT
ajlm-1048	98	24	is	be	AUX
ajlm-1048	98	25	recommended	recommend	VERB
ajlm-1048	98	26	to	to	PART
ajlm-1048	98	27	prevent	prevent	VERB
ajlm-1048	98	28	or	or	CCONJ
ajlm-1048	98	29	reduce	reduce	VERB
ajlm-1048	98	30	the	the	DET
ajlm-1048	98	31	complications	complication	NOUN
ajlm-1048	98	32	of	of	ADP
ajlm-1048	98	33	viral	viral	ADJ
ajlm-1048	98	34	co	co	NOUN
ajlm-1048	98	35	-	-	NOUN
ajlm-1048	98	36	infection	infection	NOUN
ajlm-1048	98	37	.	.	PUNCT
ajlm-1048	99	1	acknowledgements	acknowledgement	NOUN
ajlm-1048	99	2	we	we	PRON
ajlm-1048	99	3	sincerely	sincerely	ADV
ajlm-1048	99	4	acknowledge	acknowledge	VERB
ajlm-1048	99	5	all	all	DET
ajlm-1048	99	6	the	the	DET
ajlm-1048	99	7	patients	patient	NOUN
ajlm-1048	99	8	who	who	PRON
ajlm-1048	99	9	volunteered	volunteer	VERB
ajlm-1048	99	10	to	to	PART
ajlm-1048	99	11	be	be	AUX
ajlm-1048	99	12	part	part	NOUN
ajlm-1048	99	13	of	of	ADP
ajlm-1048	99	14	this	this	DET
ajlm-1048	99	15	study	study	NOUN
ajlm-1048	99	16	.	.	PUNCT
ajlm-1048	100	1	we	we	PRON
ajlm-1048	100	2	acknowledge	acknowledge	VERB
ajlm-1048	100	3	the	the	DET
ajlm-1048	100	4	lagos	lagos	PROPN
ajlm-1048	100	5	state	state	NOUN
ajlm-1048	100	6	university	university	PROPN
ajlm-1048	100	7	teaching	teaching	NOUN
ajlm-1048	100	8	hospital	hospital	NOUN
ajlm-1048	100	9	(	(	PUNCT
ajlm-1048	100	10	lasuth	lasuth	NOUN
ajlm-1048	100	11	)	)	PUNCT
ajlm-1048	100	12	directorate	directorate	NOUN
ajlm-1048	100	13	of	of	ADP
ajlm-1048	100	14	clinical	clinical	ADJ
ajlm-1048	100	15	services	service	NOUN
ajlm-1048	100	16	and	and	CCONJ
ajlm-1048	100	17	training	training	NOUN
ajlm-1048	100	18	and	and	CCONJ
ajlm-1048	100	19	the	the	DET
ajlm-1048	100	20	hospital	hospital	NOUN
ajlm-1048	100	21	research	research	PROPN
ajlm-1048	100	22	ethics	ethic	NOUN
ajlm-1048	100	23	committee	committee	PROPN
ajlm-1048	100	24	for	for	ADP
ajlm-1048	100	25	the	the	DET
ajlm-1048	100	26	approval	approval	NOUN
ajlm-1048	100	27	of	of	ADP
ajlm-1048	100	28	the	the	DET
ajlm-1048	100	29	study	study	NOUN
ajlm-1048	100	30	research	research	NOUN
ajlm-1048	100	31	proposal	proposal	NOUN
ajlm-1048	100	32	.	.	PUNCT
ajlm-1048	101	1	we	we	PRON
ajlm-1048	101	2	are	be	AUX
ajlm-1048	101	3	grateful	grateful	ADJ
ajlm-1048	101	4	to	to	ADP
ajlm-1048	101	5	the	the	DET
ajlm-1048	101	6	management	management	NOUN
ajlm-1048	101	7	and	and	CCONJ
ajlm-1048	101	8	staff	staff	NOUN
ajlm-1048	101	9	of	of	ADP
ajlm-1048	101	10	apin	apin	NOUN
ajlm-1048	101	11	-	-	PUNCT
ajlm-1048	101	12	lagos	lagos	NOUN
ajlm-1048	101	13	university	university	NOUN
ajlm-1048	101	14	teaching	teaching	NOUN
ajlm-1048	101	15	hospital	hospital	NOUN
ajlm-1048	101	16	for	for	ADP
ajlm-1048	101	17	the	the	DET
ajlm-1048	101	18	approval	approval	NOUN
ajlm-1048	101	19	for	for	ADP
ajlm-1048	101	20	sample	sample	NOUN
ajlm-1048	101	21	collection	collection	NOUN
ajlm-1048	101	22	.	.	PUNCT
ajlm-1048	102	1	special	special	ADJ
ajlm-1048	102	2	thanks	thank	NOUN
ajlm-1048	102	3	to	to	ADP
ajlm-1048	102	4	all	all	DET
ajlm-1048	102	5	the	the	DET
ajlm-1048	102	6	laboratory	laboratory	NOUN
ajlm-1048	102	7	technologists	technologist	NOUN
ajlm-1048	102	8	who	who	PRON
ajlm-1048	102	9	supported	support	VERB
ajlm-1048	102	10	the	the	DET
ajlm-1048	102	11	student	student	NOUN
ajlm-1048	102	12	’s	’s	PART
ajlm-1048	102	13	research	research	NOUN
ajlm-1048	102	14	work	work	NOUN
ajlm-1048	102	15	.	.	PUNCT
ajlm-1048	103	1	many	many	ADJ
ajlm-1048	103	2	thanks	thank	NOUN
ajlm-1048	103	3	to	to	ADP
ajlm-1048	103	4	all	all	DET
ajlm-1048	103	5	the	the	DET
ajlm-1048	103	6	senior	senior	ADJ
ajlm-1048	103	7	faculty	faculty	NOUN
ajlm-1048	103	8	members	member	NOUN
ajlm-1048	103	9	who	who	PRON
ajlm-1048	103	10	criticised	criticise	VERB
ajlm-1048	103	11	and	and	CCONJ
ajlm-1048	103	12	reviewed	review	VERB
ajlm-1048	103	13	the	the	DET
ajlm-1048	103	14	initial	initial	ADJ
ajlm-1048	103	15	manuscript	manuscript	NOUN
ajlm-1048	103	16	.	.	PUNCT
ajlm-1048	104	1	the	the	DET
ajlm-1048	104	2	abstract	abstract	NOUN
ajlm-1048	104	3	for	for	ADP
ajlm-1048	104	4	this	this	DET
ajlm-1048	104	5	study	study	NOUN
ajlm-1048	104	6	was	be	AUX
ajlm-1048	104	7	presented	present	VERB
ajlm-1048	104	8	at	at	ADP
ajlm-1048	104	9	the	the	DET
ajlm-1048	104	10	52nd	52nd	PROPN
ajlm-1048	104	11	miami	miami	PROPN
ajlm-1048	104	12	winter	winter	NOUN
ajlm-1048	104	13	symposium	symposium	NOUN
ajlm-1048	104	14	2019	2019	NUM
ajlm-1048	104	15	:	:	PUNCT
ajlm-1048	104	16	evolving	evolve	VERB
ajlm-1048	104	17	concepts	concept	NOUN
ajlm-1048	104	18	in	in	ADP
ajlm-1048	104	19	hiv	hiv	PROPN
ajlm-1048	104	20	&	&	CCONJ
ajlm-1048	104	21	emerging	emerge	VERB
ajlm-1048	104	22	viral	viral	ADJ
ajlm-1048	104	23	infections	infection	NOUN
ajlm-1048	104	24	,	,	PUNCT
ajlm-1048	104	25	organised	organise	VERB
ajlm-1048	104	26	by	by	ADP
ajlm-1048	104	27	elsevier	elsevier	PROPN
ajlm-1048	104	28	,	,	PUNCT
ajlm-1048	104	29	university	university	PROPN
ajlm-1048	104	30	of	of	ADP
ajlm-1048	104	31	miami	miami	PROPN
ajlm-1048	104	32	miller	miller	PROPN
ajlm-1048	104	33	school	school	PROPN
ajlm-1048	104	34	of	of	ADP
ajlm-1048	104	35	medicine	medicine	NOUN
ajlm-1048	104	36	,	,	PUNCT
ajlm-1048	104	37	international	international	ADJ
ajlm-1048	104	38	union	union	NOUN
ajlm-1048	104	39	of	of	ADP
ajlm-1048	104	40	biochemistry	biochemistry	NOUN
ajlm-1048	104	41	and	and	CCONJ
ajlm-1048	104	42	molecular	molecular	ADJ
ajlm-1048	104	43	biology	biology	NOUN
ajlm-1048	104	44	in	in	ADP
ajlm-1048	104	45	florida	florida	PROPN
ajlm-1048	104	46	,	,	PUNCT
ajlm-1048	104	47	united	united	PROPN
ajlm-1048	104	48	states	states	PROPN
ajlm-1048	104	49	(	(	PUNCT
ajlm-1048	104	50	27–30	27–30	NUM
ajlm-1048	104	51	january	january	PROPN
ajlm-1048	104	52	2019	2019	NUM
ajlm-1048	104	53	)	)	PUNCT
ajlm-1048	104	54	.	.	PUNCT
ajlm-1048	105	1	competing	compete	VERB
ajlm-1048	105	2	interests	interest	NOUN
ajlm-1048	105	3	the	the	DET
ajlm-1048	105	4	authors	author	NOUN
ajlm-1048	105	5	have	have	AUX
ajlm-1048	105	6	declared	declare	VERB
ajlm-1048	105	7	that	that	SCONJ
ajlm-1048	105	8	no	no	DET
ajlm-1048	105	9	competing	compete	VERB
ajlm-1048	105	10	interest	interest	NOUN
ajlm-1048	105	11	exists	exist	VERB
ajlm-1048	105	12	.	.	PUNCT
ajlm-1048	106	1	authors	author	NOUN
ajlm-1048	106	2	’	’	PART
ajlm-1048	106	3	contributions	contribution	NOUN
ajlm-1048	106	4	a.a.a	a.a.a	PROPN
ajlm-1048	106	5	.	.	PUNCT
ajlm-1048	106	6	was	be	AUX
ajlm-1048	106	7	responsible	responsible	ADJ
ajlm-1048	106	8	for	for	ADP
ajlm-1048	106	9	experimental	experimental	ADJ
ajlm-1048	106	10	design	design	NOUN
ajlm-1048	106	11	and	and	CCONJ
ajlm-1048	106	12	research	research	NOUN
ajlm-1048	106	13	supervision	supervision	NOUN
ajlm-1048	106	14	,	,	PUNCT
ajlm-1048	106	15	data	datum	NOUN
ajlm-1048	106	16	analysis	analysis	NOUN
ajlm-1048	106	17	,	,	PUNCT
ajlm-1048	106	18	laboratory	laboratory	NOUN
ajlm-1048	106	19	investigation	investigation	NOUN
ajlm-1048	106	20	and	and	CCONJ
ajlm-1048	106	21	manuscript	manuscript	NOUN
ajlm-1048	106	22	writing	writing	NOUN
ajlm-1048	106	23	.	.	PUNCT
ajlm-1048	107	1	b.a.a	b.a.a	PROPN
ajlm-1048	107	2	.	.	PUNCT
ajlm-1048	108	1	was	be	AUX
ajlm-1048	108	2	responsible	responsible	ADJ
ajlm-1048	108	3	for	for	ADP
ajlm-1048	108	4	sample	sample	NOUN
ajlm-1048	108	5	collection	collection	NOUN
ajlm-1048	108	6	,	,	PUNCT
ajlm-1048	108	7	laboratory	laboratory	NOUN
ajlm-1048	108	8	investigation	investigation	NOUN
ajlm-1048	108	9	,	,	PUNCT
ajlm-1048	108	10	data	data	VERB
ajlm-1048	108	11	analysis	analysis	NOUN
ajlm-1048	108	12	and	and	CCONJ
ajlm-1048	108	13	manuscript	manuscript	NOUN
ajlm-1048	108	14	writing	writing	NOUN
ajlm-1048	108	15	.	.	PUNCT
ajlm-1048	109	1	sources	source	NOUN
ajlm-1048	109	2	of	of	ADP
ajlm-1048	109	3	support	support	NOUN
ajlm-1048	109	4	this	this	DET
ajlm-1048	109	5	research	research	NOUN
ajlm-1048	109	6	received	receive	VERB
ajlm-1048	109	7	no	no	DET
ajlm-1048	109	8	specific	specific	ADJ
ajlm-1048	109	9	grant	grant	NOUN
ajlm-1048	109	10	from	from	ADP
ajlm-1048	109	11	any	any	DET
ajlm-1048	109	12	funding	funding	NOUN
ajlm-1048	109	13	agency	agency	NOUN
ajlm-1048	109	14	in	in	ADP
ajlm-1048	109	15	the	the	DET
ajlm-1048	109	16	public	public	ADJ
ajlm-1048	109	17	,	,	PUNCT
ajlm-1048	109	18	commercial	commercial	ADJ
ajlm-1048	109	19	or	or	CCONJ
ajlm-1048	109	20	not	not	PART
ajlm-1048	109	21	-	-	PUNCT
ajlm-1048	109	22	for	for	ADP
ajlm-1048	109	23	-	-	PUNCT
ajlm-1048	109	24	profit	profit	NOUN
ajlm-1048	109	25	sectors	sector	NOUN
ajlm-1048	109	26	.	.	PUNCT
ajlm-1048	110	1	data	datum	NOUN
ajlm-1048	110	2	availability	availability	NOUN
ajlm-1048	110	3	statement	statement	NOUN
ajlm-1048	110	4	data	datum	NOUN
ajlm-1048	110	5	sharing	sharing	NOUN
ajlm-1048	110	6	is	be	AUX
ajlm-1048	110	7	not	not	PART
ajlm-1048	110	8	applicable	applicable	ADJ
ajlm-1048	110	9	to	to	ADP
ajlm-1048	110	10	this	this	DET
ajlm-1048	110	11	article	article	NOUN
ajlm-1048	110	12	as	as	SCONJ
ajlm-1048	110	13	no	no	DET
ajlm-1048	110	14	new	new	ADJ
ajlm-1048	110	15	data	datum	NOUN
ajlm-1048	110	16	were	be	AUX
ajlm-1048	110	17	created	create	VERB
ajlm-1048	110	18	or	or	CCONJ
ajlm-1048	110	19	analysed	analyse	VERB
ajlm-1048	110	20	in	in	ADP
ajlm-1048	110	21	this	this	DET
ajlm-1048	110	22	study	study	NOUN
ajlm-1048	110	23	.	.	PUNCT
ajlm-1048	111	1	disclaimer	disclaimer	VERB
ajlm-1048	111	2	the	the	DET
ajlm-1048	111	3	views	view	NOUN
ajlm-1048	111	4	and	and	CCONJ
ajlm-1048	111	5	opinions	opinion	NOUN
ajlm-1048	111	6	expressed	express	VERB
ajlm-1048	111	7	in	in	ADP
ajlm-1048	111	8	this	this	DET
ajlm-1048	111	9	article	article	NOUN
ajlm-1048	111	10	are	be	AUX
ajlm-1048	111	11	those	those	PRON
ajlm-1048	111	12	of	of	ADP
ajlm-1048	111	13	the	the	DET
ajlm-1048	111	14	authors	author	NOUN
ajlm-1048	111	15	and	and	CCONJ
ajlm-1048	111	16	do	do	AUX
ajlm-1048	111	17	not	not	PART
ajlm-1048	111	18	necessarily	necessarily	ADV
ajlm-1048	111	19	reflect	reflect	VERB
ajlm-1048	111	20	the	the	DET
ajlm-1048	111	21	official	official	ADJ
ajlm-1048	111	22	policy	policy	NOUN
ajlm-1048	111	23	or	or	CCONJ
ajlm-1048	111	24	position	position	NOUN
ajlm-1048	111	25	of	of	ADP
ajlm-1048	111	26	any	any	DET
ajlm-1048	111	27	affiliated	affiliated	ADJ
ajlm-1048	111	28	agency	agency	NOUN
ajlm-1048	111	29	of	of	ADP
ajlm-1048	111	30	the	the	DET
ajlm-1048	111	31	authors	author	NOUN
ajlm-1048	111	32	.	.	PUNCT
ajlm-1048	112	1	references	reference	NOUN
ajlm-1048	112	2	who	who	PRON
ajlm-1048	112	3	.	.	PUNCT
ajlm-1048	113	1	influenza	influenza	NOUN
ajlm-1048	113	2	(	(	PUNCT
ajlm-1048	113	3	seasonal	seasonal	ADJ
ajlm-1048	113	4	)	)	PUNCT
ajlm-1048	113	5	signs	sign	NOUN
ajlm-1048	113	6	and	and	CCONJ
ajlm-1048	113	7	symptoms	symptom	NOUN
ajlm-1048	113	8	[	[	X
ajlm-1048	113	9	homepage	homepage	NOUN
ajlm-1048	113	10	on	on	ADP
ajlm-1048	113	11	the	the	DET
ajlm-1048	113	12	internet	internet	NOUN
ajlm-1048	113	13	]	]	PUNCT
ajlm-1048	113	14	.	.	PUNCT
ajlm-1048	114	1	geneva	geneva	PROPN
ajlm-1048	114	2	:	:	PUNCT
ajlm-1048	114	3	who	who	PRON
ajlm-1048	114	4	;	;	PUNCT
ajlm-1048	114	5	2019	2019	NUM
ajlm-1048	114	6	[	[	X
ajlm-1048	114	7	cited	cite	VERB
ajlm-1048	114	8	2019	2019	NUM
ajlm-1048	114	9	feb	feb	NOUN
ajlm-1048	114	10	06	06	NUM
ajlm-1048	114	11	]	]	PUNCT
ajlm-1048	114	12	.	.	PUNCT
ajlm-1048	115	1	available	available	ADJ
ajlm-1048	115	2	from	from	ADP
ajlm-1048	115	3	:	:	PUNCT
ajlm-1048	115	4	https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal	https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal	PROPN
ajlm-1048	115	5	)	)	PUNCT
ajlm-1048	115	6	cohen	cohen	PROPN
ajlm-1048	115	7	al	al	PROPN
ajlm-1048	115	8	,	,	PUNCT
ajlm-1048	115	9	mcmorrow	mcmorrow	PROPN
ajlm-1048	115	10	m	m	PROPN
ajlm-1048	115	11	,	,	PUNCT
ajlm-1048	115	12	walaza	walaza	PROPN
ajlm-1048	115	13	s	s	PROPN
ajlm-1048	115	14	,	,	PUNCT
ajlm-1048	115	15	et	et	PROPN
ajlm-1048	115	16	al	al	PROPN
ajlm-1048	115	17	.	.	PROPN
ajlm-1048	116	1	potential	potential	ADJ
ajlm-1048	116	2	impact	impact	NOUN
ajlm-1048	116	3	of	of	ADP
ajlm-1048	116	4	co	co	NOUN
ajlm-1048	116	5	-	-	NOUN
ajlm-1048	116	6	infections	infection	NOUN
ajlm-1048	116	7	and	and	CCONJ
ajlm-1048	116	8	co	co	NOUN
ajlm-1048	116	9	-	-	NOUN
ajlm-1048	116	10	morbidities	morbidity	NOUN
ajlm-1048	116	11	prevalent	prevalent	ADJ
ajlm-1048	116	12	in	in	ADP
ajlm-1048	116	13	africa	africa	PROPN
ajlm-1048	116	14	on	on	ADP
ajlm-1048	116	15	influenza	influenza	NOUN
ajlm-1048	116	16	severity	severity	NOUN
ajlm-1048	116	17	and	and	CCONJ
ajlm-1048	116	18	frequency	frequency	NOUN
ajlm-1048	116	19	:	:	PUNCT
ajlm-1048	116	20	a	a	DET
ajlm-1048	116	21	systematic	systematic	ADJ
ajlm-1048	116	22	review	review	NOUN
ajlm-1048	116	23	.	.	PUNCT
ajlm-1048	117	1	plos	plos	PROPN
ajlm-1048	117	2	one	one	NUM
ajlm-1048	117	3	.	.	PUNCT
ajlm-1048	118	1	2015;10(6):e0128580	2015;10(6):e0128580	X
ajlm-1048	118	2	.	.	X
ajlm-1048	119	1	https://doi.org/10.1371/journal.pone.0128580	https://doi.org/10.1371/journal.pone.0128580	VERB
ajlm-1048	119	2	cdc	cdc	PROPN
ajlm-1048	119	3	.	.	PUNCT
ajlm-1048	120	1	hiv	hiv	PROPN
ajlm-1048	120	2	basics	basic	NOUN
ajlm-1048	121	1	[	[	X
ajlm-1048	121	2	homepage	homepage	NOUN
ajlm-1048	121	3	on	on	ADP
ajlm-1048	121	4	the	the	DET
ajlm-1048	121	5	internet	internet	NOUN
ajlm-1048	121	6	]	]	PUNCT
ajlm-1048	121	7	.	.	PUNCT
ajlm-1048	122	1	atlanta	atlanta	PROPN
ajlm-1048	122	2	,	,	PUNCT
ajlm-1048	122	3	ga	ga	PROPN
ajlm-1048	122	4	:	:	PUNCT
ajlm-1048	122	5	cdc	cdc	PROPN
ajlm-1048	122	6	;	;	PUNCT
ajlm-1048	122	7	2018	2018	NUM
ajlm-1048	123	1	[	[	PUNCT
ajlm-1048	123	2	cited	cite	VERB
ajlm-1048	123	3	2019	2019	NUM
ajlm-1048	123	4	feb	feb	NOUN
ajlm-1048	123	5	06	06	NUM
ajlm-1048	123	6	]	]	PUNCT
ajlm-1048	123	7	.	.	PUNCT
ajlm-1048	124	1	available	available	ADJ
ajlm-1048	124	2	from	from	ADP
ajlm-1048	124	3	:	:	PUNCT
ajlm-1048	124	4	https://www.cdc.gov/hiv/basics/index.html	https://www.cdc.gov/hiv/basics/index.html	PROPN
ajlm-1048	124	5	who	who	PRON
ajlm-1048	124	6	.	.	PUNCT
ajlm-1048	125	1	hiv	hiv	PROPN
ajlm-1048	125	2	/	/	SYM
ajlm-1048	125	3	aids	aids	PROPN
ajlm-1048	125	4	key	key	ADJ
ajlm-1048	125	5	facts	fact	NOUN
ajlm-1048	125	6	[	[	X
ajlm-1048	125	7	homepage	homepage	NOUN
ajlm-1048	125	8	on	on	ADP
ajlm-1048	125	9	the	the	DET
ajlm-1048	125	10	internet	internet	NOUN
ajlm-1048	125	11	]	]	PUNCT
ajlm-1048	125	12	.	.	PUNCT
ajlm-1048	126	1	geneva	geneva	PROPN
ajlm-1048	126	2	:	:	PUNCT
ajlm-1048	126	3	who	who	PRON
ajlm-1048	126	4	;	;	PUNCT
ajlm-1048	126	5	2018	2018	NUM
ajlm-1048	126	6	[	[	PUNCT
ajlm-1048	126	7	cited	cite	VERB
ajlm-1048	126	8	2019	2019	NUM
ajlm-1048	126	9	feb	feb	NOUN
ajlm-1048	126	10	05	05	NUM
ajlm-1048	126	11	]	]	PUNCT
ajlm-1048	126	12	.	.	PUNCT
ajlm-1048	127	1	available	available	ADJ
ajlm-1048	127	2	from	from	ADP
ajlm-1048	127	3	:	:	PUNCT
ajlm-1048	127	4	https://www.who.int/en/news-room/fact-sheets/detail/hiv-aids	https://www.who.int/en/news-room/fact-sheets/detail/hiv-aid	NOUN
ajlm-1048	127	5	unaids	unaid	NOUN
ajlm-1048	127	6	.	.	PUNCT
ajlm-1048	128	1	joint	joint	ADJ
ajlm-1048	128	2	united	united	PROPN
ajlm-1048	128	3	nations	nations	PROPN
ajlm-1048	128	4	programme	programme	PROPN
ajlm-1048	128	5	on	on	ADP
ajlm-1048	128	6	hiv	hiv	PROPN
ajlm-1048	128	7	and	and	CCONJ
ajlm-1048	128	8	aids	aids	PROPN
ajlm-1048	128	9	,	,	PUNCT
ajlm-1048	128	10	2015	2015	NUM
ajlm-1048	128	11	.	.	PUNCT
ajlm-1048	129	1	factsheet	factsheet	NOUN
ajlm-1048	129	2	2015	2015	NUM
ajlm-1048	129	3	:	:	PUNCT
ajlm-1048	129	4	world	world	NOUN
ajlm-1048	129	5	aids	aids	PROPN
ajlm-1048	129	6	day	day	NOUN
ajlm-1048	129	7	2015	2015	NUM
ajlm-1048	129	8	.	.	PUNCT
ajlm-1048	130	1	geneva	geneva	NOUN
ajlm-1048	130	2	:	:	PUNCT
ajlm-1048	130	3	unaids	unaid	NOUN
ajlm-1048	130	4	;	;	PUNCT
ajlm-1048	130	5	2015	2015	NUM
ajlm-1048	130	6	.	.	PUNCT
ajlm-1048	131	1	awofala	awofala	PROPN
ajlm-1048	131	2	aa	aa	PROPN
ajlm-1048	131	3	,	,	PUNCT
ajlm-1048	131	4	ogundele	ogundele	PROPN
ajlm-1048	131	5	oe	oe	PROPN
ajlm-1048	131	6	.	.	PUNCT
ajlm-1048	132	1	hiv	hiv	PROPN
ajlm-1048	132	2	epidemiology	epidemiology	NOUN
ajlm-1048	132	3	in	in	ADP
ajlm-1048	132	4	nigeria	nigeria	PROPN
ajlm-1048	132	5	.	.	PUNCT
ajlm-1048	133	1	saudi	saudi	PROPN
ajlm-1048	133	2	j	j	PROPN
ajlm-1048	133	3	biol	biol	PROPN
ajlm-1048	133	4	sci	sci	PROPN
ajlm-1048	133	5	.	.	PUNCT
ajlm-1048	133	6	2018;25(4):697–703	2018;25(4):697–703	NUM
ajlm-1048	133	7	.	.	PUNCT
ajlm-1048	133	8	https://doi.org/10.1016/j.sjbs.2016.03.006	https://doi.org/10.1016/j.sjbs.2016.03.006	NOUN
ajlm-1048	133	9	unaids	unaid	NOUN
ajlm-1048	133	10	.	.	PUNCT
ajlm-1048	134	1	country	country	NOUN
ajlm-1048	134	2	factsheets	factsheet	VERB
ajlm-1048	134	3	nigeria	nigeria	PROPN
ajlm-1048	134	4	2017	2017	NUM
ajlm-1048	134	5	:	:	PUNCT
ajlm-1048	134	6	hiv	hiv	PROPN
ajlm-1048	134	7	and	and	CCONJ
ajlm-1048	134	8	aids	aids	PROPN
ajlm-1048	134	9	estimates	estimate	VERB
ajlm-1048	135	1	[	[	X
ajlm-1048	135	2	homepage	homepage	NOUN
ajlm-1048	135	3	on	on	ADP
ajlm-1048	135	4	the	the	DET
ajlm-1048	135	5	internet	internet	NOUN
ajlm-1048	135	6	]	]	PUNCT
ajlm-1048	135	7	.	.	PUNCT
ajlm-1048	136	1	unaids	unaid	NOUN
ajlm-1048	136	2	;	;	PUNCT
ajlm-1048	136	3	2017	2017	NUM
ajlm-1048	136	4	[	[	PUNCT
ajlm-1048	136	5	cited	cite	VERB
ajlm-1048	136	6	2019	2019	NUM
ajlm-1048	136	7	feb	feb	NOUN
ajlm-1048	136	8	06	06	NUM
ajlm-1048	136	9	]	]	PUNCT
ajlm-1048	136	10	.	.	PUNCT
ajlm-1048	137	1	available	available	ADJ
ajlm-1048	137	2	from	from	ADP
ajlm-1048	137	3	:	:	PUNCT
ajlm-1048	137	4	http://www.unaids.org/en/regionscountries/countries/nigeria	http://www.unaids.org/en/regionscountries/countries/nigeria	PROPN
ajlm-1048	137	5	unaids	unaid	NOUN
ajlm-1048	137	6	.	.	PUNCT
ajlm-1048	138	1	unaids	unaid	NOUN
ajlm-1048	138	2	data	data	PROPN
ajlm-1048	138	3	2018	2018	NUM
ajlm-1048	138	4	:	:	PUNCT
ajlm-1048	138	5	world	world	NOUN
ajlm-1048	138	6	’s	’s	PART
ajlm-1048	138	7	response	response	NOUN
ajlm-1048	138	8	to	to	ADP
ajlm-1048	138	9	hiv	hiv	PROPN
ajlm-1048	139	1	[	[	X
ajlm-1048	139	2	homepage	homepage	NOUN
ajlm-1048	139	3	on	on	ADP
ajlm-1048	139	4	the	the	DET
ajlm-1048	139	5	internet	internet	NOUN
ajlm-1048	139	6	]	]	PUNCT
ajlm-1048	139	7	.	.	PUNCT
ajlm-1048	140	1	geneva	geneva	NOUN
ajlm-1048	140	2	:	:	PUNCT
ajlm-1048	140	3	unaids	unaid	NOUN
ajlm-1048	140	4	;	;	PUNCT
ajlm-1048	140	5	2018	2018	NUM
ajlm-1048	140	6	[	[	PUNCT
ajlm-1048	140	7	cited	cite	VERB
ajlm-1048	140	8	2019	2019	NUM
ajlm-1048	140	9	feb	feb	NOUN
ajlm-1048	140	10	06	06	NUM
ajlm-1048	140	11	]	]	PUNCT
ajlm-1048	140	12	.	.	PUNCT
ajlm-1048	141	1	available	available	ADJ
ajlm-1048	141	2	from	from	ADP
ajlm-1048	141	3	:	:	PUNCT
ajlm-1048	141	4	http://www.unaids.org/sites/default/files/media_asset/unaids-data-2018_en.pdf	http://www.unaids.org/sites/default/files/media_asset/unaids-data-2018_en.pdf	X
ajlm-1048	141	5	patel	patel	PROPN
ajlm-1048	141	6	p	p	X
ajlm-1048	141	7	,	,	PUNCT
ajlm-1048	141	8	bush	bush	PROPN
ajlm-1048	141	9	t	t	PROPN
ajlm-1048	141	10	,	,	PUNCT
ajlm-1048	141	11	kojic	kojic	PROPN
ajlm-1048	141	12	em	em	PRON
ajlm-1048	141	13	,	,	PUNCT
ajlm-1048	141	14	et	et	PROPN
ajlm-1048	141	15	al	al	PROPN
ajlm-1048	141	16	.	.	PUNCT
ajlm-1048	141	17	duration	duration	NOUN
ajlm-1048	141	18	of	of	ADP
ajlm-1048	141	19	influenza	influenza	NOUN
ajlm-1048	141	20	virus	virus	NOUN
ajlm-1048	141	21	shedding	shed	VERB
ajlm-1048	141	22	among	among	ADP
ajlm-1048	141	23	hiv	hiv	PROPN
ajlm-1048	141	24	-	-	PUNCT
ajlm-1048	141	25	infected	infect	VERB
ajlm-1048	141	26	adults	adult	NOUN
ajlm-1048	141	27	in	in	ADP
ajlm-1048	141	28	the	the	DET
ajlm-1048	141	29	cart	cart	NOUN
ajlm-1048	141	30	era	era	NOUN
ajlm-1048	141	31	,	,	PUNCT
ajlm-1048	141	32	2010–2011	2010–2011	NUM
ajlm-1048	141	33	.	.	PUNCT
ajlm-1048	142	1	aids	aids	PROPN
ajlm-1048	142	2	res	re	NOUN
ajlm-1048	142	3	hum	hum	ADJ
ajlm-1048	142	4	retrovir	retrovir	PROPN
ajlm-1048	142	5	.	.	PUNCT
ajlm-1048	143	1	2016;32(12):1180–1186	2016;32(12):1180–1186	X
ajlm-1048	143	2	.	.	PUNCT
ajlm-1048	144	1	https://doi.org/10.1089/aid.2015.0349	https://doi.org/10.1089/aid.2015.0349	PROPN
ajlm-1048	144	2	abadom	abadom	PROPN
ajlm-1048	144	3	tr	tr	VERB
ajlm-1048	144	4	,	,	PUNCT
ajlm-1048	144	5	smith	smith	PROPN
ajlm-1048	144	6	ad	ad	NOUN
ajlm-1048	144	7	,	,	PUNCT
ajlm-1048	144	8	tempia	tempia	PROPN
ajlm-1048	144	9	s	s	PROPN
ajlm-1048	144	10	,	,	PUNCT
ajlm-1048	144	11	madhi	madhi	PROPN
ajlm-1048	144	12	sa	sa	PROPN
ajlm-1048	144	13	,	,	PUNCT
ajlm-1048	144	14	cohen	cohen	PROPN
ajlm-1048	144	15	c	c	PROPN
ajlm-1048	144	16	,	,	PUNCT
ajlm-1048	144	17	cohen	cohen	PROPN
ajlm-1048	144	18	al	al	PROPN
ajlm-1048	144	19	.	.	PROPN
ajlm-1048	145	1	risk	risk	NOUN
ajlm-1048	145	2	factors	factor	NOUN
ajlm-1048	145	3	associated	associate	VERB
ajlm-1048	145	4	with	with	ADP
ajlm-1048	145	5	hospitalization	hospitalization	NOUN
ajlm-1048	145	6	for	for	ADP
ajlm-1048	145	7	influenza	influenza	NOUN
ajlm-1048	145	8	-	-	PUNCT
ajlm-1048	145	9	associated	associate	VERB
ajlm-1048	145	10	severe	severe	ADJ
ajlm-1048	145	11	acute	acute	ADJ
ajlm-1048	145	12	respiratory	respiratory	ADJ
ajlm-1048	145	13	illness	illness	NOUN
ajlm-1048	145	14	in	in	ADP
ajlm-1048	145	15	south	south	PROPN
ajlm-1048	145	16	africa	africa	PROPN
ajlm-1048	145	17	:	:	PUNCT
ajlm-1048	145	18	a	a	DET
ajlm-1048	145	19	case	case	NOUN
ajlm-1048	145	20	-	-	PUNCT
ajlm-1048	145	21	population	population	NOUN
ajlm-1048	145	22	study	study	NOUN
ajlm-1048	145	23	.	.	PUNCT
ajlm-1048	146	1	vaccine	vaccine	NOUN
ajlm-1048	146	2	.	.	PUNCT
ajlm-1048	147	1	2016;34(46):5649–5455	2016;34(46):5649–5455	X
ajlm-1048	147	2	.	.	PUNCT
ajlm-1048	148	1	https://doi.org/10.1016/j.vaccine.2016.09.011	https://doi.org/10.1016/j.vaccine.2016.09.011	PROPN
ajlm-1048	148	2	cohen	cohen	NOUN
ajlm-1048	148	3	c	c	PROPN
ajlm-1048	148	4	,	,	PUNCT
ajlm-1048	148	5	moyes	moyes	PROPN
ajlm-1048	148	6	j	j	PROPN
ajlm-1048	148	7	,	,	PUNCT
ajlm-1048	148	8	tempia	tempia	PROPN
ajlm-1048	148	9	s	s	PROPN
ajlm-1048	148	10	,	,	PUNCT
ajlm-1048	148	11	et	et	PROPN
ajlm-1048	148	12	al	al	PROPN
ajlm-1048	148	13	.	.	PROPN
ajlm-1048	149	1	severe	severe	ADJ
ajlm-1048	149	2	influenza	influenza	NOUN
ajlm-1048	149	3	-	-	PUNCT
ajlm-1048	149	4	associated	associate	VERB
ajlm-1048	149	5	respiratory	respiratory	ADJ
ajlm-1048	149	6	infection	infection	NOUN
ajlm-1048	149	7	in	in	ADP
ajlm-1048	149	8	high	high	ADJ
ajlm-1048	149	9	hiv	hiv	PROPN
ajlm-1048	149	10	prevalence	prevalence	NOUN
ajlm-1048	149	11	setting	setting	NOUN
ajlm-1048	149	12	,	,	PUNCT
ajlm-1048	149	13	south	south	PROPN
ajlm-1048	149	14	africa	africa	PROPN
ajlm-1048	149	15	,	,	PUNCT
ajlm-1048	149	16	2009–2011	2009–2011	NUM
ajlm-1048	149	17	.	.	PUNCT
ajlm-1048	150	1	emerg	emerg	PROPN
ajlm-1048	150	2	infect	infect	PROPN
ajlm-1048	150	3	dis	dis	PROPN
ajlm-1048	150	4	.	.	PUNCT
ajlm-1048	151	1	2013;19(11):1766	2013;19(11):1766	X
ajlm-1048	151	2	.	.	PUNCT
ajlm-1048	151	3	https://doi.org/10.3201/eid1911.130546	https://doi.org/10.3201/eid1911.130546	PROPN
ajlm-1048	151	4	castrucci	castrucci	PROPN
ajlm-1048	151	5	mr	mr	PROPN
ajlm-1048	151	6	.	.	PROPN
ajlm-1048	151	7	factors	factor	NOUN
ajlm-1048	151	8	affecting	affect	VERB
ajlm-1048	151	9	immune	immune	ADJ
ajlm-1048	151	10	responses	response	NOUN
ajlm-1048	151	11	to	to	ADP
ajlm-1048	151	12	the	the	DET
ajlm-1048	151	13	influenza	influenza	NOUN
ajlm-1048	151	14	vaccine	vaccine	NOUN
ajlm-1048	151	15	.	.	PUNCT
ajlm-1048	152	1	hum	hum	PROPN
ajlm-1048	152	2	vaccin	vaccin	PROPN
ajlm-1048	152	3	immunother	immunother	PROPN
ajlm-1048	152	4	.	.	PUNCT
ajlm-1048	153	1	2018;14(3):637–646	2018;14(3):637–646	X
ajlm-1048	153	2	.	.	PUNCT
ajlm-1048	154	1	https://doi.org/10.1080/21645515.2017.1338547	https://doi.org/10.1080/21645515.2017.1338547	PROPN
ajlm-1048	154	2	ceravolo	ceravolo	PROPN
ajlm-1048	154	3	a	a	PRON
ajlm-1048	154	4	,	,	PUNCT
ajlm-1048	154	5	orsi	orsi	PROPN
ajlm-1048	154	6	a	a	PRON
ajlm-1048	154	7	,	,	PUNCT
ajlm-1048	154	8	parodi	parodi	PROPN
ajlm-1048	154	9	v	v	NOUN
ajlm-1048	154	10	,	,	PUNCT
ajlm-1048	154	11	rosselli	rosselli	NOUN
ajlm-1048	154	12	r	r	NOUN
ajlm-1048	154	13	,	,	PUNCT
ajlm-1048	154	14	ansaldi	ansaldi	PROPN
ajlm-1048	154	15	f.	f.	PROPN
ajlm-1048	154	16	influenza	influenza	PROPN
ajlm-1048	154	17	vaccination	vaccination	NOUN
ajlm-1048	154	18	in	in	ADP
ajlm-1048	154	19	hiv	hiv	PROPN
ajlm-1048	154	20	-	-	PUNCT
ajlm-1048	154	21	positive	positive	ADJ
ajlm-1048	154	22	subjects	subject	NOUN
ajlm-1048	154	23	:	:	PUNCT
ajlm-1048	154	24	latest	late	ADJ
ajlm-1048	154	25	evidence	evidence	NOUN
ajlm-1048	154	26	and	and	CCONJ
ajlm-1048	154	27	future	future	ADJ
ajlm-1048	154	28	perspective	perspective	NOUN
ajlm-1048	154	29	.	.	PUNCT
ajlm-1048	155	1	j	j	PROPN
ajlm-1048	155	2	prevent	prevent	VERB
ajlm-1048	155	3	med	med	PROPN
ajlm-1048	155	4	hyg	hyg	PROPN
ajlm-1048	155	5	.	.	PROPN
ajlm-1048	155	6	2013;54(1):1	2013;54(1):1	PROPN
ajlm-1048	155	7	.	.	PUNCT
ajlm-1048	156	1	laurie	laurie	PROPN
ajlm-1048	156	2	kl	kl	PROPN
ajlm-1048	156	3	,	,	PUNCT
ajlm-1048	156	4	huston	huston	PROPN
ajlm-1048	156	5	p	p	PROPN
ajlm-1048	156	6	,	,	PUNCT
ajlm-1048	156	7	riley	riley	PROPN
ajlm-1048	156	8	s	s	PROPN
ajlm-1048	156	9	,	,	PUNCT
ajlm-1048	156	10	et	et	PROPN
ajlm-1048	156	11	al	al	PROPN
ajlm-1048	156	12	.	.	PUNCT
ajlm-1048	157	1	influenza	influenza	ADJ
ajlm-1048	157	2	serological	serological	ADJ
ajlm-1048	157	3	studies	study	NOUN
ajlm-1048	157	4	to	to	PART
ajlm-1048	157	5	inform	inform	VERB
ajlm-1048	157	6	public	public	ADJ
ajlm-1048	157	7	health	health	NOUN
ajlm-1048	157	8	action	action	NOUN
ajlm-1048	157	9	:	:	PUNCT
ajlm-1048	157	10	best	good	ADJ
ajlm-1048	157	11	practices	practice	NOUN
ajlm-1048	157	12	to	to	PART
ajlm-1048	157	13	optimise	optimise	VERB
ajlm-1048	157	14	timing	timing	NOUN
ajlm-1048	157	15	,	,	PUNCT
ajlm-1048	157	16	quality	quality	NOUN
ajlm-1048	157	17	and	and	CCONJ
ajlm-1048	157	18	reporting	reporting	NOUN
ajlm-1048	157	19	.	.	PUNCT
ajlm-1048	158	1	influenza	influenza	NOUN
ajlm-1048	158	2	other	other	ADJ
ajlm-1048	158	3	respir	respir	VERB
ajlm-1048	158	4	viruses	virus	NOUN
ajlm-1048	158	5	.	.	PUNCT
ajlm-1048	159	1	2013;7(2):211–224	2013;7(2):211–224	X
ajlm-1048	159	2	.	.	PUNCT
ajlm-1048	159	3	https://doi.org/10.1111/j.1750-2659.2012.0370a.x	https://doi.org/10.1111/j.1750-2659.2012.0370a.x	PROPN
ajlm-1048	159	4	alsuwaidi	alsuwaidi	PROPN
ajlm-1048	159	5	ar	ar	PROPN
ajlm-1048	159	6	,	,	PUNCT
ajlm-1048	159	7	al	al	PROPN
ajlm-1048	159	8	-	-	PUNCT
ajlm-1048	159	9	mekaini	mekaini	PROPN
ajlm-1048	159	10	la	la	PROPN
ajlm-1048	159	11	,	,	PUNCT
ajlm-1048	159	12	kamal	kamal	PROPN
ajlm-1048	159	13	sm	sm	PROPN
ajlm-1048	159	14	,	,	PUNCT
ajlm-1048	159	15	narchi	narchi	PROPN
ajlm-1048	159	16	h	h	PROPN
ajlm-1048	159	17	,	,	PUNCT
ajlm-1048	159	18	souid	souid	ADJ
ajlm-1048	159	19	a	a	PRON
ajlm-1048	159	20	-	-	PUNCT
ajlm-1048	159	21	k.	k.	NOUN
ajlm-1048	159	22	seroprevalence	seroprevalence	NOUN
ajlm-1048	159	23	of	of	ADP
ajlm-1048	159	24	influenza	influenza	NOUN
ajlm-1048	159	25	a	a	PRON
ajlm-1048	159	26	and	and	CCONJ
ajlm-1048	159	27	b	b	NOUN
ajlm-1048	159	28	viruses	virus	NOUN
ajlm-1048	159	29	among	among	ADP
ajlm-1048	159	30	unvaccinated	unvaccinated	ADJ
ajlm-1048	159	31	children	child	NOUN
ajlm-1048	159	32	in	in	ADP
ajlm-1048	159	33	the	the	DET
ajlm-1048	159	34	united	united	PROPN
ajlm-1048	159	35	arab	arab	PROPN
ajlm-1048	159	36	emirates	emirates	PROPN
ajlm-1048	159	37	:	:	PUNCT
ajlm-1048	159	38	a	a	DET
ajlm-1048	159	39	cross	cross	ADJ
ajlm-1048	159	40	-	-	ADJ
ajlm-1048	159	41	sectional	sectional	ADJ
ajlm-1048	159	42	study	study	NOUN
ajlm-1048	159	43	.	.	PUNCT
ajlm-1048	160	1	bmc	bmc	ADJ
ajlm-1048	160	2	res	re	NOUN
ajlm-1048	160	3	notes	note	NOUN
ajlm-1048	160	4	.	.	PUNCT
ajlm-1048	161	1	2017;10(1):379	2017;10(1):379	NUM
ajlm-1048	161	2	.	.	PUNCT
ajlm-1048	162	1	https://doi.org/10.1186/s13104-017-2720-8	https://doi.org/10.1186/s13104-017-2720-8	NUM
ajlm-1048	162	2	anjorin	anjorin	ADV
ajlm-1048	162	3	a	a	PRON
ajlm-1048	162	4	,	,	PUNCT
ajlm-1048	162	5	oyefolu	oyefolu	ADV
ajlm-1048	162	6	a	a	X
ajlm-1048	162	7	,	,	PUNCT
ajlm-1048	162	8	omilabu	omilabu	PROPN
ajlm-1048	162	9	s.	s.	PROPN
ajlm-1048	162	10	seasonal	seasonal	PROPN
ajlm-1048	162	11	influenza	influenza	PROPN
ajlm-1048	162	12	virus	virus	NOUN
ajlm-1048	162	13	infection	infection	NOUN
ajlm-1048	162	14	among	among	ADP
ajlm-1048	162	15	unvaccinated	unvaccinated	ADJ
ajlm-1048	162	16	pregnant	pregnant	ADJ
ajlm-1048	162	17	women	woman	NOUN
ajlm-1048	162	18	in	in	ADP
ajlm-1048	162	19	lagos	lagos	PROPN
ajlm-1048	162	20	,	,	PUNCT
ajlm-1048	162	21	nigeria	nigeria	PROPN
ajlm-1048	162	22	.	.	PUNCT
ajlm-1048	163	1	int	int	PROPN
ajlm-1048	163	2	j	j	PROPN
ajlm-1048	163	3	infect	infect	VERB
ajlm-1048	163	4	dis	dis	PROPN
ajlm-1048	163	5	.	.	PUNCT
ajlm-1048	164	1	2018;73(suppl.):368	2018;73(suppl.):368	PROPN
ajlm-1048	164	2	.	.	PUNCT
ajlm-1048	165	1	https://doi.org/10.1016/j.ijid.2018.04.4248	https://doi.org/10.1016/j.ijid.2018.04.4248	PROPN
ajlm-1048	165	2	sauerbrei	sauerbrei	PROPN
ajlm-1048	165	3	a	a	PRON
ajlm-1048	165	4	,	,	PUNCT
ajlm-1048	165	5	langenhan	langenhan	PROPN
ajlm-1048	165	6	t	t	PROPN
ajlm-1048	165	7	,	,	PUNCT
ajlm-1048	165	8	brandstädt	brandstädt	VERB
ajlm-1048	165	9	a	a	PRON
ajlm-1048	165	10	,	,	PUNCT
ajlm-1048	165	11	et	et	PROPN
ajlm-1048	165	12	al	al	PROPN
ajlm-1048	165	13	.	.	PUNCT
ajlm-1048	166	1	prevalence	prevalence	NOUN
ajlm-1048	166	2	of	of	ADP
ajlm-1048	166	3	antibodies	antibody	NOUN
ajlm-1048	166	4	against	against	ADP
ajlm-1048	166	5	influenza	influenza	NOUN
ajlm-1048	166	6	a	a	PRON
ajlm-1048	166	7	and	and	CCONJ
ajlm-1048	166	8	b	b	NOUN
ajlm-1048	166	9	viruses	virus	NOUN
ajlm-1048	166	10	in	in	ADP
ajlm-1048	166	11	children	child	NOUN
ajlm-1048	166	12	in	in	ADP
ajlm-1048	166	13	germany	germany	PROPN
ajlm-1048	166	14	,	,	PUNCT
ajlm-1048	166	15	2008	2008	NUM
ajlm-1048	166	16	to	to	ADP
ajlm-1048	166	17	2010	2010	NUM
ajlm-1048	166	18	.	.	PUNCT
ajlm-1048	167	1	eurosurveillance	eurosurveillance	NOUN
ajlm-1048	167	2	.	.	PUNCT
ajlm-1048	168	1	2014;19(5):20687	2014;19(5):20687	NOUN
ajlm-1048	168	2	.	.	PUNCT
ajlm-1048	169	1	https://doi.org/10.2807/1560-7917.es2014.19.5.20687	https://doi.org/10.2807/1560-7917.es2014.19.5.20687	NOUN
ajlm-1048	169	2	parmigiani	parmigiani	PROPN
ajlm-1048	169	3	a	a	X
ajlm-1048	169	4	,	,	PUNCT
ajlm-1048	169	5	alcaide	alcaide	ADV
ajlm-1048	169	6	ml	ml	PROPN
ajlm-1048	169	7	,	,	PUNCT
ajlm-1048	169	8	freguja	freguja	PROPN
ajlm-1048	169	9	r	r	PROPN
ajlm-1048	169	10	,	,	PUNCT
ajlm-1048	169	11	et	et	PROPN
ajlm-1048	169	12	al	al	PROPN
ajlm-1048	169	13	.	.	PUNCT
ajlm-1048	169	14	impaired	impair	VERB
ajlm-1048	169	15	antibody	antibody	NOUN
ajlm-1048	169	16	response	response	NOUN
ajlm-1048	169	17	to	to	ADP
ajlm-1048	169	18	influenza	influenza	ADJ
ajlm-1048	169	19	vaccine	vaccine	NOUN
ajlm-1048	169	20	in	in	ADP
ajlm-1048	169	21	hiv	hiv	PROPN
ajlm-1048	169	22	-	-	PUNCT
ajlm-1048	169	23	infected	infect	VERB
ajlm-1048	169	24	and	and	CCONJ
ajlm-1048	169	25	uninfected	uninfected	ADJ
ajlm-1048	169	26	aging	age	VERB
ajlm-1048	169	27	women	woman	NOUN
ajlm-1048	169	28	is	be	AUX
ajlm-1048	169	29	associated	associate	VERB
ajlm-1048	169	30	with	with	ADP
ajlm-1048	169	31	immune	immune	ADJ
ajlm-1048	169	32	activation	activation	NOUN
ajlm-1048	169	33	and	and	CCONJ
ajlm-1048	169	34	inflammation	inflammation	NOUN
ajlm-1048	169	35	.	.	PUNCT
ajlm-1048	170	1	plos	plos	PROPN
ajlm-1048	170	2	one	one	NUM
ajlm-1048	170	3	.	.	PUNCT
ajlm-1048	171	1	2013;8(11):e79816	2013;8(11):e79816	NUM
ajlm-1048	171	2	.	.	PUNCT
ajlm-1048	172	1	https://doi.org/10.1371/journal.pone.0079816	https://doi.org/10.1371/journal.pone.0079816	PROPN
ajlm-1048	172	2	hung	hang	VERB
ajlm-1048	172	3	c	c	NOUN
ajlm-1048	172	4	-	-	SYM
ajlm-1048	172	5	c	c	NOUN
ajlm-1048	172	6	,	,	PUNCT
ajlm-1048	172	7	zhao	zhao	PROPN
ajlm-1048	172	8	t	t	PROPN
ajlm-1048	172	9	-	-	PUNCT
ajlm-1048	172	10	l	l	NOUN
ajlm-1048	172	11	,	,	PUNCT
ajlm-1048	172	12	sun	sun	PROPN
ajlm-1048	172	13	h	h	PROPN
ajlm-1048	172	14	-	-	PUNCT
ajlm-1048	172	15	y	y	PROPN
ajlm-1048	172	16	,	,	PUNCT
ajlm-1048	173	1	et	et	PROPN
ajlm-1048	173	2	al	al	PROPN
ajlm-1048	173	3	.	.	PUNCT
ajlm-1048	173	4	seroepidemiology	seroepidemiology	NOUN
ajlm-1048	173	5	of	of	ADP
ajlm-1048	173	6	novel	novel	ADJ
ajlm-1048	173	7	influenza	influenza	NOUN
ajlm-1048	173	8	a	a	DET
ajlm-1048	173	9	(	(	PUNCT
ajlm-1048	173	10	h1n1	h1n1	NOUN
ajlm-1048	173	11	)	)	PUNCT
ajlm-1048	173	12	infection	infection	NOUN
ajlm-1048	173	13	among	among	ADP
ajlm-1048	173	14	hiv	hiv	PROPN
ajlm-1048	173	15	-	-	PUNCT
ajlm-1048	173	16	infected	infect	VERB
ajlm-1048	173	17	patients	patient	NOUN
ajlm-1048	173	18	in	in	ADP
ajlm-1048	173	19	the	the	DET
ajlm-1048	173	20	era	era	NOUN
ajlm-1048	173	21	of	of	ADP
ajlm-1048	173	22	highly	highly	ADV
ajlm-1048	173	23	active	active	ADJ
ajlm-1048	173	24	antiretroviral	antiretroviral	ADJ
ajlm-1048	173	25	therapy	therapy	NOUN
ajlm-1048	173	26	.	.	PUNCT
ajlm-1048	174	1	j	j	PROPN
ajlm-1048	174	2	microbiol	microbiol	PROPN
ajlm-1048	174	3	immunol	immunol	PROPN
ajlm-1048	174	4	infect	infect	NOUN
ajlm-1048	174	5	.	.	PUNCT
ajlm-1048	175	1	2013;46(3):151–157	2013;46(3):151–157	X
ajlm-1048	175	2	.	.	X
ajlm-1048	175	3	https://doi.org/10.1016/j.jmii.2012.03.002	https://doi.org/10.1016/j.jmii.2012.03.002	NUM
ajlm-1048	176	1	agrati	agrati	NOUN
ajlm-1048	176	2	c	c	NOUN
ajlm-1048	176	3	,	,	PUNCT
ajlm-1048	176	4	gioia	gioia	PROPN
ajlm-1048	176	5	c	c	PROPN
ajlm-1048	176	6	,	,	PUNCT
ajlm-1048	176	7	castilletti	castilletti	NOUN
ajlm-1048	176	8	c	c	PROPN
ajlm-1048	176	9	,	,	PUNCT
ajlm-1048	176	10	et	et	PROPN
ajlm-1048	176	11	al	al	PROPN
ajlm-1048	176	12	.	.	PUNCT
ajlm-1048	177	1	cellular	cellular	ADJ
ajlm-1048	177	2	and	and	CCONJ
ajlm-1048	177	3	humoral	humoral	ADJ
ajlm-1048	177	4	immune	immune	ADJ
ajlm-1048	177	5	responses	response	NOUN
ajlm-1048	177	6	to	to	ADP
ajlm-1048	177	7	pandemic	pandemic	ADJ
ajlm-1048	177	8	influenza	influenza	NOUN
ajlm-1048	177	9	vaccine	vaccine	NOUN
ajlm-1048	177	10	in	in	ADP
ajlm-1048	177	11	healthy	healthy	ADJ
ajlm-1048	177	12	and	and	CCONJ
ajlm-1048	177	13	in	in	ADP
ajlm-1048	177	14	highly	highly	ADV
ajlm-1048	177	15	active	active	ADJ
ajlm-1048	177	16	antiretroviral	antiretroviral	ADJ
ajlm-1048	177	17	therapy	therapy	NOUN
ajlm-1048	177	18	-	-	PUNCT
ajlm-1048	177	19	treated	treat	VERB
ajlm-1048	177	20	hiv	hiv	PROPN
ajlm-1048	177	21	patients	patient	NOUN
ajlm-1048	177	22	.	.	PUNCT
ajlm-1048	178	1	aids	aids	PROPN
ajlm-1048	178	2	res	re	NOUN
ajlm-1048	178	3	hum	hum	ADJ
ajlm-1048	178	4	retrovir	retrovir	PROPN
ajlm-1048	178	5	.	.	PUNCT
ajlm-1048	179	1	2012;28(12):1606–1616	2012;28(12):1606–1616	X
ajlm-1048	179	2	.	.	PUNCT
ajlm-1048	180	1	https://doi.org/10.1089/aid.2011.0371	https://doi.org/10.1089/aid.2011.0371	PROPN
ajlm-1048	180	2	ho	ho	PROPN
ajlm-1048	180	3	a	a	PROPN
ajlm-1048	180	4	,	,	PUNCT
ajlm-1048	180	5	aston	aston	PROPN
ajlm-1048	180	6	sj	sj	PROPN
ajlm-1048	180	7	,	,	PUNCT
ajlm-1048	180	8	jary	jary	PROPN
ajlm-1048	180	9	h	h	PROPN
ajlm-1048	180	10	,	,	PUNCT
ajlm-1048	180	11	et	et	PROPN
ajlm-1048	180	12	al	al	PROPN
ajlm-1048	180	13	.	.	PROPN
ajlm-1048	180	14	impact	impact	NOUN
ajlm-1048	180	15	of	of	ADP
ajlm-1048	180	16	human	human	ADJ
ajlm-1048	180	17	immunodeficiency	immunodeficiency	NOUN
ajlm-1048	180	18	virus	virus	NOUN
ajlm-1048	180	19	on	on	ADP
ajlm-1048	180	20	the	the	DET
ajlm-1048	180	21	burden	burden	NOUN
ajlm-1048	180	22	and	and	CCONJ
ajlm-1048	180	23	severity	severity	NOUN
ajlm-1048	180	24	of	of	ADP
ajlm-1048	180	25	influenza	influenza	ADJ
ajlm-1048	180	26	illness	illness	NOUN
ajlm-1048	180	27	in	in	ADP
ajlm-1048	180	28	malawian	malawian	ADJ
ajlm-1048	180	29	adults	adult	NOUN
ajlm-1048	180	30	:	:	PUNCT
ajlm-1048	180	31	a	a	DET
ajlm-1048	180	32	prospective	prospective	ADJ
ajlm-1048	180	33	cohort	cohort	NOUN
ajlm-1048	180	34	and	and	CCONJ
ajlm-1048	180	35	parallel	parallel	ADJ
ajlm-1048	180	36	case	case	NOUN
ajlm-1048	180	37	-	-	PUNCT
ajlm-1048	180	38	control	control	NOUN
ajlm-1048	180	39	study	study	NOUN
ajlm-1048	180	40	.	.	PUNCT
ajlm-1048	181	1	clin	clin	PROPN
ajlm-1048	181	2	infect	infect	PROPN
ajlm-1048	181	3	dis	dis	PROPN
ajlm-1048	181	4	.	.	PUNCT
ajlm-1048	182	1	2017;66(6):865–876	2017;66(6):865–876	X
ajlm-1048	182	2	.	.	PUNCT
ajlm-1048	183	1	https://doi.org/10.1093/cid/cix903	https://doi.org/10.1093/cid/cix903	PROPN
ajlm-1048	183	2	ope	ope	PROPN
ajlm-1048	183	3	mo	mo	PROPN
ajlm-1048	183	4	,	,	PUNCT
ajlm-1048	183	5	katz	katz	PROPN
ajlm-1048	183	6	ma	ma	PROPN
ajlm-1048	183	7	,	,	PUNCT
ajlm-1048	183	8	aura	aura	NOUN
ajlm-1048	183	9	b	b	NOUN
ajlm-1048	183	10	,	,	PUNCT
ajlm-1048	183	11	et	et	PROPN
ajlm-1048	183	12	al	al	PROPN
ajlm-1048	183	13	.	.	PUNCT
ajlm-1048	184	1	risk	risk	NOUN
ajlm-1048	184	2	factors	factor	NOUN
ajlm-1048	184	3	for	for	ADP
ajlm-1048	184	4	hospitalized	hospitalize	VERB
ajlm-1048	184	5	seasonal	seasonal	ADJ
ajlm-1048	184	6	influenza	influenza	NOUN
ajlm-1048	184	7	in	in	ADP
ajlm-1048	184	8	rural	rural	ADJ
ajlm-1048	184	9	western	western	ADJ
ajlm-1048	184	10	kenya	kenya	PROPN
ajlm-1048	184	11	.	.	PUNCT
ajlm-1048	185	1	plos	plos	PROPN
ajlm-1048	185	2	one	one	NUM
ajlm-1048	185	3	.	.	PUNCT
ajlm-1048	186	1	2011;6(5):e20111	2011;6(5):e20111	ADJ
ajlm-1048	186	2	.	.	PUNCT
ajlm-1048	186	3	https://doi.org/10.1371/journal.pone.0020111	https://doi.org/10.1371/journal.pone.0020111	ADJ
ajlm-1048	186	4	domínguez	domínguez	NOUN
ajlm-1048	186	5	-	-	PUNCT
ajlm-1048	186	6	cherit	cherit	NOUN
ajlm-1048	186	7	g	g	NOUN
ajlm-1048	186	8	,	,	PUNCT
ajlm-1048	186	9	lapinsky	lapinsky	ADJ
ajlm-1048	186	10	se	se	PROPN
ajlm-1048	186	11	,	,	PUNCT
ajlm-1048	186	12	macias	macias	PROPN
ajlm-1048	186	13	ae	ae	PROPN
ajlm-1048	186	14	,	,	PUNCT
ajlm-1048	186	15	et	et	PROPN
ajlm-1048	186	16	al	al	PROPN
ajlm-1048	186	17	.	.	PROPN
ajlm-1048	187	1	critically	critically	ADV
ajlm-1048	187	2	ill	ill	ADJ
ajlm-1048	187	3	patients	patient	NOUN
ajlm-1048	187	4	with	with	ADP
ajlm-1048	187	5	2009	2009	NUM
ajlm-1048	187	6	influenza	influenza	NOUN
ajlm-1048	187	7	a	a	DET
ajlm-1048	187	8	(	(	PUNCT
ajlm-1048	187	9	h1n1	h1n1	NOUN
ajlm-1048	187	10	)	)	PUNCT
ajlm-1048	187	11	in	in	ADP
ajlm-1048	187	12	mexico	mexico	PROPN
ajlm-1048	187	13	.	.	PUNCT
ajlm-1048	188	1	jama	jama	PROPN
ajlm-1048	188	2	.	.	PUNCT
ajlm-1048	189	1	2009;302(17):1880–1887	2009;302(17):1880–1887	NUM
ajlm-1048	189	2	.	.	PUNCT
ajlm-1048	190	1	https://doi.org/10.1001/jama.2009.1536	https://doi.org/10.1001/jama.2009.1536	PROPN
ajlm-1048	190	2	perez	perez	PROPN
ajlm-1048	190	3	-	-	PUNCT
ajlm-1048	190	4	padilla	padilla	PROPN
ajlm-1048	190	5	r	r	PROPN
ajlm-1048	190	6	,	,	PUNCT
ajlm-1048	190	7	de	de	X
ajlm-1048	190	8	la	la	PROPN
ajlm-1048	190	9	rosa	rosa	PROPN
ajlm-1048	190	10	-	-	PUNCT
ajlm-1048	190	11	zamboni	zamboni	PROPN
ajlm-1048	190	12	d	d	PROPN
ajlm-1048	190	13	,	,	PUNCT
ajlm-1048	190	14	ponce	ponce	PROPN
ajlm-1048	190	15	de	de	PROPN
ajlm-1048	190	16	leon	leon	PROPN
ajlm-1048	190	17	s	s	PROPN
ajlm-1048	190	18	,	,	PUNCT
ajlm-1048	190	19	et	et	PROPN
ajlm-1048	190	20	al	al	PROPN
ajlm-1048	190	21	.	.	PUNCT
ajlm-1048	190	22	pneumonia	pneumonia	NOUN
ajlm-1048	190	23	and	and	CCONJ
ajlm-1048	190	24	respiratory	respiratory	ADJ
ajlm-1048	190	25	failure	failure	NOUN
ajlm-1048	190	26	from	from	ADP
ajlm-1048	190	27	swine	swine	ADJ
ajlm-1048	190	28	-	-	PUNCT
ajlm-1048	190	29	origin	origin	NOUN
ajlm-1048	190	30	influenza	influenza	NOUN
ajlm-1048	190	31	a	a	DET
ajlm-1048	190	32	(	(	PUNCT
ajlm-1048	190	33	h1n1	h1n1	NOUN
ajlm-1048	190	34	)	)	PUNCT
ajlm-1048	190	35	in	in	ADP
ajlm-1048	190	36	mexico	mexico	PROPN
ajlm-1048	190	37	.	.	PUNCT
ajlm-1048	191	1	n	n	PROPN
ajlm-1048	191	2	engl	engl	PROPN
ajlm-1048	191	3	j	j	PROPN
ajlm-1048	191	4	med	med	PROPN
ajlm-1048	191	5	.	.	PUNCT
ajlm-1048	192	1	2009;361(7):680–689	2009;361(7):680–689	NUM
ajlm-1048	192	2	.	.	PUNCT
ajlm-1048	192	3	https://doi.org/10.1056/nejmoa0904252	https://doi.org/10.1056/nejmoa0904252	PROPN
ajlm-1048	192	4	cdc	cdc	PROPN
ajlm-1048	192	5	.	.	PUNCT
ajlm-1048	192	6	influenza	influenza	PROPN
ajlm-1048	192	7	:	:	PUNCT
ajlm-1048	192	8	people	people	NOUN
ajlm-1048	192	9	65	65	NUM
ajlm-1048	192	10	years	year	NOUN
ajlm-1048	192	11	and	and	CCONJ
ajlm-1048	192	12	older	old	ADJ
ajlm-1048	192	13	&	&	CCONJ
ajlm-1048	192	14	influenza	influenza	NOUN
ajlm-1048	193	1	[	[	X
ajlm-1048	193	2	homepage	homepage	NOUN
ajlm-1048	193	3	on	on	ADP
ajlm-1048	193	4	the	the	DET
ajlm-1048	193	5	internet	internet	NOUN
ajlm-1048	193	6	]	]	PUNCT
ajlm-1048	193	7	.	.	PUNCT
ajlm-1048	194	1	atlanta	atlanta	PROPN
ajlm-1048	194	2	,	,	PUNCT
ajlm-1048	194	3	ga	ga	PROPN
ajlm-1048	194	4	:	:	PUNCT
ajlm-1048	194	5	centers	center	NOUN
ajlm-1048	194	6	for	for	ADP
ajlm-1048	194	7	disease	disease	NOUN
ajlm-1048	194	8	control	control	NOUN
ajlm-1048	194	9	and	and	CCONJ
ajlm-1048	194	10	prevention	prevention	NOUN
ajlm-1048	194	11	,	,	PUNCT
ajlm-1048	194	12	national	national	ADJ
ajlm-1048	194	13	center	center	NOUN
ajlm-1048	194	14	for	for	ADP
ajlm-1048	194	15	immunization	immunization	NOUN
ajlm-1048	194	16	and	and	CCONJ
ajlm-1048	194	17	respiratory	respiratory	ADJ
ajlm-1048	194	18	diseases	disease	NOUN
ajlm-1048	194	19	(	(	PUNCT
ajlm-1048	194	20	ncird	ncird	ADV
ajlm-1048	194	21	)	)	PUNCT
ajlm-1048	194	22	;	;	PUNCT
ajlm-1048	194	23	2018	2018	NUM
ajlm-1048	195	1	[	[	PUNCT
ajlm-1048	195	2	cited	cite	VERB
ajlm-1048	195	3	2019	2019	NUM
ajlm-1048	195	4	feb	feb	NOUN
ajlm-1048	195	5	07	07	NUM
ajlm-1048	195	6	]	]	PUNCT
ajlm-1048	195	7	.	.	PUNCT
ajlm-1048	196	1	available	available	ADJ
ajlm-1048	196	2	from	from	ADP
ajlm-1048	196	3	:	:	PUNCT
ajlm-1048	196	4	https://www.cdc.gov/flu/about/disease/65over.htm	https://www.cdc.gov/flu/about/disease/65over.htm	PROPN
ajlm-1048	196	5	lambert	lambert	PROPN
ajlm-1048	196	6	nd	nd	PROPN
ajlm-1048	196	7	,	,	PUNCT
ajlm-1048	196	8	ovsyannikova	ovsyannikova	PROPN
ajlm-1048	196	9	ig	ig	PROPN
ajlm-1048	196	10	,	,	PUNCT
ajlm-1048	196	11	pankratz	pankratz	NOUN
ajlm-1048	196	12	vs	vs	ADP
ajlm-1048	196	13	,	,	PUNCT
ajlm-1048	196	14	jacobson	jacobson	PROPN
ajlm-1048	196	15	rm	rm	PROPN
ajlm-1048	196	16	,	,	PUNCT
ajlm-1048	196	17	poland	poland	PROPN
ajlm-1048	196	18	ga	ga	PROPN
ajlm-1048	196	19	.	.	PUNCT
ajlm-1048	197	1	understanding	understand	VERB
ajlm-1048	197	2	the	the	DET
ajlm-1048	197	3	immune	immune	ADJ
ajlm-1048	197	4	response	response	NOUN
ajlm-1048	197	5	to	to	ADP
ajlm-1048	197	6	seasonal	seasonal	ADJ
ajlm-1048	197	7	influenza	influenza	NOUN
ajlm-1048	197	8	vaccination	vaccination	NOUN
ajlm-1048	197	9	in	in	ADP
ajlm-1048	197	10	older	old	ADJ
ajlm-1048	197	11	adults	adult	NOUN
ajlm-1048	197	12	:	:	PUNCT
ajlm-1048	197	13	a	a	DET
ajlm-1048	197	14	systems	system	NOUN
ajlm-1048	197	15	biology	biology	NOUN
ajlm-1048	197	16	approach	approach	NOUN
ajlm-1048	197	17	.	.	PUNCT
ajlm-1048	198	1	exp	exp	NOUN
ajlm-1048	198	2	rev	rev	PROPN
ajlm-1048	198	3	vaccin	vaccin	PROPN
ajlm-1048	198	4	.	.	PUNCT
ajlm-1048	199	1	2012;11(8):985–994	2012;11(8):985–994	NUM
ajlm-1048	199	2	.	.	PUNCT
ajlm-1048	199	3	https://doi.org/10.1586/erv.12.61	https://doi.org/10.1586/erv.12.61	PROPN
ajlm-1048	199	4	ho	ho	PROPN
ajlm-1048	199	5	a	a	PROPN
ajlm-1048	199	6	,	,	PUNCT
ajlm-1048	199	7	mallewa	mallewa	PROPN
ajlm-1048	199	8	j	j	PROPN
ajlm-1048	199	9	,	,	PUNCT
ajlm-1048	199	10	peterson	peterson	PROPN
ajlm-1048	199	11	i	i	PROPN
ajlm-1048	199	12	,	,	PUNCT
ajlm-1048	199	13	et	et	PROPN
ajlm-1048	199	14	al	al	PROPN
ajlm-1048	199	15	.	.	PUNCT
ajlm-1048	200	1	epidemiology	epidemiology	NOUN
ajlm-1048	200	2	of	of	ADP
ajlm-1048	200	3	severe	severe	ADJ
ajlm-1048	200	4	acute	acute	ADJ
ajlm-1048	200	5	respiratory	respiratory	ADJ
ajlm-1048	200	6	illness	illness	NOUN
ajlm-1048	200	7	and	and	CCONJ
ajlm-1048	200	8	risk	risk	NOUN
ajlm-1048	200	9	factors	factor	NOUN
ajlm-1048	200	10	for	for	ADP
ajlm-1048	200	11	influenza	influenza	ADJ
ajlm-1048	200	12	infection	infection	NOUN
ajlm-1048	200	13	and	and	CCONJ
ajlm-1048	200	14	clinical	clinical	ADJ
ajlm-1048	200	15	severity	severity	NOUN
ajlm-1048	200	16	among	among	ADP
ajlm-1048	200	17	adults	adult	NOUN
ajlm-1048	200	18	in	in	ADP
ajlm-1048	200	19	malawi	malawi	PROPN
ajlm-1048	200	20	,	,	PUNCT
ajlm-1048	200	21	2011–2013	2011–2013	NUM
ajlm-1048	200	22	.	.	PUNCT
ajlm-1048	201	1	am	be	AUX
ajlm-1048	201	2	j	j	PROPN
ajlm-1048	201	3	trop	trop	X
ajlm-1048	201	4	med	med	PROPN
ajlm-1048	201	5	hyg	hyg	PROPN
ajlm-1048	201	6	.	.	PUNCT
ajlm-1048	202	1	2018;99(3):772–779	2018;99(3):772–779	NUM
ajlm-1048	202	2	.	.	PUNCT
ajlm-1048	203	1	https://doi.org/10.4269/ajtmh.17-0905	https://doi.org/10.4269/ajtmh.17-0905	PROPN
ajlm-1048	203	2	sant	sant	PROPN
ajlm-1048	203	3	aj	aj	PROPN
ajlm-1048	203	4	,	,	PUNCT
ajlm-1048	203	5	mcmichael	mcmichael	PROPN
ajlm-1048	203	6	a.	a.	NOUN
ajlm-1048	203	7	revealing	reveal	VERB
ajlm-1048	203	8	the	the	DET
ajlm-1048	203	9	role	role	NOUN
ajlm-1048	203	10	of	of	ADP
ajlm-1048	203	11	cd4(+	cd4(+	NOUN
ajlm-1048	203	12	)	)	PUNCT
ajlm-1048	203	13	t	t	NOUN
ajlm-1048	203	14	cells	cell	NOUN
ajlm-1048	203	15	in	in	ADP
ajlm-1048	203	16	viral	viral	ADJ
ajlm-1048	203	17	immunity	immunity	NOUN
ajlm-1048	203	18	.	.	PUNCT
ajlm-1048	204	1	j	j	PROPN
ajlm-1048	204	2	exp	exp	NOUN
ajlm-1048	204	3	med	med	PROPN
ajlm-1048	204	4	.	.	PUNCT
ajlm-1048	205	1	2012;209(8):1391–1395	2012;209(8):1391–1395	X
ajlm-1048	205	2	.	.	PUNCT
ajlm-1048	206	1	https://doi.org/10.1084/jem.20121517	https://doi.org/10.1084/jem.20121517	PROPN
ajlm-1048	206	2	tempia	tempia	PROPN
ajlm-1048	206	3	s	s	PROPN
ajlm-1048	206	4	,	,	PUNCT
ajlm-1048	206	5	walaza	walaza	PROPN
ajlm-1048	206	6	s	s	PROPN
ajlm-1048	206	7	,	,	PUNCT
ajlm-1048	206	8	moyes	moyes	PROPN
ajlm-1048	206	9	j	j	PROPN
ajlm-1048	206	10	,	,	PUNCT
ajlm-1048	206	11	et	et	PROPN
ajlm-1048	206	12	al	al	PROPN
ajlm-1048	206	13	.	.	PROPN
ajlm-1048	207	1	attributable	attributable	ADJ
ajlm-1048	207	2	fraction	fraction	NOUN
ajlm-1048	207	3	of	of	ADP
ajlm-1048	207	4	influenza	influenza	NOUN
ajlm-1048	207	5	virus	virus	NOUN
ajlm-1048	207	6	detection	detection	NOUN
ajlm-1048	207	7	to	to	ADP
ajlm-1048	207	8	mild	mild	ADJ
ajlm-1048	207	9	and	and	CCONJ
ajlm-1048	207	10	severe	severe	ADJ
ajlm-1048	207	11	respiratory	respiratory	ADJ
ajlm-1048	207	12	illnesses	illness	NOUN
ajlm-1048	207	13	in	in	ADP
ajlm-1048	207	14	hiv	hiv	PROPN
ajlm-1048	207	15	-	-	PUNCT
ajlm-1048	207	16	infected	infect	VERB
ajlm-1048	207	17	and	and	CCONJ
ajlm-1048	207	18	hiv	hiv	NOUN
ajlm-1048	207	19	-	-	PUNCT
ajlm-1048	207	20	uninfected	uninfected	ADJ
ajlm-1048	207	21	patients	patient	NOUN
ajlm-1048	207	22	,	,	PUNCT
ajlm-1048	207	23	south	south	PROPN
ajlm-1048	207	24	africa	africa	PROPN
ajlm-1048	207	25	,	,	PUNCT
ajlm-1048	207	26	2012–2016	2012–2016	NUM
ajlm-1048	207	27	.	.	PUNCT
ajlm-1048	208	1	emerg	emerg	PROPN
ajlm-1048	208	2	infect	infect	PROPN
ajlm-1048	208	3	dis	dis	PROPN
ajlm-1048	208	4	.	.	PUNCT
ajlm-1048	209	1	2017;23(7):1124	2017;23(7):1124	NUM
ajlm-1048	209	2	.	.	PUNCT
ajlm-1048	210	1	https://doi.org/10.3201/eid2307.161959	https://doi.org/10.3201/eid2307.161959	VERB
ajlm-1048	210	2	crotty	crotty	PROPN
ajlm-1048	210	3	s.	s.	PROPN
ajlm-1048	210	4	follicular	follicular	PROPN
ajlm-1048	210	5	helper	helper	NOUN
ajlm-1048	210	6	cd4	cd4	PROPN
ajlm-1048	210	7	t	t	PROPN
ajlm-1048	210	8	cells	cell	NOUN
ajlm-1048	210	9	(	(	PUNCT
ajlm-1048	210	10	tfh	tfh	NOUN
ajlm-1048	210	11	)	)	PUNCT
ajlm-1048	210	12	.	.	PUNCT
ajlm-1048	211	1	ann	ann	PROPN
ajlm-1048	211	2	rev	rev	PROPN
ajlm-1048	211	3	immunol	immunol	NOUN
ajlm-1048	211	4	.	.	PUNCT
ajlm-1048	212	1	2011;29:621–663	2011;29:621–663	X
ajlm-1048	212	2	.	.	PUNCT
ajlm-1048	213	1	https://doi.org/10.1146/annurev-immunol-031210-101400	https://doi.org/10.1146/annurev-immunol-031210-101400	PROPN
ajlm-1048	213	2	jambo	jambo	PROPN
ajlm-1048	213	3	kc	kc	PROPN
ajlm-1048	213	4	,	,	PUNCT
ajlm-1048	213	5	sepako	sepako	PROPN
ajlm-1048	213	6	e	e	PROPN
ajlm-1048	213	7	,	,	PUNCT
ajlm-1048	213	8	glennie	glennie	NOUN
ajlm-1048	213	9	sj	sj	NOUN
ajlm-1048	213	10	,	,	PUNCT
ajlm-1048	213	11	et	et	PROPN
ajlm-1048	213	12	al	al	PROPN
ajlm-1048	213	13	.	.	PROPN
ajlm-1048	213	14	naturally	naturally	ADV
ajlm-1048	213	15	-	-	PUNCT
ajlm-1048	213	16	acquired	acquire	VERB
ajlm-1048	213	17	influenza	influenza	NOUN
ajlm-1048	213	18	-	-	PUNCT
ajlm-1048	213	19	specific	specific	ADJ
ajlm-1048	213	20	cd4	cd4	PROPN
ajlm-1048	213	21	+	+	PROPN
ajlm-1048	213	22	t	t	PROPN
ajlm-1048	213	23	-	-	PUNCT
ajlm-1048	213	24	cell	cell	NOUN
ajlm-1048	213	25	proliferative	proliferative	ADJ
ajlm-1048	213	26	responses	response	NOUN
ajlm-1048	213	27	are	be	AUX
ajlm-1048	213	28	impaired	impair	VERB
ajlm-1048	213	29	in	in	ADP
ajlm-1048	213	30	hiv	hiv	PROPN
ajlm-1048	213	31	-	-	PUNCT
ajlm-1048	213	32	infected	infect	VERB
ajlm-1048	213	33	african	african	ADJ
ajlm-1048	213	34	adults	adult	NOUN
ajlm-1048	213	35	.	.	PUNCT
ajlm-1048	214	1	plos	plos	PROPN
ajlm-1048	214	2	one	one	NUM
ajlm-1048	214	3	.	.	PUNCT
ajlm-1048	215	1	2012;7(6):e38628	2012;7(6):e38628	PROPN
ajlm-1048	215	2	.	.	PUNCT
ajlm-1048	216	1	https://doi.org/10.1371/journal.pone.0038628	https://doi.org/10.1371/journal.pone.0038628	PROPN